{"title": "PDF", "author": "PDF", "url": "https://www.donau-uni.ac.at/dam/jcr:8eb69ad2-9890-4574-b122-18056797e45b/Intellectual%20Output%202%20-%20Digitale%20Kommunikationsr%C3%A4ume.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": " \n \nIntellectual Output \u2013  IO 2 \nDigitale Kommunikationsr \u00e4ume  \n \n \n \n \n \nHEALTHY HERBS  \n \nPhytotherapie als Strategie gegen antimikrobielle \nResistenzen  \n \n \n \n \n \n \n \n \n \n \n \n \n \nINTELLEC TUAL OUTPUT 2 \u2013 Digitale K ommunikationsr\u00e4ume  \n \n \n \n \n \n \n \n \n \n \nE-Learning Plattform  \n \nDigitale Kommunikationsr\u00e4ume  \n \nVortragsmaterialien zu den Lehr - und Lernkursen  \nBeispielvorschlag f\u00fcr einen Kurs  \n- Als Gesamtkurs  \n- Als modularer Baustein  \n \n \n \n \n \n \n \n \n \n \n \nKURS HEALTHY HERBS  \n \n \nBeispiel - Empfehlung zur Einbettung als Gesamtkurs in  der \nAus- und Weiterbildung im Hochschulsektor  \n \n \n \n \n \n \n \n \n \n \nBasismodul 1 Traditionelle Phytotherapie  \nModulinhalt  \n\u2022 Phytotherapie - aktuelle Rechtslage in der Europ \u00e4ischen Union  \n\u2022 Globale Relevanz von Infektionen in der Medizin und Herausforderungen in Bezug auf \nAntibiotikaresistenzen  \n\u2022 Traditionelle Anwendung in der Phytotherapie  - Europ \u00e4ische Phytotherapie in der \nKloster medizin  \nLernziele: Kenntnisse der Relevanz von Antimikrobiellen Resistenzen, Surveillance -  Tools; Zugriff auf \ndie Europ \u00e4ischen Monografien  und Assessmentsysteme; Kenntnis der wichtigsten Kernbegriffe von \nResistenzen  \nLernunterlagen -Lecture Notes -  Part I ; Geschichte der Europ \u00e4ischen Phytotherapie (S. 3 ff. ); Lecture \nNotes, Part II Resistenzen ( S 23 ff.) Lecrure Notes, Part III Europ \u00e4ische  Monographien und \nAssessmentreports (S. 82 ff.).  \n\u2022 LINK: Europ \u00e4ische Heilpflanzenmonographien  \n\u2022 LINK: Assessmentreports der Europ \u00e4ischen Arzneimittelagentur   \nKursvorb ereitung: VIDEO Animation of Antimicrobial Resistance  \nVortragsfolien  \n: \nKlostermedizin.pdf\n \nSelbst studienphase und Eigen \u00fcberpr \u00fcfung > Eigen \u00fcberpr \u00fcfungsfragen  \n \n \n \n \n \n \n \n \n \n  \n \nBasismodul 2-  Atemwegserkrankungen und Resistenzen \nModulinhalt  \n\u2022 Atemwegsinfekte  \nPublic Health Aspekte, Gesundheitskompetenz > Gesundheitsapps  \nLernziele: \u00dcberblick \u00fcber die wichtigsten Erkrankungen im Bereich der Atemwege; Gesundheitsapps \nevaluieren   \nLernunterlagen: Lekture Notes, Part I - Atemwegserkrankungen (S 7 ff.)  \n\u2022 LINK: I CD - 10, Codes > Erkrankungen der Atemwege  \n\u2022 Kursvorbereitung: The Loss of Health Literacy  \n\u2022 Vortragsfolien  \n \n\u2022 \nHEALTHY \nGOOGLE.pdf\nHealth literacy and \nthe public health pers\nHealth_Literacy.pdf\n \n\u2022 \nCASE 1.pdf\n Case 2.pdf\n Phytotherapy in \nclinical management.p \n\u2022  \nModulvorbereitung und Wissens \u00fcberpr \u00fcfung > Eigen \u00fcberpr \u00fcfungsfragen  \n \n \n  \n \n \n \n \n \n \n \n \n \nBasismodul 3 - Heilpflanzenanwendungen bei Atemwegsinfekten  \nModulinhalt  \n\u2022 Heilpflanzenportr\u00e4 ts  \nLernziele  \nnach Absolvierung des Moduls k \u00f6nnen Studierende  \n1. Aktuelle Monographien und Assessmentreports der European Medicines Agency finden, \nlesen und interpret ieren  \n2. Basiswissen zu relevanten Heilpflanzen zur Anwendung bei Infektionen der Atemwege \nkennen  \n3. Eine korrekte Auswahl von Heilpflanzen zu bestimmten Indikationen treffen und sicher anwenden k \u00f6nnen  \nLernunterlagen  \n\u2022 LINK: Europ \u00e4ische  Monographien \n \n\u2022 LINK: \u00dcbung zu Mo nograph  \n \n\u2022 LINK: Assessmentreport Heilpflanzen  \n\u2022 LINK: Flashcards  \n\u2022 Vortragsfolien:  \n\u2022 \nEMA Mongraphs \n1.pdf\nWorkshop  Wie man \nEMA Dokumente gezie   \nHow to find HMPC \nMonographs easily.pd\nEMA_Monographs \n2.pdf \nFlashcards.pdf\n Remeides.pdf\n \nModulvorbereitung und Wissens \u00fcberpr \u00fcfung > Pr \u00fcfungsfragen Pflanzen  \n \n \n \n \nBasismodul 4 - Wissenschaftliches Arbeiten  \nModulinhalt  \n\u2022 Wissenschaftliches Arbeiten -  Basics  \n\u2022 Literaturrecherche und Literaturbewertung  \n\u2022 Forschungsdesigns  \nLernziele: Grundlagen der Recherche und Bewertung Wissenschaftlicher Arbeiten, Literatursuche \nund Arbeiten mit PubMed  \nLernunterlagen :  \n\u2022 LINK: Care Guidelines  \n\u2022 LINK: Studiendesigns  \nModulvorbereitung und Wissens \u00fcberpr \u00fcfung > Eigen \u00fcberpr \u00fcfung  \nVortragsfolien:  \nCS - Search for \nLITERATURE.pdf\nCurrent Studies and \nCases I.pdf\nCurrent Studies and \nCases II.pdf \n \n \n \n \n \n \n \n \n \n \n  \n \n  \n \nBasismodul 5  \u2013 Galenik und Qualit \u00e4t \nModulinhalt  \n\u2022 Rezeptierkunde und galenische Zubereitungsmethoden  \n\u2022 Moderne Technologien  \n\u2022 Qualit \u00e4tspr\u00fcfung von Heilpflanzen  \nLernziele: Kennen und Beschreiben  der wichtigsten Galeniken f \u00fcr Heilpflanzen im Bereich der \nAtemwege   \nKursvorbereitung: VIDEO  -  Lab Experience  und Tinctures  \nKursunterlagen: Lecture Notes, Part II, Galenik (S. 26 ff.); Lecture Notes, Part II, \nQualit \u00e4tsmanagement von Heilpflanzen (S. 71 ff.)  \nVorlesungsfolien:  \n \nFrom Galen to \nGalenics \u2013 Properties o   \nChallenges and \nSafety of Nanotechno\nLab experience.pdf\n Lab experience \nessential oils.pdf\nQuality management \nof medicinal plants fo   \nHerbal formulas and \nmicroscopic.identificat \n \n \n \n \n \n \n  \n \n \n \n  \n \n \nBasismodul  - Praxismodul  \nLerninhalt  \n\u2022 Galenische \u00dcbungen  \n\u2022 \u00dcbungen zur Qualit \u00e4tspr\u00fcfung von Heilpflanzen   \n\u2022 Wickel und \u00e4 u\u00dfere Anwendungen  \n\u2022 Wissenschaftliche \u00dcbungen, Studiensuche. Close Readings  \n\u2022 Fallbesprechungen  \nFreies M odul  \n \nLink: Empfehlung f \u00fcr die Nutzung des Kursraumes    \n \n \n  \n \n  \n \n \nHEALTHY HERBS  \n \nBeispiel - Empfehlung zur Einbettung als modular er Baustein  in \nder Aus - und Weiterbildung im Hochschulsektor  \nAm Beispiel Kapitel/Modul  Galenik  \n  \n \n \n  \n \n \n \n[I] Asynchrone Vorbereitungsphase  \n \nIn der Vorbereitungsphase sollen sich die Studierenden mit dem Fachthema des Moduls \nvertraut machen; Hierf\u00fcr werden Videosequenzen, Textmaterialien oder \nwissenschaftliche Studien zur Verf\u00fcgung gestellt (im Beispiel: galenisch)  \n \n1. Video  \n\uf0d8 Antibiotikaresistenz - VIDEO  \n\uf0d8 Galenic \u2013 VIDEO: : wie man eine Tinktur zubereitet  \n \n Die Studierenden k\u00f6nnen zur Vorbereitung Videos mit Inhalten ansehen, die im Modul unterrichtet \nwerden  \n \n2. Prereading : Kapitel  Galenik  aus dem Skriptum , S. 25 (Deutsch, Englisch, Italienisch)  \n \n \n \n Die Studierenden erhalten Textreferenzen zur Vorbereitung auf die Kursinha lt \n \n1 HEALTHY HERBS  \n \n \nPhytotherapie als \nStrategie gegen \nantimikrobielle \nResistenzen  \n \nErasmus+ cofinanzierte Strategische Partnerschaft  \nUniversit\u00e4t f\u00fcr Weiterbildung Krems  \nCharit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin  \nUniverist\u00e0 degli Studi di F irenze  \nKottas Pharma GmbH  \nOpen Acces Erasmus+ Strategische Partn erschaft  \n \n \nInhaltsverzeichnis  \nInhaltsverzeichnis  ................................ ................................ ................................ .........  iv \nVorwort  ................................ ................................ ................................ ..........................  1 \nTEIL I: EINLEITUNG  ................................ ................................ ................................ .. 2 \nEin kurzer geschichtlicher \u00dcberblick der europ\u00e4ischen Phytotherapie \u2013 R. Stange, \nBerlin  3 \nAtemwegsinfekte  7 \nTEIL II: HAUPTTEIL  ................................ ................................ ................................ . 21 \nResistenz  22 \nGalenik  25 \nAnwendungen  43 \nQualit\u00e4tsmanagement von Heilpflanzen  67 \nTEIL III:  ................................ ................................ ................................ .......................  77 \n  \n \n[II] Pr\u00e4senzmodule \u2013  digital / hybrid / face \u2013  to \u2013 face  \n \nIn den Einheiten des Kurses wird das vorbereitete Material ausgearbeitet und mit den \nDozenten diskutiert, in Fachvortr\u00e4gen von Experten vorgetragen  und praktische \nF\u00e4higkeiten werden in Workshops  erlernt.   Die Vorlesungsskripte werden von den \nLehrkr\u00e4ften on line im Kursraum zur Verf\u00fcgung gestellt.  \n \n \n \n \n \n \nDie Studierenden besuchen Kurse und Workshops,  online und/oder  auch im Pr \u00e4senzunterricht\nFrom Galen to \nGalenics \u2013 Properties o   \nChallenges and \nSafety of Nanotechno\nLab experience.pdf\n Lab experience \nessential oils.pdf\nQuality management \nof medicinal plants fo   \nHerbal formulas and \nmicroscopic.identificat \n \n \n \n \n[III] Postdidaktische Phase  \n \nDie Post -Training -Phase  (Blended oder Guided E -Learning) umfasst die Bearbeitung und \ndas Hochladen von Aufgaben, interaktive Foren zu Kursinhalten, Selbsttesteinheiten f\u00fcr \neigene Wissenstests, die Vorbereitung auf die Kurspr\u00fcfung (Skript, Kurs mitschriften , \nVideo, wissenschaftliche Literatur) sowie die Abschlusspr\u00fcfung mit der Vergabe von ECTS  \n \n \n \n1. Quiz -Selbstpr\u00fcfung  \n \n Die Studierenden k\u00f6nnen ihre Wissensbewertung nach dem Modul abschlie\u00dfen  \n \n \n \n2. Upload - Bereich  \n \n \n \n Studierende erhalten nach dem Modul eine Aufgabe zum digitalen Hochladen  \n  \n3. Abschlusspr\u00fcfung\n \n \n \n \n \n \n \n \n \n[IV] F ollow Up  \nNach Abschluss einzelner  Module oder des gesamten Kurses stehen die Online -Karteikarten f\u00fcr \ndie weitere Verwendung am Point of Care zur Verf\u00fcgung. Diese erm\u00f6glichen einen schnellen und \neinfachen Zugriff auf die wesentlichen Inhalte von Heilpflanzen f\u00fcr den Einsatz bei \nAtemwegsinfektionen.  \n Karteikarte (Deutsch, Englisch, Italienisch)  \n \n \n \n \n Einen Kurs erstellen \u2013 Empfehlungen  \nAnteil der Vorbereitungsphase ca. 20% der Gesamtdauer des Kurses  \nTeilnahme phase (Pr\u00e4senz/hybrid/online) : Vortr\u00e4ge und Workshops ca. 5 0% der Gesamtdauer des \nKurses  \nNachbearbeitung ca. 30% der Gesamtdauer des Kurses einschlie\u00dflich der Pr\u00fcfung  \nDie Inhalte (erg\u00e4nzende Dokumentenskripte -  digitale Toolkits) k\u00f6nnen als kompletter Kurs \n\"Healthy Herbs , Thema Atemwegsinfektionen \" oder als einzelne Komponenten des Moduls (z.B. \nSeminar -Galenik\n) genutzt  werden.  \n  \nHealthy Herbs\nFlashcards\nHealthy Herbs\nFlashcards\nKompaktes P\ufb02anzenwissen f\u00fcr den Point -of-Care\n \n \nIntellectual Output \u2013  IO 2 \nDigital communicatio n tools  \n \n \n \n \n \nHEALTHY HERBS  \nPhytotherapy as a strategy against antimicrobial \nresistance  \n \nExample - Recommendation for incorporation as a full course or into modules in \neducation and training in the field of higher education  \n \n \n \n \n \n \n \n \n \n \n \n \n \nINTELLEC TUAL  OUTPUT 2 \u2013  Digital Communication   \n \n \n \n \n \n \n \n \n \n \nE-Learning Platform  \n \nDigital communication  \n \nLecture materials for the teaching and learning courses  \nExample suggestion for a course  \n- As a complete course  \n- As a modular building block  \n  \n \n \n \n \n \nHEALTHY HERBS  \nExample - Recommendation for embedding as a complete course in education and training  in the \nhigher education sector  \n \nBasic Module 1 Traditional Phytotherapy  \nObjectives  \n\u2022 Phytotherapy - current legal situation in the  European Union  \n\u2022 Global relevance of infections in medicine and challenges related to antibiotic resistance  \n\u2022 Traditional application in phyotherapy \u2013 European  phytotherapy in Monastary Medicine  \nLearning objectives : Knowledge of the relevance of antimicrobial resistance, surveillance tools; \naccessto European  subsidiaries and assessment systems; Knowledge of the most important core \nconcepts of resistance  \nLearning materials -Lecture Notes - Part I; History of EuropeanPhytotherapy (p. 3 ff. );  Lecture \nNotes, Part II Resistances (S 23 ff.)  Lec ture Notes, Part III European  Monographs and Assessment \nReports (p. 82 ff.).  \n\u2022 LINK :European  medicinal plant monographs  \n\u2022 LINK: Assessment reports of the  European Medicines Agency  \nMaterial : VIDEO Animation of Antimicrobial  Resistance  \nLectures  \nKlostermedizin.pdf\n \n Self-study  phase and self -examination > Annex to Lecture N otes  \n \n \n \nBasic Module 2 - Respiratory diseases and  health care  \nObjectives  \n\u2022 Respiratory Tract Infections  \nPublic Health , Health Literacy - Health App s \nLearning objectives: Overview  of the most imp ortant diseases in the respiratory tract; Evacuating \nhealth apps  \nMaterial:   Lecture Notes, Part I  - Resp iratory Tract Dise ases  (S 7 ff.)  \n\u2022 LINK: I CD - 10, Codes > Diseases of the Respiratory Tract  \n\u2022 Preparing for the c ourse : The Loss of Health Literacy  \n \n\u2022 \nHEALTHY \nGOOGLE.pdf\nHealth literacy and \nthe public health perspective.pdf\nHealth_Literacy.pdf  \n\u2022 \nCASE 1.pdf\nCase 2.pdf\nPhytotherapy in \nclinical management.pdf  \n\u2022  \nSelf-study  phase and self -examination > Annex to Lecture N otes  \n \n \n \n \n \n \n \n \n \n \n \n \n \nBasic Module 3 - Medicinal Plant Applications for Respiratory  Tract \nInfections  \nContent   \n\u2022 Knowledge about Herbs  \nObjectives  \nAfter completing the module,  students are a ble to   \n1.  Find, read  and interpret current monographs and assessment reports of the European \nMedicines Agency  \n2. Know basic knowledge of relevant medicinal plants for use in respiratory infections  \n3. Make a correct selection of medicinal plants for specificindications and use the m safely  \nMaterial  \n\u2022 LINK :European monographs   \n\u2022 LINK : Translation on monograph  \n \n\u2022 LINK: Assessment Report Medicinal Plants  \n\u2022 LINK: Flashcards  \n\u2022 Lectures  \n\u2022 \nEMA Mongraphs \n1.pdf\nWorkshop  Wie man \nEMA Dokumente gezielt liest.pdf  \nHow to find HMPC \nMonographs easily.pdf\nEMA_Monographs \n2.pdf  \nFlashcards.pdf\nRemeides.pdf\n \n\u2022  \nModule preparation  and knowledge  review> self \u2013 study area > Annex to Lecture Notes   \n \n \n \n \n \n \n \n \nBasic Module 4 - Scientific Work  \nObjectives  \n\u2022 Scientific Work - Basics  \n\u2022 Literature research and literature evaluation  \n\u2022 Study Designs  \nLearning objectives: Basics of research and evaluation of scientific pa pers, literature search and \nworking with PubMed  \nMaterial : \n\u2022 LINK: Care Guidelines  \n\u2022 LINK: Studiendesigns    \nLectures:   \n\u2022 \nCS - Search for \nLITERATURE.pdf\nCurrent Studies and \nCases I.pdf\nCurrent Studies and \nCases II.pdf  \n \n  Module preparationand knowledge verification  > Self Study Area (quizzes)  > Annex to Lecture \nNotes  \n \n \n \n \n \n \n \n \n \n \n \n \n  \n \nBasic Mo dule 5 \u2013 Galenics  and Quality  \nObjectives   \n\u2022 Recipe science and galenic preparation methods  \n\u2022 Modern technologies  \n\u2022 Qualitytesting  of medicinal plants  \nLearning objectives:  Getting to know and discerning the most important galenics   plants in  the field  \nof respiratory tract  \nTraining : VIDEO  - Lab Experience  \nMaterial : Lecture Notes, Part II, Galeni c (S. 26 ff.);  Lecture Notes, Part II, Quality Management of \nHerbal Remedies  (S. 71 ff.)  \nLectures:  \n \nFrom Galen to \nGalenics \u2013 Properties of Herbal Drugs.pdf\nChallenges and \nSafety of Nanotechnology.pdf\nLab experience.pdf\nLab experience \nessential oils.pdf\nQuality management \nof medicinal plants for respiratory diseases.pdf\nHerbal formulas and \nmicroscopic.identification.pdf\n \n \n \n \n \n \n \n \n \n \n \n \n  \n \nBasic Module 6 - Practical Module  \nObjectives  \n\u2022 Galenic s \n\u2022 Measures for the qualityof medicinal plants  \n\u2022 Winding and other applications , Workshops and Practical  Training  \n\u2022 Scientific research, study search. Close Readings   \n \n \n  \n \n  \n \n \nHEALTHY HERBS  \n \nExample -  Recommendation for embedding as a modular  \nbuilding block  in education and training in the higher education \nsector  \nUsing the example of Chapter/Module  Galenics  \n \n \n \n \n \n \n \n[I] Asynchronous preparation phase  \n \nIn the preparatory phase, students should familiarize themselves with the subject matter \nof the module; For this purpose, video sequences, text materials or scientific studies are \nprovided (in the example: galenic)  \n \n1. Video  \n\uf0d8 Antimicrobial Resistance  - VIDEO  \n\uf0d8 Galenic \u2013 VIDEO: : how to prepare a tincture  \n \n Students can watch videos with content taught in the module  as preparation  \n \n2. Prereading : Chapter  Galenics from the Scriptum , p. 25 (German, English, Italian)  \n \n \n \n Students receive text references to prepare for the course \n \n1 HEALTHY HERBS  \n \n \nPhytotherapie als \nStrategie gegen \nantimikrobielle \nResistenzen  \n \nErasmus+ cofinanzierte Strategische Partnerschaft  \nUniversit\u00e4t f\u00fcr Weiterbildung Krems  \nCharit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin  \nUniverist\u00e0 degli Studi di F irenze  \nKottas Pharma GmbH  \nOpen Acces Erasmus+ Strategische Partn erschaft  \n \n \nInhaltsverzeichnis  \nInhaltsverzeichnis  ................................ ................................ ................................ .........  iv \nVorwort  ................................ ................................ ................................ ..........................  1 \nTEIL I: EINLEITUNG  ................................ ................................ ................................ .. 2 \nEin kurzer geschichtlicher \u00dcberblick der europ\u00e4ischen Phytotherapie \u2013 R. Stange, \nBerlin  3 \nAtemwegsinfekte  7 \nTEIL II: HAUPTTEIL  ................................ ................................ ................................ . 21 \nResistenz  22 \nGalenik  25 \nAnwendungen  43 \nQualit\u00e4tsmanagement von Heilpflanzen  67 \nTEIL III:  ................................ ................................ ................................ .......................  77 \n  \n \n[II] Presence phas e \u2013 digital / hybrid / face \u2013  to \u2013 face  \n \nIn the units of the course, the prepared material is worked out and discussed with the \nlecturers, presented  in specialist lectures by experts  and practical skills are learned in \nworkshops.   The lecture notes are provided by the teachers online in the classroom.  \n \n \n \n \n \n \n Students attend courses and workshops, online and/or  in classroom lessons  \n \nFrom Galen to \nGalenics \u2013 Properties o   \nChallenges and \nSafety of Nanotechno\nLab experience.pdf\n Lab experience \nessential oils.pdf\nQuality management \nof medicinal plants fo   \nHerbal formulas and \nmicroscopic.identificat \n \n \n \n \n \n[III] Course post phase  \n \nThe post -training phase  (blended or guided e -learning) includes the processing and \nuploading of tasks, interactive forums on course content, self- test units for your own \nknowledge tests, preparation for the course exam (script, course transcripts , video, \nscientific literature) and the final exam with the awarding of ECTS  \n \n \n \n1. Quiz -self \u2013 check  (Annex to Lecture Notes \u2013 questions and solutions)  \n \n Students can complete their knowledge assessment after the module  \n \n \n \n2. Upload Area  \n \n \n \n Students receive a task for digital upload after the module  \n \n \n3. Final examination  \n \n \n \n \n \n[IV] F ollow Up  \nAfter completion of individual  modules or the entire course, the online index cards are available \nfor further use at the point of care. These allow quick and easy access to the essential contents \nof medicinal plants for use in respiratory infections.  \n Index card (German, English, Italia n) \n \n \n \n \n Create a Course  Recommendations   \nProportion of the preparation phase approx. 20% of the total duration of the course  \nParticipation phase (presence/hybrid/online) : Lectures and workshops approx. 50% of the total \nduration of the course  \nPost -processing approx. 30% of the total duration of the course including the exam  \nThe contents (supplementary document scripts -  digital toolkits) can be \nused  as a complete course \n\"Healthy Herbs , Topic Respiratory Infections \" or as individual components of the module (e.g. \nSeminar  Galenics   ). \n  \n \n \nIntellectual Output \u2013  IO 2 \nComunicazione digital e \n \n \n \n \n \nHEALTHY HERBS  \nFitoterapia come strategia contro la resisten za \nantimicrobica  \n \nEsempio - Raccomandazione per l'incorporamento come corso completo o in \nmoduli nell'istruzione e  nella formazione nel  settore dell'istruzione superiore  \n \n \n \n \n \n \n \n \n \n \n \n \n \nINTELLEC TUAL OUTPUT 2 \u2013  Comunica zione digitale   \n \n \n \n \n \n \n \n \n \n \nPiattaforma E -Learning  \n \nComunicazione digitale  \n \nMateriali didattici per i corsi di insegnamento e apprendimento  \nEsempio di suggerimento per un corso  \n- Come corso completo  \n- Come elemento costitutivo \nmodulare  \n \n \n \n \n \n \n \nHEALTHY HERBS  \nEsempio - Raccomandazione per l'incorporamento come corso completo nell'istruzione e  nella \nformazione nel settore dell'istruzione superiore  \n \n \nModulo Base 1 Fitoterapia Tradizionale  \nObiettivi  \n\u2022 Fitoterapia - situazione giuridica attuale nell'Unione europea  \n\u2022 Rilevanza globale delle infezioni in medicina e sfide legate alla resistenza agli antibiotici  \n\u2022 Applicazione tradizionale in fioterapia \u2013  Fitoterapia europea in Monastary Medicine  \nObiettivi di apprendimento: Conoscenza della rilevanza della resistenza antimicrobica, strumenti di \nsorveglianza; l'accesso alle filiali europee e ai sistemi di valutazione; Conoscenza dei pi\u00f9  importanti \nconcetti fondamentali di resistenza  \nMateriali didattici - Dispense - Parte I; Storia della fitoterapia europea (p. 3 ss.) ;  Dispense, Parte II \nResistenze (S 23 ss.)  Letture Notes, Part III European  Monographs and Assessment Reports (p. 82 \nss.).  \n\u2022 LINK :Monografie europee sulle piante medicinali  \n\u2022 LINK: Relazioni di valutazione dell'Agenzia europea  per i medicinali  \nI Materiai : VIDEO Animazione della  resistenza antimicrobica  \n Appunti delle lezioni : \n \nFase di autoapprendimento e autoesame  \n \n \n \nModulo base 2 -  Malattie respiratorie e assistenza sanitaria  \nObiettivi  \n\u2022 Infezioni del tratto respiratorio  \nSanit \u00e0 pubblica, Apps  \nObiettivi  di apprendimento: Cenni sulle pi \u00f9 importanti patologie delle vie respiratorie; Evacuazione \ndelle app sanitarie  \nI Materiali: Dispense, Parte I - Atemwegserkrankungen (S 7 ss.)  \n\u2022 LINK: I CD - 10, Codici > Malattie delle Vie Respiratorie  \n\u2022 Preparazione del corso : la perdita di alfabetizzazione sanitaria  \n\u2022 Appun ti delle lezion i \n\u2022 \nHEALTHY \nGOOGLE.pdf\nHealth literacy and \nthe public health pers\nHealth_Literacy.pdf\n \nCASE 1.pdf\n Case 2.pdf\n Phytotherapy in \nclinical management.p \n \nPreparazione del modulo e verifica delle conoscenze>question , area di auto -studio  \n \n \n \n \n \n \n \n  \n \n \n \n \n \n \nModulo base 3 -  Applicazioni di piante medicinali per le infezioni del \ntratto respiratorio  \nContenuto  \n\u2022 Conoscenza delle erbe  \nObiettivi  \nDopo aver completato il modulo, gli studenti possono aprirsi  \n1.  Trovare, leggere e interpretare le monografie e le relazioni di valutazione attuali \ndell'Agenzia europea per i medicinali  \n2. Conoscere le conoscenze di base delle piante medicinali  rilevanti per l'uso nelle infezioni \nrespiratorie  \n3. Fare una corretta selezione di piante medicinali per indicare specificamente e usarle in modo \nsicuro  \nI Materiali  \n\u2022 LINK :Monografie  europee  \n\u2022 LINK : Traduzione su monografia  \n \n\u2022 LINK: Rapporto di valutazione Piante medicinali  \n\u2022 LINK: Flashcard  \nAppunti delle lezioni:  \n \n\u2022 \nEMA Mongraphs \n1.pdf\nWorkshop  Wie man \nEMA Dokumente gezie   \nHow to find HMPC \nMonographs easily.pd\nEMA_Monographs \n2.pdf \nFlashcards.pdf\n Remeides.pdf\n \n \nPreparazione del modulo e revisione delle conoscenze> area di auto -studio  \n  \n \n \n \n \n \n \nModulo base 4 - Lavoro scientifico  \nObiettivi  \n\u2022 Lavoro scientifico -  Nozioni di base  \n\u2022 Ricerca bibliografica e valutazione della letteratura  \n\u2022 Disegni di studio  \nObiettivi di apprendimento: Nozioni di base di ricerca e valutazione di articoli scientifici, ricerca \nbibliografica e collaborazione con PubMed  \nI Materiali : \n\u2022 LINK: Linee guida per la cura  \n\u2022 LINK: Studiendesigns  \nAppun ti delle lezioni:  \n \n \nCS - Search for \nLITERATURE.pdf\nCurrent Studies and \nCases I.pdf\nCurrent Studies and \nCases II.pdf \n \n Preparazion e del modulo e verifica delle conoscenze  > Area di autoapprendimento (quiz)  \n  \n \n \n \n \n \n \n \n \n  \n \n \n \n \n \nModulo base 5 \u2013 Galenica e qualit \u00e0 \nObiettivi  \n\u2022 Scienza delle ricette e metodi di preparazione galenica  \n\u2022 Tecnologie moderne  \n\u2022 Test di qualit \u00e0 delle piante medicinali  \nObiettivi di apprendimento: Conoscere e discernere le galeniche pi \u00f9 importanti  per le piante \nmedicinali nel campo delle vie respiratorie  \nFormazione: VIDEO - Esperienza di laboratorio  \nI Materiali : Dispense, Parte II, Galenic  (S. 26 ss.);  Dispense, Parte II, Gestione della qualit \u00e0 dei rimedi \nerboristici  (S. 71 ss.)  \nAppun ti delle lezio ni:  \n \nFrom Galen to \nGalenics \u2013 Properties o   \nChallenges and \nSafety of Nanotechno\nLab experience.pdf\n Lab experience \nessential oils.pdf\nQuality management \nof medicinal plants fo   \nHerbal formulas and \nmicroscopic.identificat \n  \n \n  \n \n \n \n \n  \n \n \n \n \n \n \n \nModulo Base  -  Modul o Pratico  \nObiettivi  \n\u2022 Galenic a \n\u2022 Misure per la qualit \u00e0 delle piante medicinali  \n\u2022 Avvolgimento e altre applicazioni , workshop e formazione pratica  \n\u2022 Ricerca scientifica, ricerca di studio   \n \n \n  \n \n  \n \n \nHEALTHY HERBS  \n \nEsempio -  Raccomandazione per l'integrazione come elemento \ncostitutivo  modulare  nell'istruzione e nella formazione nel \nsettore dell'istruzione superiore  \nUsando l'esempio di Capitolo/Modul -  Galenic i \n \n \n \n \n \n \n \n \n \n[I] Fase di preparazione asincrona  \n \nNella fase preparatoria, gli studenti dovrebbero familiarizzare con l'argomento del \nmodulo; A tale scopo vengono fornite sequenze video, materiali testuali o studi scientifici (nell'esempio: galenico)  \n \n1. Video  \n\uf0d8  Resistenza antimicrobica  - VIDEO  \n\uf0d8 Galenico \u2013 VIDEO: : come preparare una tintura  \n \n Gli studenti possono guardare video con contenuti insegnati nel modulo  come preparazione  \n \n2. Prelettura : Capitolo  Galenico dallo Scriptum , p. 25 (tedesco, inglese, italiano)  \n \n \n \n Gli studenti ricevono riferimenti testuali per prepararsi al corso  \n1 HEALTHY HERBS  \n \n \nPhytotherapie als \nStrategie gegen \nantimikrobielle \nResistenzen  \n \nErasmus+ cofinanzierte Strategische Partnerschaft  \nUniversit\u00e4t f\u00fcr Weiterbildung Krems  \nCharit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin  \nUniverist\u00e0 degli Studi di F irenze  \nKottas Pharma GmbH  \nOpen Acces Erasmus+ Strategische Partn erschaft  \n \n \nInhaltsverzeichnis  \nInhaltsverzeichnis  ................................ ................................ ................................ .........  iv \nVorwort  ................................ ................................ ................................ ..........................  1 \nTEIL I: EINLEITUNG  ................................ ................................ ................................ .. 2 \nEin kurzer geschichtlicher \u00dcberblick der europ\u00e4ischen Phytotherapie \u2013 R. Stange, \nBerlin  3 \nAtemwegsinfekte  7 \nTEIL II: HAUPTTEIL  ................................ ................................ ................................ . 21 \nResistenz  22 \nGalenik  25 \nAnwendungen  43 \nQualit\u00e4tsmanagement von Heilpflanzen  67 \nTEIL III:  ................................ ................................ ................................ .......................  77 \n  \n \n \n[II] Corso in presenza  \u2013 digitale / ibrido / presenza  \n \nNelle unit\u00e0 del corso, il materiale preparato viene elaborato e discusso con i docenti, \npresentato  in lezioni specialistiche da esperti e le abilit\u00e0 pratiche vengono apprese in \nworkshop.   Gli appunti delle lezioni sono forniti dai docenti online in aula.  \n \n \n \n \n \n \n Gli studenti frequentano corsi e workshop, online e/o  in aula \n \n \n  \n \n \n[III] Fase successiva al corso  \n \nLa fase post -formazione  (blended o guided e -learning) comprende l'elaborazione e il \ncaricamento di compiti, forum interattivi sui contenuti del corso, unit\u00e0 di auto -test per i \npropri test di conoscenza, preparazione all'esame del corso (script, trascrizioni  del corso, \nvideo, letteratura scientifica) e l'esame finale con l'assegnazione di ECTS  \n \n \n \nQuiz di autovalutazione  \n Gli studenti possono completare la loro valutazione delle conoscenze dopo il modulo  \n \n \n \n1. Area di caricamento  \n \n \n \n Gli studenti ricevono un'attivit\u00e0 per il caricamento digitale dopo il modulo  \n \n 2. Esame finale\n \n \n \n \n \n \n \n \n \n[IV] F ollow Up  \nDopo il completamento dei singoli  moduli o dell'intero corso, le schede indice online sono \ndisponibili per un ulteriore utilizzo presso il punto di cura. Questi consentono un accesso rapido \ne facile ai contenuti essenziali delle piante medicinali per l'uso  nelle infezioni respiratorie.  \n Scheda indice (tedesco, inglese, italiano)  \n \n  \n \n \n Creare  consigli per il corso  \nPercentuale della fase di preparazione circa il 20% della durata totale del corso  \nFase di partecipazione (presenza/ibrida/online):\n Lezioni frontali e workshop circa il 50% della \ndurata totale del corso  Post -elaborazione circa il 30% della durata totale d el corso compreso l'esame  \nI contenuti (script di documenti supplementari - toolkit digitali) possono essere \nutilizzati come corso \ncompleto \" Erbe sane , argomento Infezioni respiratorie \" o come singoli componenti del modulo \n(ad es . Seminario galenico ). \n  \n \n \nVorlesungsunterlagen Kurs Healthy Herbs  \nLecture Material Healthy Herbs - Materiale didattico  \n \n \n \n \n \n \n \n  \n \n \n \n \n \n \n   \n \n \n \n \nVorlesungsunterlagen Kurs Healthy Herbs  \nLecture Material Healthy Herbs - Materiale didattico  \n \n \n \n \n \n \n \n  \n \n \n \n \n \n \n   \n \n \nKlostermedizin:  \nTraditionelle Europ\u00e4ische  \nMedizin und Phytotherapie\nBernhard Uehleke\nAbt. Naturheilkunde der Charit\u00e9, Berlin  \nForschergruppe Klostermedizin, GmbH W\u00fcrzburg  \nClinical Evidence Evaluations, Berlin\nUnd vormals\nPrivatgelehrter , Old -Manali, India\nFr\u00fche Anwendung vonHeilpflanzen\n\u2022Fr\u00fche Anwendung von lokal wachsenden Pflanzen\n\u2013Ethnobotanik, Ethnopharmakologie\n\u2022Fr\u00fcher Handel von Drogen mit offensichtlichen  \nWirkungen\n\u2013Asien, Afrika nach Europa und umgekehrt\n\u2013Austausch und Wechselwirkung bei der Entwicklung  \nTraditioneller Medizin -Systeme\n\u2022Heilpflanzen spielen wichtige Rolle bei TCM,  \nAyurveda and TEM\n\u2013Verschiedene Sichtweisen f\u00fchren zu verschiedenen  IndikationenTraditionelle Medizinsysteme  \n(Whole medical Systems): TCM\n\u2022TCM \u2013lange diverse Entwicklungsstr\u00e4nge,  \nverloren gegangen nach Revolution, neu\n\u201eerfunden\u201c von deutschen Medizinhistorikern  \n(Porkert).\n\u2022Die Idee von Selbstregulation,  \nSelbstheilungskraft etc. ist dem chinesischen  \nDenken v\u00f6llig kontr\u00e4r. (Unschuld)\n\u2022Multi-Kombinationen mit toxischen  \nBestandteilen\nBernhard Uehleke\nTraditionelle Medizinsysteme (Whole  \nmedical Systems): Ayurveda\n\u2022Ayurveda \u2013lange Entwicklungsstr\u00e4nge, regional  \ndiversifiziert, verst\u00e4ndlich gemacht von  \nbritischen \u00c4rzten und von AYUSH neu geordnet\n\u2022Auch stark wirksame Arzneipflanzen werden in  \nniedriger Dosierung genutzt\n\u2022Preiswerte Alternative zur westlichen Medizin in  \neinem desolaten Gesundheitssystem bzw. Staat\nBernhard Uehleke\u201eAyurveda -\u00c4rzte\u201c\ne\u201c\u2022\u201eKr\u00e4uterverk\u00e4ufer mit Beratung\u201c\n\u2022Reiche bevorzugen Western  \nMedicine\n\u2022Fokussiert auf\u201eMedikament\n\u2022Individuelle Mixturen\nBernhard Uehleke\n\u201eKlostermedizin\u201c\n\u2022Eher Epochenbezeichnung: i.e.S. 8-12.Jh.\n\u2013Schnittstelle Antike -Neuzeit\n\u2013Kl\u00f6ster tragen die Kultur\n\u2022Wichtiger Teil der TEM\n\u2022heute: Phytotherapie mit\n\u2022\u201etraditionellem\u201c Hintergrund  \n(=V olksmedizin)\nForschergruppe Klostermedizin\n\u2022Kooperation seit 1999\n\u2013Institut f\u00fcr Geschichte der Medizin, Uni W\u00fcrzburg\n\u2013Abtei (Glaxo -Smith -Kline), inzwischen weitere  \nSponsoren und Auftraggeber\n\u2022Interdisziplin\u00e4res Team\n\u2013Medizingeschichte (G. Keil, J. Mayer +)\n\u2013Pharmazeutische Biologie (F.Czygan+)\n\u2013Medizin / Naturheilkunde (B. Uehleke)\n\u2013Statistik (B. Uehleke, )\n\u2013Ethnobotanik (G. Heinrich, London)\n\u2013und viele andere\nAutoren:\nJ. G. Mayer\nB.Uehleke\nPater Kilian Saum OSB\nVerlag Zabert Sandmann  \nGmbH M\u00fcnchen\n9. Auflage 2004Handbuch der  \nKlosterheilkundeTEM, TEN\n\u2022Versuch, durch eine breitere Definition sdas  \nDefinitions -und Abgrenzungs -problem der\n\u201eNaturheilkunde\u201c zu umgehen\n\u2022Unabh\u00e4ngige??? Erfinder des Begriffs  \nTEM: Pandalis, Leuchtens/V olger, Uehleke,  \nB\u00fchring, H\u00fcbener\n\u2022TEN: Ausrichtung der europ\u00e4ischen  Naturheilkunde gegen\u00fcber der Chin.  Naturheilkunde und der Hom\u00f6opathie\n\u2022TEM teilweise identisch mit Unani\nBernhard UehlekeNeue Definition TEM\n\u2022TEM ist die Behandlung (Therapie und Pr\u00e4vention)  \nmit humoralpathologisch begr\u00fcndeten Verfahren  entsprechend den V orstellungen der europ\u00e4ischen  \nMedizin, deren Wurzeln auf die griechische\nMedizin  \nder Antike zur\u00fcckgehen,\n\u2022soweit diese nicht nach den V orstellungen der  \nmodernen Medizin kontraindiziert sind.\nUehleke B: Results of a modified Delphi consensus- building process to classify Natural  \nhealing methods and \u201cTraditional European Medicine (TEM)\u201d. Swiss Journal of Integrative  \nMedicine 2007, 19(4):199- 203The 4 Humors\nK\u00f6rpersaft  \nHumorBlut  \nSanguisSchleim  \nPhlegmaGelbe Galle  \nCholicaSchw. Galle  \nMelancholica\nPrim\u00e4r-\nqualit\u00e4tenwarm\nfeuchtkalt\nfeuchtwarm\ntrockenkalt\ntrocken\nOrganbezug Herz Gehirn Leber Milz\nElement -\nbezugLuft Wasser Feuer ErdeFunctions of the 4Humors  \n(Galen and Avicenna)\nsanguis: Endproduct of \u201emetabolism\u201c, \u201enutrition\u201c for body\nlike water forplants\nphlegma: Pre-cursor of blood in \u201emetabolism\u201c:\n\u201enutrition\u201c for brain\nCholica: product of liver: is needed for gut function\nmelancholica: \u201enutrition\u201c for splen; needed for stomach function\nGood mixture: eukrasy otherwise: dyskrasyHumorism and constitution:  \nThe 4 constitutions /temperaments\nK\u00f6rpersaft  \nHumorBlut  \nSanguisSchleim  \nPhlegmaGelbe Galle  \nCholicaSchw. Galle  \nMelancholica\nPrim\u00e4r-\nqualit\u00e4tenwarm  \nfeuchtkalt  \nfeuchtwarm  \ntrockenkalt  \ntrocken\nOrganbezug Herz Gehirn Leber Milz\nKonstitutions -\ntypSanguiniker Phlegmatiker Choleriker MelancholikerDevelopments in the concept ofTemperaments\nAdaptation by Immanuel Kant (1724- 1804) and\nWilhelm Wundt (1832- 1920):\nSanguiniker:\nCholeriker:weniger gef\u00fchlsbetont, meist zufrieden, verspielt, gesellig\naufbrausend, sehr emotional, oft unberechenbar, giltals\negozentrisch undexhibitionistisch\nPhlegmatiker: wenige emotional, ruhig, vern\u00fcnftig, prinzipientreu,  \nbeherrscht u. standhaft (Kants Idealtyp)\nMelancholiker : leidet unter seinen Stimmungsschwankungen,  \nmisstrauisch, \u00e4ngstlich, sehrernst.\u2022Geschlecht\n\u2022Alter\n\u2022Physical items\n\u2022Mental habits\n\u2022Variation bestimmter Ma\u00dfzahlen/Eigenschaften  \nbez\u00fcglich des pathophysiologischen ModellsTypes, Classes, \u201eConstitutions\u201c gibt  \nes in allen Medizinsystemen speziell  \nin traditionellen MedizinsystemenKeine Studien zur medizinischen  \nRelevanz von Konstitution\n\u2022Abh\u00e4ngigkeit einer Wirksamkeit von Typ\n\u2022\u201eErfahrung\u201c wird \u00fcberbewertet\n\u2013Subjektive Fehleinsch\u00e4tzungen\n\u2022Die Falsifizierung wird erschwert\nBernhard Uehleke  \nBernhard UehlekeVoraussetzungen der  \nKlostermedizin\n\u2022um 527 Klosterregel des Hl. Benedict von  \nNursia in Monte Cassino\n\u2013Ordensregel: 1 religi\u00f6ses Buch pro Jahr zu  \nlesen (und damit schreiben zu k\u00f6nnen)\n\u2013Kapitel 37 der \u201aRegula\u2019: \u201eDie Sorge f\u00fcr die  \nKranken steht vor und \u00fcber allen anderen  \nPflichten.\u201c\n\u2013Pflege der Kranken im Kloster durch eigene\n\u201eDiener\u201c (M\u00f6nchsarzt und Klosterapotheker)  und in speziellem Raum \u201eInfirmarium\u201cQuellen der Klostermedizin\n\u2022Cassiodor empfiehlt den M\u00f6nchen das  \nStudium der antiken medizinischenV orbilder:\n\u2013Hippokrates (5. Jh. vor Chr.)\n\u2013Dioskurides (um 60/70)\n\u2013Galen (gest. nach 200)\n\u2013Caelius Aurelianus (5. Jh.)\n\u2022au\u00dferdem werden herangezogen\n\u2013Plinius der \u00c4ltere + 79 n. Chr.Erste Werke derKlostermedizin\n\u2022Lorscher Arzneibuch (um 795)\n\u2013politisch und Rezeptsammlungen\n\u2022Hortulus\u2019 des Walahfrid Strabo (um830)\n\u2013zeitl. Zusammenhang zu St. Galler KlosterplanHochmittelalter\n\u2022\u201aMacer\u2019 oder \u201aDe viribus herbarum\u2019 des Odo  \nMagdunensis (2. H\u00e4lfte 11. Jh.)\n\u201360 medizinische Pflanzen\n\u2022Constantinus Africanus (gest. 1087) sein\n\u201aLiber graduum\u2019 und die Schule von Salerno\n\u2013arabische Quellen\n\u2013laikale \u00c4rzteausbildung\n\u2022Hildegard von Bingen (1098 -1179) \u201aPhysica\u2019  \nund \u201aCausae et Curae\u2019 (zwischen 1150 und  \n1160)Phytotherapie (Klosterheilkunde):  \nStatistisches Modell zu alten Quellen\nFragestellung: Sind die im Mittelalter angegebenen  \nvielen Indikationsangaben (\u201eIndikationslyrik\u201c) nur  \ngelegentlich richtig oder gibt es einen  \nsystematischen Zusammenhang mit den heute  \nanerkannten Indikationen?\nDesign: \u00dcberpr\u00fcfung aller Indikationsangaben eines  \nKr\u00e4uterbuches/Autors auf \u00dcbereinstimmung mit  \nheute anerkannten Indikationen (Monographien  \nder Kommission E).\nMathematisches Modell zur Verteilungsfunktion  \nder statistisch erwartbaren \u201eTreffer\u201c.\nMayer, JG, Uehleke B, Saum K: Handbuch der Klosterheilkunde. M\u00fcnchen 2002Phytotherapie: Quantitative Modelle  \nzu Indikationsangaben\n\u2022Hintergrund : Mittelalterliche Indikationslyrik gem\u00e4\u00df 4-\nS\u00e4ftelehre erscheint unglaubhaft und Herauspicken  \neinzelner Treffer verzerrt.\n\u2022Beispiel : Hildegard von Bingen behandelt 175 heute aktuelle  \nPflanzen, davon 85 Pflanzen, die heute 310 Indikationen haben\n\u2022Indikationsmenge die Hildegard nennt I = 115\n\u2022Hildegard verteilt 437 Indikationszuweisungen auf 175  \nPflanzen\n\u2022bzw. 212 auf Indikationszuweisungen auf die 85 Pflanzen\n\u2022Hildegard gibt bei 152 Pflanzen keine richtige Indikation an, bei 18  \nPflanzen eine richtige, bei 4 Pflanzen 2 richtige, und bei 1 Pflanze  \n4 richtige Indikationen an \u2013zusammen 30\u201eTreffer \u201c.\n\u2022Modell: Uehleke B und Hopfenm\u00fcller W\n\u2022Ausarbeitung Hildegard: Maier -Nicolai C und Uehleke BTreffer von Hildegard nicht durch  \nZufall zu erkl\u00e4ren\nHochmittelalter II\n\u2022\u201aCirca instans\u2019 (\u201ade simplicibus\u2019) wahrschn.  \nV on Matthaeus Platearius. (Mitte 12. Jh.)\n\u2013270Monographien\n\u2022Avicenna (980-1037) um 1170 \u00fcbersetzt in  \nToledo\n\u2022\u201aAggregator\u2019 (Pseudo-Serapion) (um 1250)Entwicklung innerhalb der TEM zur  \nmodernen \u201ePhytotherapie\u201c\n1)Transfer von den alten Griechen zum Mittelalter  \n(\u201eKlostermedizin\u201c) \u00fcber arabische Transkription\n2)Transfer von Klostermedizin bis ins 19.  \nJahrhundert (akademische und V olksmedizin)\n3)Transfer in die Naturheilkunde (Ende des 19.  \nJahrhunderts)\n4)Transfer indie regulierte und moderne\n\u201ePhytotherapie\u201c in Deutschland (Ende des 20.  \nJahrhunderts)Part 2: Transfer von  \nKlostermedizin bis zum 19. Jh.\n\u2022Strikte Trennung von Medizin and Theologie\n\u2022V olksmedizin sehr nahe an Klostermedizin\n(Hebammen, Lehrer)\n\u2013keine \u00c4nderung von Indikationen und Anwendung\n\u2022Kr\u00e4uter mit abortiven or gef\u00e4hrlichen Wirkungen  \nprofessionell durch \u00c4rzte und Apotheker\n\u2013Wechsel in Gebrauch und Indikation mit neuen medizinischen\nKonzepten\n\u2013wiss. Interesse fokussiert im 18. und 19. Jh. aufPflanzen mit  \nstarken akuten Wirkungen, die in groben Tiermodellen me\u00dfbar  \nsind und zur Isolation aktiver Substanzen f\u00fchrenPart 3:Transfer in Naturheilkunde\n\u2022Sebastian Kneipp (1821- 97) f\u00fchrt ungef\u00e4hrliche  \nmilde Heilkr\u00e4uter der V olksmedizin in die  \nNaturheilkunde ein\n\u2022Erbeschr\u00e4nkt dieIndikationen seiner ca.90\nPflanzen aufeine einzelne organ-spezifische\nIndikation f\u00fcrjede Pflanze\n\u2013gef\u00fchrt vonStudien alter Kr\u00e4uterb\u00fccher (?)\n\u2013undeigener systematischer Erfahrung anseinen\nPatienten (?)Preisaufgabe von Uehleke  \nzum 200. Geburtstag Kneipp\n\u2022Finde die Quelle, aus der Sebastian Kneipp  \nseine Angaben zu Organbezogenen  \nIndikationen/Claims \u00fcbernommen hat\n\u2022Preisgeld: 3000 Euro\nBernhard UehlekeWozu Besch\u00e4ftigung mit alten  \nKr\u00e4uterb\u00fcchern?\n\u2022Suche nach Indikationen/Pflanzen, die in der zeitlichen  \nEntwicklung verloren gegangen sind\n\u2022vorsichtiger Vergleich mit heute anerkannten  \nIndikationen\n\u2022Verwendung von einer neuen statischen Pr\u00fcfung zur  \nBer\u00fccksichtigung der vollen Information eines  \nKr\u00e4uterbuches/Autors\n\u2022Vermeidung des h\u00e4ufigen systematischen Bias durch \nHerauspicken partieller Information, die heute ins  \nBild pa\u00dft.\n\u2022Machen Sie mit bei der Forschergruppe KlostermedizinPhytotherapie \u2013\nDie aktuelle Rechtslage in der EU\nBernhard Uehleke\nAbt. Naturheilkunde der Charit\u00e9, Berlin  \nForschergruppe Klostermedizin GmbH, W\u00fcrzburg  \nClinical Evidence Evaluations UG, Berlin\u201ePhytothera pie\u201c\n\u2022Die Pflanzenheilkunde ist die Lehre der  \nVerwendung von Heilpflanzen als  \nPhytotherapeutika genannte Arzneimittel.\n\u2022Die Phytotherapie nutzt ganze Pflanzen oder  \nPflanzenteile und wird in vielen Heilpraktikerpraxen  \nangewendet.\n\u2022Die Phytotherapie oder Pflanzenheilkunde ist eines der  \n\u00e4ltesten Therapieverfahren. Sie geh\u00f6rt zu den  \nvolksheilkundlichen Behandlungsma\u00dfnahmen.Transfer in die regulierte, moderne  \nPhytotherapie in Deutschland\n\u2022Arzneibuch -vorl\u00e4ufer seit dem Mittelalter, Pharmacopoe\n\u20221872 Deutsches Arzneibuch DAB1\n\u20221965 Europ\u00e4isches Arzneibuch, Ph. Eur. 1\n\u20221978 Arzneimittelgesetz Zulassung vonArzneimitteln\n\u2022Nachzulassung von 100.000 pflanzlicher Arzneimitteln\n\u2022Substanz -bezogener Ansatz \u00fcber Nachzulassungs -\nkommissionen zur Erstellung einer Wirkstoff -MonographieTransfer in die regulierte, moderne  \nPhytotherapie in Deutschland II\n\u2022Substanz -bezogener Ansatz \u00fcber Nachzulassungs -\nkommissionen zur Erstellung einer Wirkstoff -Monographie\n\u2022eigene spezielle Komissionen f\u00fcr die \u201eSpeziellen  \nTherapierichtungen\u201c: Kommission E f\u00fcr Phytotherapeutika\n\u2022\u00fcber 300 Monographien der Kommission E1982 -1995,\n\u2013erstellt durch ein interdisziplin\u00e4res Team (Pharmazeut/Medizinisch)\n\u2013die meisten positiv (abh\u00e4ngig von Evidenz, Indikation und Risiko)\n\u2013negativ bei gef\u00e4hrlichen oder toxischen Heilpflanzen\n\u20222005 sind etwa 5000 Phytotherapeutika (nach -)zugelassen\n\u2013viele Kombinationspr\u00e4parate gescheitertMonographien der Komission E\n\u2022Viel umfassender als die entsprechenden  \nBeschreibungen in \u00fcblichen Lehrb\u00fcchern \u2013Ausnahme  \ndie meist sp\u00e4ter erschienenen Kapitel in\nHagers Handbuch der Pharmazeutischen Praxis.\n\u2022Grundlage das ganze verf\u00fcgbare Wissen \u2013\nfirmen\u00fcbergreifend gesammelt vonder\nKooperation Phytpharmaka\n\u2022Vermeidung des h\u00e4ufigen systematischen Bias durch \nHerauspicken partieller Information, die heute ins  \nBild pa\u00dft.Monographie nder Kommissi on E II\n\u2022Zweistufiges Publikationsverfahren im  \nBundesanzeiger\n\u2022\u201eAntizipiertes Sachverst\u00e4ndigen -Gutachten\u201c\n\u2022Ohne Quellenangaben\n\u2022Knappe Texte, Dosierung meist auf Tee  \nbezogen: sp\u00e4terer Streit um\u201ePhyto\u00e4quivalenz\u201c\n\u2022wenige Claims bei +Monographien\n\u2022Pharmakologische Plausibilit\u00e4t \u00fcberbewertet\n\u2022Sog. \u201eErfahrung\u201c der \u00c4rzte \u00fcberbewertet aber  \nobjektive Werte der Patienten gefordertSp\u00e4tere Entwicklungen in D\n\u20221994 Wechsel auf Extrakt -spezifische  \nMonographien bei \u201ehochwertigen Indikationen\u201c\n\u2013Gastroenterologica und Erk\u00e4ltungsmittel weiterhin  \nweniger streng beurteilt\n\u2022\u201eTraditionelle Claimliste\u201c f\u00fcrfreiverk\u00e4ufliche  \nbzw. nicht -rezeptpflichtige AM\n\u2022Aufspaltung der Phytotherapie in \u201etraditionelle  \nund in \u201erationale\u201c Phytotherapie\n\u2013Beide ohne Konzeptionalisierung\nBernhard UehlekeTraditionelle AM\n\u2022Politisch gewollt: Bestandschutz f\u00fcr alte AM,\n\u2013die trotz Anpassungsm\u00f6glichkeiten nicht  \nnachzulassungsf\u00e4hig sind z.B.unterdosiert\n\u2022Insbesondere freiverk\u00e4ufliche AM\n\u2022L\u00f6sung: traditionelle AM\n\u2013die bereits 30 Jahre im Markt sind\n\u2013Abgeschw\u00e4chte Claims (Claimliste)\n\u2022Zur F\u00f6rderung, Anregung, V orbeugung\n\u2013Dosierung 10-90% derMonographiedosierungen\n\u2013Weiche Kombinationsbegr\u00fcndungen ausreichend\n\u2013Dysclaimer\u2026.. (zun\u00e4chst RegNr.)\nBernhard UehlekeSchlu\u00dffolgerung\n\u2022Die Arbeit der Kommission E war pragmatisch und f\u00fchrt  \nzu einem gut regulierten (\u00fcberregulierten?) Markt von  \npflanzliche Heilmitteln als Arzneimitteln in Deutschland\n\u2013Minimierung von Risiko f\u00fcr Patienten\n\u2013AM-Bestand weitgehend \u201egerettet\u201c\n\u2022Jedoch keine vergleichbaren Regularien in anderen EU-\nL\u00e4ndern (au\u00dfer) \u00d6sterreich\n\u2013Vergleichbare oder identische Mittel werden sonst als  \nLebensmittel oder K\u00f6rperpflegemittel vermarktetEntwicklungen in EU\n\u2022M\u00f6glichkeit von zentralen Zulassungen\n\u2022Monographien der ESCOP bzw. der EMA  \n(HMPC)\n\u20132-Teilung in \u201ewell established use\u201c und\n\u201etraditional use\u201c\nBernhard Uehleke  \nBernhard UehlekeNeue Situation gem\u00e4ss EU-Recht\nEuropean Directive on Traditional Herbal  \nMedicinal Products 2004/24/EC\n\u202230 Jahre in Use in EU (oder 15 EU + 15 outside\n\u2022Traditional history + recognized  \npharmacological properties\n\u2022Ohne \u00e4rztliche \u00dcberwachung\n\u2022Kombinationen mit Vitaminen etc. m\u00f6glichWeitere M\u00f6glichkeiten undTricks  \nf\u00fcrAnbieter\n\u2022Medizinprodukte: angeblich keine  \npharmakologische Wirkung bzw.  \nUnterdosierung!\n\u2022Kosmetika\n\u2022Di\u00e4tetische Lebensmittel\n\u2022Nahrungserg\u00e4nzungsmittel\n\u2022NahrungsmittelGibt es verschiedene Phytopharmaka?\n\u2022Neu-oder Nachzugelassene PP\n\u2022Traditionelle PP (\u00a7109AMG)\n\u2022zur St\u00e4rkung, Besserung des Befindens...\n\u2022Dosierung 10 -90 % der Dosierung (Komm E)\n\u2022Standardzulassung (Tees)\n\u2022Kleinmengenregelungen\n\u2022Medizinprodukte\n\u2022Nahrungs(erg\u00e4nzungs)mittel -functional food\n\u2022K\u00f6rperpflegemittelZubereitungsformen und  \n\u00e4quivalente Dosierung\n\u2022DROGE\n\u2013Tee 2g3xt\u00e4glich =6g\n\u2013Droge in festen oralen Formen 3 x 4 Drgs.\u00e1 500 mg\n\u2013Extrakt D:E -Verh\u00e4ltnis!!!\n\u2013Tinktur 1:1 3x 20 Tropfen\n\u2022FRISCHPFLANZE\n\u2013Saft 3x 20 ml\n\u2013Gem\u00fcse? mind. 3x 20 g\n\u2022\u00c4therisches \u00d6lca. 3 x 20-100mgPhytotherapie bei Erk\u00e4ltung\n\u2022Schleimdrogen\n\u2013Spitzwegerich, Malve, Eibisch\n\u2022Refle xexpektorantien\n\u2013Schl\u00fcsselblume, Efeu\n\u2022\u00c4therische \u00d6le\n\u2013(Pfeffer -)Minze, Eukalyptus, Konfipheren, Anis\n\u2022Spasmolytika\n\u2013Efeu\n\u2022Immunstimulation/Adaptogen\n\u2013EchinaceaHealth literacy \nand the public health perspective of phytotherapeutical knowledge\nMARIELLA SEEL , BAMSC\nSPRINGSCHOOL HEALTHY HERBSContent\n\uf0a7antimicrobial resistances as a public health threat\n\uf0a7health literac y\n\uf0a7how canwepromote health literacy\n\uf0a7E-Learning Task for Day 1Antimicrobial resistances\n\uf0a7Antibiotics = used totreat infections coming from bacteria\n\uf0a7increase oflifeexpectancy due toantibiotics\n\uf0a7widespread useinhuman and veterinary medicine \uf0e0development ofresistance mechanisms\n\uf0a7reduced /noeffect when needed\n\uf0a7patients demand antibiotics ,even when notindicated\n\uf0a7viral infections!\n\uf0a7selected plants show therapeutic effects\uf0e0first-line therapy!\n\uf0a7Sambucus nigra ,Althaea off., Hedera helix AND MANY MOR E\n\uf0a7Enioutina , E. Yu., Teng, L., Fateeva , T. V., Brown, J. C. S., Job, K. M., Bortnikova , V. V., Krepkova , L. V., Gubarev , M. I., & Sherwin , C. \nM. T. (2017). Phytotherapy asan alternative toconventional antimicrobials : Combating microbial resistance . Expert Review of\nClinical Pharmacology , 10(11), 1203 \u20131214. https://doi.org/10.1080/17512433.2017.1371591\n\uf0a7seeliterature recommendations intheend\u201eTrue orfalse : Nearly half of the population of Austria and/or Germany show \ninadequate or problematic health literacy ( Gesundheitskompetenz ).\"\nHLS-EU comparative report :\nImage 1: Health Literacy levels in Europe. Taken from HLS-EU comparative report (2012)Health literacy\nTheindividual\u2019s ability to\n\uf0a7search forhealth -related information,\n\uf0a7understand and\n\uf0a7critically assess thefindings aswell as\n\uf0a7being able toapply them totheir personal situation,\nwhich leads to thoughtful and informed health decisions.\nImage 2: Health decision making examples, taken from M. Seel, KARLI \u2013 Kidfriendly Augmented Reality Learning Interface: Augmented Reality for health literacy and \nhealth education among primary school pupils. St. Poelten : St. Poelten University of Applied Sciences, 2020 [Online]. Available: https://phaidra.fhstp.ac.at/open/o:4313Forexample :\nA patient suffering from a headache, wanting to find appropriate medication to stop his condition\nBlue :look up information and buy OTC drug\nGreen :consult a doctor and adhere to a drug scheme\nOrange: consult a telecare hotline and buy a OTC drug\nImage 3: Health decision making examples, taken from M. Seel, KARLI \u2013 Kidfriendly Augmented Reality Learning Interface: Augmented Reality for health literacy and \nhealth education among primary school pupils. St. Poelten : St. Poelten University of Applied Sciences, 2020 [Online]. Available: https://phaidra.fhstp.ac.at/open/o:4313Why ishealth literacy important ?\nHealth literacy is seen as a key determinant of health!\nInfluence on \n\uf0a7personal health status \n\uf0a7population -related health status\nLow health literacy among adults is seen as one of the \u201ctriple threats to effective health communication and patient safety\u201d\nEven without profound evidence of a causal link between low health literacy and poor outcomes in terms of health , \ndifferent findings indicate a causal relationship between them.How canwepromote health literacy ?\n\uf0a7Connection between health education and health literacy \n\uf0a7Switch from \u201cpaternalistic\u201d to \u201cpatient- centered \u201d models in healthcare\n\uf0a7Need of \u201cgood\u201d educational resources for patient for informed decision making\n\uf0a7Written information in simple language, not too many medical/scientific terms\n\uf0a7Use of images, video etc.\n\uf0a7\u201cassessment skills\u201d for looking up information on the internet etc.\n\uf0a7Healthcare professionals as multipliers of knowledge\n\uf0a7e.g. by relying on traditionally used preparations instead of \u201cfirst -line chemicals\u201d\n\uf0a7explaining why some preparations should be used with caution etc.\n\uf0a7\u201chelp for self -help\u201d (education on OTC drugs etc.)How canwepromote health literacy ?\n\uf0a7hereditary transmission of knowledge\n\uf0a7e.g. from mother to daughter\n\uf0a7\u201chome remedies\u201d transferred from generation to generation\n\uf0a7part of the cultural capital of a societyTools, knowledge, skills, traditions  \netc. \nof a society  of an individual  \n \nObjectified cultural capital  Institutionalized cultural \ncapital  Incorporated cultural capital  \nwork of art, scientific \ninstruments etc.  academic degrees, university, \npublications etc.  things you learned at \nschool/university, parental \neducation etc.  \ncan be directly transmitted by \nbuying -and-selling etc.  \u201cproof\u201d of knowledge/skills \nyou can show to others  you need to embody  that \nknowledge by learning  and \nyou can\u2019t inherit it to the next \ngeneration directly (by birth)  \n Image 4: Cultural Capital ofa society , own illustration based on Pierre Bourdieus capital theoryHome remedies and cultural capital\nHome remedies :\u201cAtraditional therapy often utilizing natural products, nutritional supplements, orphysical measures. Its\neffectiveness may besupported byfamilial, local, orculturally accepted stories orrituals .\u201d\nTransmission from one generation tothenext\nForexample\n\uf0a7wet feet wraps with vinegar (\u201cEssigpatscherl \u201d)tocure fever\n\uf0a7mixtures from honey, citrus juice and hotwater totreat asore throat\n\uf0a7different teapreparations\n\uf0a7traditionally used phytotherapeutic preparations!Why isthisimportant?\n\uf0a7\u201cinformed patients\u201d \uf0e0sources of information?!\n\uf0a7people tend to visit the hospital or a doctor before thinking of how they could help themselves\n\uf0a7patients demand antibiotic treatment\n\uf0a7we tend to forget about traditional home remedies and preparations Therefore :\nKeep traditions alive, transmit knowledge \u2013YOU are a multiplier of herbal knowledge\n\uf0a7promote the continued existence of home remedies\n\uf0a7conservation and maintenance of cultural capital\n\uf0a7important step towards reducing antimicrobial resistances and reducing the amount of antibiotics used in medicine!\nStay educated and curious !Task on Moodle\nPadlet task (noregistration needed )\nWhat canI do (in myprofession etc.) \ntoimprove health literacy and foster\nhealth education?\nLink and task description also on Moodle\n(E-Learning task \u2013Day 1)https://padlet.com/mariellaseel/3smqx8xyagdxmups\nPlease write your name in \u201c Betreff /subject\u201d!Literature recommendations : plants and antimicrobial resistances\nBaharara , H., Moghadam, A. T., Sahebkar , A., Emami, S. A., Tayebi, T., & Mohammadpour , A. H. (2021). The Effects of Ivy (Hedera helix) on Respiratory Problems and Cough in Humans: A \nReview. In A. Sahebkar & T. Sathyapalan (Hrsg .), Natural Products and Human Diseases (Bd. 1328, S. 361\u2013 376). Springer International Publishing. https://doi.org/10.1007/978- 3-030-73234 -\n9_23\nHawkins, J., Baker, C., Cherry, L., & Dunne, E. (2019). Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta- analysis of randomized, \ncontrolled clinical trials. Complementary Therapies in Medicine , 42, 361\u2013 365. https://doi.org/10.1016/j.ctim.2018.12.004\nKadmon , M., Ten Cate, O., Harendza , S., & Berberat, P . O. (2017). Postgraduate Medical Education \u2013an increasingly important focus of study and innovation. GMS Journal for Medical \nEducation, 34(5). https://doi.org/10.3205/zma001146\nMahboubi , M. (2020). Marsh Mallow (Althaea officinalis L.) and Its Potency in the Treatment of Cough. Complementary Medicine Research , 27(3), 174\u2013 183. \nhttps://doi.org/10.1159/000503747\nMichael, C. A., Dominey- Howes, D., & Labbate, M. (2014). The Antimicrobial Resistance Crisis: Causes, Consequences, and Management. Frontiers in Public Health , 2(145). \nhttps://doi.org/10.3389/fpubh.2014.00145\nParham, S., Kharazi, A. Z., Bakhsheshi -Rad, H. R., Nur, H., Ismail, A. F., Sharif, S., RamaKrishna, S., & Berto , F. (2020). Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials. \nAntioxidants , 9(12), 1309. https://doi.org/10.3390/antiox9121309\nSharifi -Rad, M., Mnayer , D., Morais -Braga, M. F. B., Carneiro, J. N. P ., Bezerra , C. F., Coutinho, H. D. M., Salehi, B., Martorell, M., del Mar Contreras, M., Soltani- Nejad , A., Uribe, Y. A. H., Yousaf, \nZ., Iriti, M., & Sharifi -Rad, J. (2018). Echinacea plants as antioxidant and antibacterial agents: From traditional medicine to biotechnological applications: Echinacea plants as antioxidant and \nantibacterial agents. Phytotherapy Research, 32(9), 1653\u2013 1663. https://doi.org/10.1002/ptr.6101Springschool Healthy Herbs : Health literacy and the public health perspective of phytotherap. knowledge  (M. Seel)  \n1 Health literacy and the \npublic health perspective of   \nphytotherapeutical  knowledge\nHealth Literacy \nHealth Literacy can be described as t he individual\u2019s ability to \n\u2022search for health -related information,\n\u2022understand and\n\u2022critically assess the findings as well as\n\u2022being able to apply them to their personal situation,\nwhich leads to thoughtful and informed health decisions.  \nFor example: A patient suffering from a headache, wanting to find  appropriate  medication  to stop  \nhis condition.1 \n1 M. Seel, KARLI \u2013 Kidfriendly  Augmented Reality Learning Interface: Augmented Reality for health literacy and  \nhealth education among primary school pupils. St. Poelten: St. Poelten University of Applied Sciences, 2020 [Online]. \nAvailable: https://phaidra.fhstp.ac.at/open/o:4313  \nSpringschool Healthy Herbs : Health literacy and the public health perspective of phytotherap. knowledge  (M. Seel)  \n \n \n2 \n Blue:  use books or the internet to look for adequate over the counter (OTC) medication  and \nbackground  information,  such  as mechanisms  of action  or contraindication. With this information \nin mind, the patient can go to a pharmacy, discuss the options he has found and decide on an \nappropriate pain reliever.  \nGreen:  For a more severe or longer existing headache, he could get in touch with health \nprofessionals like a general practitioner. The health -literate patient can interact with the doctor at \neye level because he can describe the symptoms and effects of his headache in a proper way. He \ncan also understand  what the doctor advises him to do (e.g. to increase the daily water intake) and \nhe can ask questions if needed. The doctor can issue a prescription for painkillers and explain the treatment in detail to the patient. The health -literate patient can than get the medication from the \npharmacy and will stick to the prescribed dosage because he is aware of the consequences of non -\nadherence.  \nOrange:  In times of teleconsultation and healthcare hotlines, the patient can also rely on support \nvia telephone. The patient phones the healthcare hotline, describes and discusses his symptoms and receives advice on his situation. With this in mind, he can then visit a pharmacy and purchase \nan adequate OTC medication.  \n \nWhy is this important?  \nHealth literacy is seen as a key determinant of health\n2, therefore as part of the range of factors \nthat influence the personal or population -related health status3.  \nLow health literacy among adults is seen as one of the \u201ctriple threats to effective health  \ncommunication  and patient safety\u201d,  also enforced  by the facts  that the individual level of health \nliteracy cannot be estimated by looking at a person and doctors generally overestimating the \nhealth literacy skills of their patients. A factor adding additional weight to low health literacy is a \nlack of literacy in general. Poor reading skills can lead to non- adherence in therapy and treatment. \nThe greatest challenges  are described  regarding medication  intake  when  the patients  have \ndifficulties understanding written information4. \nEven without profound evidence of a causal link between low health literacy and  poor outcomes \nin terms of health, different findings indicate a causal relationship between them.5 \n \n2 I. Kickbusch, J. M. Pelikan, F. Apfel, A. D. Tsouros, and World Health Organization, Eds., Health literacy: the solid facts. \nCopenhagen: World Health Organization Regional Office for Europe, 2013 [Online]. Available:  \nhttps://apps.who.int/iris/bitstream/handl e/10665/128703/e96854.pdf  \n3 World Health Organization, \u2018Health Promotion Glossary\u2019, Geneva, 1998 [Online]. Available:  \nhttps://www.who.int/healthpromotion/about/HPR%20Glossary%201998.pdf?ua=1.  \n4 R. A. Connelly and M. E. Speer, \u2018Health Literacy and Health C ommunication\u2019, in Health Literacy and Child Health \nOutcomes, R. A. Connelly and T. Turner, Eds. Cham: Springer International Publishing, 2017, pp. 1 \u201313 [Online]. \nAvailable: http://link.springer.com/10.1007/978 -3-319-50799 -6_1.  \n5 L. Nielsen -Bohlman, A. M. Panzer, and D. A. Kindig, Health Literacy: A Prescription to End Confusion. Washington, \nD.C.: National Academies Press, 2004 [Online]. Available: http://www.nap.edu/catalog/10883.  Springschool Healthy Herbs : Health literacy and the public health perspective of phytotherap. knowledge  (M. Seel)  \n \n \n3 \n How can health literacy be developed? \n\u2022 (Hea lth) education: strong connection between education and health in general; with the \nswitch from a paternalistic to patient- centered perspective, the engagement of the patient \nincreases,  and the patient should be empowered by being pr ovided with adequate \nresources to learn and to develop health knowledge, which influences health literacy  \n \nAn interesting paper from the field of physiotherapy : H. Wittink, J. Oosterhaven,  Patient \neducation and health literacy,  Musculoskeletal Science and Practice,  Volume 38,  2018,  \nPages 120- 127,  ISSN 2468- 7812,  https://doi.org/10.1016/j.msksp.2018.06.004.  \n(can be found on M oodle)  \n \n\u2022 Health care professionals  as multipliers  of health knowledge: e.g. by relying on traditionally \nused preparations instead of \u201cfirst- line chemicals\u201d , explaining why some preparations \nshould be used with caution etc. , \u201chelp for self- help\u201d (education on OTC drugs etc.)  \n \n\u2022 Hereditary knowledge transmission: e.g. within families from mother to daughter , \u201chome \nremedies \u201d \u2013 part of the cultural capital of a s ociety  \nCultural capital  \nTools, knowledge, skills, traditions  \netc. \nof a society  of an individual  \n \nObjectified cultural capital  Institutionalized cultural \ncapital  Incorporated cultural capital  \nwork of art, scientific \ninstruments etc.  academic degrees, university, \npublications etc.  things you learned at \nschool/university, parental \neducation etc.  \ncan be directly transmitted by \nbuying- and-selling etc.  \u201cproof\u201d of knowledge/skills \nyou can show to others  you need to embody  that \nknowledge by learning and \nyou can\u2019t inherit it to the next \ngeneration directly (by birth)  \nFigure 1: Cultural Capital based on Pierre Bourdieus capital theory , own illustration \n\uf0e8 Resource for informed decision making!  \n Springschool Healthy Herbs : Health literacy and the public health perspective of phytotherap. knowledge  (M. Seel)  \n \n \n4 \n Home remedies  and phytotherapy as cultural capital  \nHome remedies: \u201cA traditional therapy  often  utilizing  natural  products,  nutritional  supplements,  \nor physical  measures.  Its effectiveness  may  be supported  by familial,  local,  or culturally accepted  \nstories  or rituals. \u201d6 \nKnowledge about home remedies needs transmission from one generation onto the next to \n\u201csurvive\u201d -> traditional knowledge (in families, societies etc.) is part of the cultural heritage and \ntherefore of the cultural capital  \nFor example  \n\u2022 wet feet wraps with vinegar (\u201cEssigpatscherl\u201d) to cure fever  \n\u2022 mixtures from honey, citrus juice and hot water to treat a sore throat \n\u2022 different tea preparations  \n\u2022 traditionally used phytotherapeutic preparations!  \n \nWhy is this important?  \nSociologists and public health researchers observe certain trends:  \n\u2022 \u201cinformed patients\u201d need sources to become \u201cinformed\u201d - greater emphasi s should be put \non health education and improvement of health literacy in general  \n\u2022 People tend to visit the hospital or a doctor before thinking of how they could help \nthemselves. Many conditions could be treated at home without the need of advanced \nmedical or pharmaceutical knowledge , e.g. y oung parents prefer going to the A&E \ndepartmen ts instead of trying to treat their kid\u2019s conditions at home first  \n\u2022 Patients demand  antibiotic treatment without knowing the negative side effects on their \nbody and the rise of antimicrobial resistances. Doctors are used to prescribing antimicrobial drugs \u2013 even in cases without indication! - because patients \u201cwant it\u201d.  \n\u2022 With a trend to chemical/synthetic medication  and ready -to-use products, we tend to \nforget about traditional home remedies and preparation s  \n \nWe therefore need to keep these traditions alive and transmit the knowledge to the next \ngenerations (by educating young mothers, teaching healthcare professionals etc.).  \nThis does not only promote the continued existence of home remedies and therefore a  \nconservation and maintenance of cultural capital \u2013 this is also an important step towards reducing \nantimicrobial resistances and reducing the amount of antibiotics used in medicine!  \n \n6 Medical Dictionary . S.v. \"Home remedies.\" Retrieved September 1 2021 from https://medical-\ndictionary.thefreedictionary.com/Home+remedies  Methodik klinischer Studien\nTeil I: Fragestellung, Studiendesign und Festlegung derOutcomes\nTeil II: Bias, statistische Analyse und spezifische Probleme in derPhytotherapie\nKlaus Linde\nInstitut f\u00fcr Allgemeinmedizin, TUM\u00fcnchen\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschung\nWiek\u00f6nnen wirWirksamkeit und\nunerw\u00fcnschte Wirkungen von\n\u201eHealthy Herbs\u201c untersuchen?\nKlaus Linde\nInstitut f\u00fcr Allgemeinmedizin, TUM\u00fcnchen\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungEckpunkte\n\u2022Klinische Studien zu \u201eHealthy Herbs\u201c imKontext\n\u2022Untersuchung derWirksamkeit\n\u2022Untersuchung unerw\u00fcnschter Wirkungen\n\u2022Schlussfolgerungen\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschung4 Phasen der klinischen Pr\u00fcfung von\nneuen Arzneimitteln\nPhase I Phase II Phase III Phase IV\nAim-Pharmacology\n-Testing safety/  \ntolerability-Testing safety/\ntolerability\n-Dose -finding /\ninteractions\n-Efficacy-Efficacy\n-Testing safety/  \ntolerability (also in  \nsubpopulations)-Long term safety\n-cost-effectiveness\n-further product  \nprofiling\nMethods\n-about 60to80  \nvolunteers-about 100to500  \npatients\n-double -blind RCTs-up to10,000  \npatients\n-double -blind RCTs-mostly >10,000  \npatients\n-endpoint RCTs,  \nobservational  \nstudies\nPhase I Phase II Phase III Phase IV\nAim-Pharmacology\n-Testing safety/  \ntolerability-Testing safety/\ntolerability\n-Dose -finding /  \ninteractions\n-Efficacy-Efficacy\n-Testing safety/  \ntolerability (also in  \nsubpopulations)-Long term safety\n-cost-effectiveness\n-further product\nprofiling\nMethods\n-about 60to80\nvolunteers-about 100 to500\npatients\n-double -blind RCTs-up to10,000\npatients\n-double -blind RCTs-mostly >10,000\npatients\n-endpoint RCTs,  \nobservational  \nstudies\nAber passt dieses Schema f\u00fcrdie\nPhytotherapie (und CAM -Therapien)?Was istbei\u201eHealthy Herbs\u201c besonders?\n\u2022Sehr unterschiedliche Segmente\n-pflanzliche Arzneimittel\n-healthy herbs jenseits desArzneimittelgesetzes\n-healthy herbs als T eil komplexer, ganzheitlicher Therapien\n\u2022Sehr h\u00e4ufig erfahrungsheilkundliche Wurzeln\n\u2022Parallele statt sequenzielle Forschungsschritte\n\u2022Investition in teure klinische Forschung f\u00fcr Hersteller  \n\u00f6konomisch wenig lukrativ (z.B. kaum Patente), f\u00fcr  \nunabh\u00e4ngige Forscher kaum umsetzbar\n\u2022Vielsubstanzgemische, Zielgr\u00f6\u00dfen meist weich,  \nEffektgr\u00f6\u00dfen meist nicht sehr gro\u00df, inhaltliche  \nHerausforderung bei Studienplanung h\u00e4ufig gro\u00df\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungResearch strategies\nindrug trials andCAM\nScreening of chemical substances\nPhase I trials\nPhase IItrials\nPhase IIItrialsContext, paradigms, \nphilosophical understanding,\nandutilizationComponent efficacy\nComparative effectiveness\nSafety status\nBiological mechanisms\nBiological mechanisms\nW e n n Cl\u00fcinbi c aelrphraacut i cpet klinische F o r sch Culningi c abl pertarctiieceb e n  wird,  \nentsteht eher einFlickenteppich\nF\u00f8nneb\u00f8 etal.BMC Medical Research Methodology 2007 7:7DiePerspektiven f\u00fcrklinischen Studien  \nin der Phytotherapie in Deutschland/  \nEuropa sind nicht gerade ermutigend \u2026\n\u2026 aber es gibt viele Studien aus der  \nVergangenheit undauch heute werden  \nnoch Studien gemacht\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungWann isteine Behandlung wirksam?\nEine typische Antwort:\n\u201eWenn es der Patientin nach der Behandlung besser\ngeht alsvorher\u201c\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungSchmerzintensit\u00e4t\nvorTherapie nach Therapie\nz.B. Gliederschmerz bei  \nErk\u00e4ltungvorTherapie nach Therapie\nz.B. R\u00fcckenschmerz bei\nCa mitKnochenmetastasen\nInstitut f\u00fcrAllgemeinmedizin\n Institut f\u00fcr Allgemeinmedizin undVersorgungsforschungWann isteine Behandlung wirksam?\nWenn es dem Patienten mit der Intervention  \n(wahrscheinlich) besser geht wieohne\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungSchmerzintensit\u00e4t\nTherapiegruppe KontrollgruppevorTherapie nach Therapie\nz.B. Gliederschmerz bei  \nErk\u00e4ltungvorTherapie nach Therapie\nz.B. R\u00fcckenschmerz bei\nCa mitKnochenmetastasen\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungSchmerzintensit\u00e4t\nvorTherapie nach Therapie\nz.B. Gliederschmerz bei  \nErk\u00e4ltungvorTherapie nach Therapie\nz.B. R\u00fcckenschmerz bei\nCa mitKnochenmetastasen\nTherapiegruppe Kontrollgruppe\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungWas w\u00e4hle ichf\u00fcrdieKontrollgruppe\n\u2022Keine Intervention (Ist meine Therapie besser als keine  \nBehandlung?)\n\u2022Andere Intervention (Ist meine Therapie so gut wie  \nTherapie X?)\n\u2022Placebo (Ist meine Therapie spezifisch wirksam?)\n\u2022Usual care only /Minimalinterventionen\n\u2022Kontrollgruppe im Kopf des Betrachters (wie w\u00e4re der\nVerlauf ohne dieTherapie?)\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungWas istanderPlacebofrage besonders?\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschung\n\u2022Keine Intervention (Ist meine Therapie besser alskeine\nBehandlung?)\n\u2022Andere Intervention (Ist meine Therapie so gutwie\nTherapie X?)\n\u2022Placebo (Ist meine Therapie spezifisch wirksam?)\n\u2022Usual care only /Minimalinterventionen\n\u2022Kontrollgruppe im Kopf des Betrachters (wie w\u00e4re der  \nVerlauf ohne dieTherapie?)\nSieuntersucht keine realistische AlternativoptionFragen zur Wirksamkeit  \nfunktionieren IMMER nach dem  \nPIKO -Prinzip\nP  \nI  \nK  \nOPatienten/Participants\nIntervention (z.B. Laif 600 1x tgl. f\u00fcr 6 Wochen)  \nKontrolle bzw. Vergleich (Comparison)  \nOutcome an dem ich esfestmache\nDesigns\n\u2022Randomisierte (kontrollierte) Studie (RCT)\n\u2022Nicht -randomisierte vergleichende Studie\n\u2022Studie ohne Vergleichsgruppe (Fallserien, Kohortenstudien)\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungMerkmale methodisch guter Studien\n\u2022M\u00f6glichst zuf\u00e4llige Zuteilung (Randomisation) zuden\nGruppen\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungInstitut f\u00fcrAllgemeinmedizin\nWarum istRandomisation sotollaus\nmethodischer Sicht?\nRandomisation schafft antikausale Bedingungen \u2192  \nwenn ich Unterschiede zwischen 2 Gruppen sehe, ist  \ndies wahrscheinlich auf die unterschiedlichen  \nInterventionen zur\u00fcckzuf\u00fchren\n(wenn sonst kein Bias oder Zufallseinfluss)Institut f\u00fcrAllgemeinmedizin\nMerkmale methodisch guter Studien\n\u2022M\u00f6glichst zuf\u00e4llige Zuteilung (Randomisation) zuden\nGruppen\n\u2022Wenn m\u00f6glich Verblindung m\u00f6glichst vieler Beteiligter\n-Patient*innen\n-Behandler*innen\n-Beurteilende\n-Statistiker*innen\n\u2022Vorabfestlegung von prim\u00e4ren und sekund\u00e4ren  \nZielkriterien und (angemessenen) Auswertungsmethoden\n\u2022M\u00f6glichst wenig Studienabbr\u00fcche/Datenverlust und  \nangemessener Umgang damit\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungInstitut f\u00fcrAllgemeinmedizin\nWas kann zufalschen Ergebnissen\nf\u00fchren? Methodische Sicht\n\u2022Zufall\nBias (systematische Fehler)\n\u2022Ungleiche Ausgangssituation\n\u2022Ungleichheiten bei der  \n(Begleit)Behandlung\n\u2022Ungleiche Bewertungen\n\u2022Ungleiche Abbr\u00fcche etc.\n\u2022Selektive/multiple/unge -\neignete StatistikFallzahl/Statistische Tests\nRandomisation (gr. Fallzahl)  \n(Adjustierung)  \nVerblindung/Standardisierung\nVerblindung/objektive Ziel-\nkriterien  \nVermeidung/Ber\u00fccksichtigung  \nin derAnalyse\nVorfestlegung angemessener\nstat. MethodenInstitut f\u00fcrAllgemeinmedizin\nWas istanRandomisation inder\nklinischen Praxis schwierig?\n\u2022Widerspricht (hoffentlich!) total dem \u00e4rztlichen Vorgehen\nin derPraxis!\n\u2022H\u00e4ufig Konflikt mit den eigenen \u00dcberzeugungen der\nbeteiligten \u00c4rzt*innen\n\u2022Pr\u00e4ferenzen derPatient*innen\n\u2022Rekrutierung und Zustimmung derPatient*innen\n\u2022Bei kleinen Fallzahlen zuf\u00e4llige Unterschiede bzgl.\nprognostisch relevanter Merkmale\n\u2022Auschlie\u00dflicher Fokus aufZwischengruppenunterschiede\n(eigentlich Problem aller kontrollierter Studien)C\nI\nP \nOC\nI\nP\nO\nNur darum geht es:Unterschied\nzwischen denGruppenDas wird ignoriert :Die\u00c4nderung,\ndieauch inderPlacebo -/Kontroll -\ngruppe beobachtet wirdWarum sind Placebokontrollen wichtig?\n\u2022Legitimation: sie gew\u00e4hrleisten, dass Behandlungen\n\u201efunktional spezifisch\u201c sind1,2\n\u2022Biasvermeidung: Sie erlauben Verblindung bei einem  \nVergleich mit einer Nicht -Therapie (????)2\n\u2022Zulassung\n1T. Parsons. The Social System, 1961\n2Besonders wichtig wenn, Interessenskonflikte bestehen (z.B. Unternehmen pr\u00fcft sein  \nProdukt), Risiken relevant sind und Wirkmechanismen unklar sind\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungInstitut f\u00fcrAllgemeinmedizin\n\u2022Umsetzung  meist einfacher  (z.B. Zuteilung nach\nPr\u00e4ferenzen;  falls vorhanden Daten ausRegistern)\n\u2022Praktisch unvermeidlich:  Die Startbedingungen der\nGruppen unterscheiden sich!!!\nWas kann man tun?\n\u2022Statistische Adjustierung von Baseline -Unterschieden\n\u2022MatchingNichtrandomisierte, vergleichende  \nStudienInstitut f\u00fcrAllgemeinmedizin\n\u2022Fallserien, fr\u00fcher h\u00e4ufig Anwendungsbeobachtungen\n\u2022Im Prinzip einfach durchzuf\u00fchren\n\u2022Wenn zu pflanzlichem Arzneimittel meist unter das AMG  \nArzneimittelgesetz fallen) und damit doch aufw\u00e4ndig\n\u2022Kausalit\u00e4tsbewertung schwierig (bis unm\u00f6glich)\n\u2022Eher zur \u00dcberpr\u00fcfung von Verl\u00e4ufen undVertr\u00e4glichkeit\nunter PraxisbedingungenBeobachtungsstudien ohne  \nVergleichsgruppeInstitut f\u00fcrAllgemeinmedizin\nKasuistiken\n\u2022Zum Wirksamkeitbeleg nur in Sonderf\u00e4llen verwenden\n\u2022F\u00fcr eine ganzheitliche Betrachtung eines Einzelfalls sinnvoll (und\nals didaktisches Instrument Mittel derWahl)\n\u2022Zwei zentrale (selbst)kritisch Fragen\n-Hat sich der Zustand wirklich relevant ver\u00e4ndert?\n-Was au\u00dfer meiner Therapie k\u00f6nnte  die  \u00c4nderung bewirkt haben?\nN-of-1trials\n\u2022Bei einem einzelnen Patienten zuf\u00e4llig abwechselnde Phasen mit  \nGabe der Therapie und des Placebos/der Vergleichstherapie\n\u2022Nur sinnvoll, wenn nach Absetzen der Therapie wieder der  \nAusgangszustand eintrittKasuistiken/multiple Kasuistiken/\nn-of-1 trials/multiple n -og-1trialsInstitut f\u00fcrAllgemeinmedizin\nWann isteine Intervention sicher und\nvertr\u00e4glich?\nInstitut f\u00fcr Allgemeinmedizin undVersorgungsforschungInstitut f\u00fcrAllgemeinmedizin\n\u2022K\u00f6nnen bei h\u00e4ufigen unerw\u00fcnschten Wirkungen kausale\nZusammenh\u00e4nge h\u00e4ufig (einigerma\u00dfen) gutbelegenRCTs und Sicherheit/Vertr\u00e4glichkeitInstitut f\u00fcrAllgemeinmedizin\n\u2022K\u00f6nnen bei h\u00e4ufigen unerw\u00fcnschten Wirkungen (UW)  \nkausale Zusammenh\u00e4nge h\u00e4ufig (einigerma\u00dfen) gut  \nbelegen\n\u2022Seltene UW werden in der Regel nicht erfasst, da  \nTeilnehmerzahl zu klein (z.B. Sinusvenenthrombosen bei  \nder AstraZeneca Covid -19-Impfung)\n\u2022Durch Ausschluss gef\u00e4hrdeter Personengruppen k\u00f6nnen  \nrelevante UW \u00fcbersehen werden (z.B. Interaktionen bei  \nJohanniskrautextrakten bei HIV-oder  \nTransplantationspatienten)RCTs und Sicherheit/Vertr\u00e4glichkeitInstitut f\u00fcrAllgemeinmedizin\n\u2022Wissen zuInhaltsstoffen\n\u2022Kontrollierter Bedingungen bei Anbau, Extraktion etc.\n\u2022Pharmakologische/toxikologische Untersuchungen\n\u2022Surveillance (systematische Meldung undRegistrierung\nvon potenziellen UW)\n\u2022Kasuistiken\n\u2022Anwendungsbeobachtungen\n\u2022RCTs/kontrollierte StudienBewertung von  \nSicherheit/Vertr\u00e4glichkeitInstitut f\u00fcrAllgemeinmedizin\nZusammenfassung\nSchlussfolgerungen?Institut f\u00fcrAllgemeinmedizin\n\u2022Klinische Forschung zu \u201eHealthy Herbs\u201c ist eine  \nHerausforderung und erfolgt unter schwierigen  \nRahmenbedigungen\n\u2022Eine evidence -based herbal medicine nach strengen  \nStandards ist nur in kleinen Teilbereichen erreichbar\n\u2022Aber: eine strenge evidence -based medicine ist in weiten  \nBereichen der Medizin eine Illusion\n\u2022Meine Sicht: Eine kritisch reflektierter (und nicht von  \nWerbung und \u00f6konomischen Interesse geleiteter) Einsatz  \nvon \u201eHealthy Herbs\u201c erscheint aber zur Vermeidung  \nnebenwirkungsreicherer Therapien und als Teil einer  \npatientenzentrierten Medizin sinnvoll undw\u00fcnschenswertZusammenfassung  \nSchlussfolgerungen?Institut f\u00fcrAllgemeinmedizin\nVielen Dank!\nLeseempfehlung f\u00fcr Interessierte:\nFletcher, R: Clinical Epidemiology: The Essentials (eine gute Einf\u00fchrung  \nin die Methodik und \u201cIdeologie\u201d hinter der evidenzbasierten Medizin)\uf07aSecondary metabolites\nof plants used for t he\nr\nespiratory tractMag. Gudrun Englmaier\nCenter for Traditional Chinese Medicine and Complementary \nMedicine, Donau- Universit\u00e4t, Krems\n\uf07a\nSecondary metabolites \u2013Introduction \nConstituents \nfor treating \nrespiratory \ndiseasesEssential \noils\nMucilages\nSaponines FlavonoidsSalicylates\uf07a\nSecondary metabolites \u2013Introduction \nConstituents \nfor treating \nrespiratory \ndiseasesEssential \noils\nMucilages\nSaponines FlavonoidsSalicylates\n\u00a9 Kenraiz\n\u00a9 ArtMechanic\n\u00a9 p40p\n\u00a9 T. Kebert\n\u00a9 Henry Brisse\uf07a\nSecondary metabolites \u2013Introduction \nConstituents \nfor treating \nrespiratory \ndiseasesGlucosinolates\nTerpenoids \n(Iridoids and \nDiterpenes)Coumarin and \nderivatives \uf07a\nSecondary metabolites \u2013Introduction \nConstituents \nfor treating \nrespiratory \ndiseasesGlucosinolates\nTerpenes \n(Iridoids and \nDiterpenes)Coumarin and \nderivatives \n\u00a9 Abrahami\n\u00a9 Stickpen \n\u00a9 Hans \nHillewaert\uf07a\nSecondary metabolites \u2013 Introduction \n\uf0a7not necessary for the organism to live\n\uf0a7for interaction of plants with the \nenvironment \n\uf0a7can be used as medicines, flavorings and pigments\n\uf0a7important constituents of plants for \nrespiratory diseases : Essential oils, \nMucilages, Saponines, Flavonoids, Salicylates, \u2026\nSecondary metabolites \u2013Introduction \n\u00a9 in Heilmann et al. (2015), p. 7 \uf07a\n\uf0a7non-volatile, water -soluble anions, \nglucosides\n\uf0a7in plants of the order Brassicales \n(Brassicaceae, Capparaceae, Resedaceae\nand Tropaeolaceae), including edible plants \n(broccoli, brussels sprouts\u2026)\n\uf0a7> 120 different glucosinolates\n\uf0a7pungent smelling or taste because of mustard oils produced from glucosinolates when the plant material is damaged (breakdown products)Glucosinolates \n\u00a9 Eric Hunt\n\u00a9 Fire0002\n\u00a9 Edal Anton LefterovGlucosinolates \u2013chemistry, biochemistry and occurrence \uf07a\n\uf0a7derive from glucose + an amino acid\n\uf0a7contain sulfur and nitrogen\n\uf0a7central carbon atom (+ side group), \nthioglucose group, nitrogen atom + \nsulfate group\n\uf0a7ability to convert into an isothiocyanate \n(\"mustard oil\u201c = lipophilic, liquid, mostly volatile and pungent smelling) by enzymatic processes ( myrosinase)\n\uf0a7myrosinase and glucosinolates are stored in separate compartments of the cellGlucosinolates \n\u00a9 Benjah -bmm27Glucosinolates \u2013chemistry, biochemistry and occurrence \uf07a\nenzyme myrosinase cleaves \noff the glucose group \uf0e0\nremaining molecules = \nisothiocyanate, nitrile or thiocyanate\nmustard oil Glucosinolates \n\u00a9 in Lindequist et al. \n(2020), p. 464Glucosinolates \u2013chemistry, biochemistry and occurrence \uf07a\n\uf0a7fungicide, bactericide, antiproliferative, antiviral, anti-inflammatory effects\n\uf0a7discussed modes of action: reduce or even inhibit the activity of NF -kappaB, \ninteraction with bacterial biofilm , ITC-specific targets still unknown \n\uf0a7strong skin and mucosal irritation \uf0e0hyperemising effect, i ncrease of gastric juice \nsecretion, appetite and digestion stimulating effect \n\uf0a7Metabolism: glutathione conjugation, further modification, excreted via urine\n\uf0a7Use: used for treatment of upper respiratory and urinary tract infections \n(internal and external), muscular pains\n\uf0a7Side effects: \n\uf0a7skin and mucosal irritation , not longer than 4 -6 weeks \n\uf0a7Gastrointestinal problems (intake after meals)\n\uf0a7Contraindications: children, gastroduodenal ulcers, kidney diseaseGlucosinolates Glucosinolates \u2013properties\uf07a\nGlucosinolates \u2013plant examples used for respiratory tract Glucosinolates Medical plants Armoracia rusticana\nHerbal drug Armoraciae radix\nFamily Brassicaceae\nHerbal prep. powder in capsule, wraps (traditional) \nIndication no monographs, used for treatment of upper \nrespiratory and urinary tract infections in combination with Armoracia \nMedical plants Tropaeolum majus\nHerbal drug Tropaeoli maji herba\nFamily Tropaeolaceae\nHerbal prep. powder in capsule, wraps (traditional) \nIndication no monographs, used for treatment of upper \nrespiratory and urinary tract infections in \ncombination with Armoracia \n\u00a9 Wouter Hagens \n\u00a9 Anna reg\uf07a\nGlucosinolates \u2013plant examples used for respiratory tract Glucosinolates \nSinigrin\uf0e0mustard oil (allyl isothiocyanate)\n\u00a9 Anna reg\n\u00a9 Wouter Hagens \nGlucotropaeolin \uf0e0Mustard oil ( benzyl- ITC)\nhttps://upload.wikimedia.org/wikipedia/commons/b/bc/Thioglycoside_to_Benzyl_Isothiocyanate_V.1.pnghttps://upload.wikimedia.org/wikipedia/commons/f/f1/Thioglycoside_to_Allyl_Isothiocyanate_V.1.png\uf07a\nGlucosinolates Medical plants Sinapis alba\nHerbal drug Erucae semen \nFamily Brassicaceae\nHerbal prep. wraps (traditional) \nIndication DAC and Commission E monographs: local \napplication for treatment of catarrhs of the upper respiratory tract\nMedical plants Sinapis nigra \nHerbal drug Sinapis nigrae semen\nFamily Brassicaceae\nHerbal prep. wraps (traditional) \nIndication DAC and Commission E monographs: local application for treatment of catarrhs of the upper \nrespiratory tract\u00a9 Anna reg\n\u00a9 AbrahamiGlucosinolates \u2013plant examples used for respiratory tract \uf07a\nGlucosinolates Medical plants Sisymbrium officinale\nHerbal drug Sisymbrii herba\nFamily Brassicaceae\nHerbal prep. Dry extracts \nIndication HMPC Monograph (trad. use):  for the relief of\nthe symptoms of throat irritation such ashoarseness and dry cough\u00a9 Anna regGlucosinolates \u2013plant examples used for respiratory tract \nMedical plants Nasturtium officinale\nHerbal drug Nasturtii herba\nFamily Brassicaceae\nHerbal prep. fresh plant or drug \nIndication Commission E: for treatment of catarrhs of the upper respiratory tract\n\u00a9  Paul Venter\n\u00a9  Rafandalucia\uf07a\nCoumarin and derivatives \u2013chemistry and occurrence \n\uf0a7coumarins = 1,2-benzopyrones\n\uf0a7originate from the phenylpropanoid pathway\n\uf0a7coumarin = colorless crystalline solid, sweet odor and \nbitter taste; dicumarol naturally occurring \nanticoagulant drug\n\uf0a7different classes (hydroxylated and methoxylated \ncoumarins, furanocoumarins, pyranocoumarins ,\u2026)\n\uf0a7ubiquitously found in higher plants, e.g. Meliloti herba, Ammeos visnagae fructus, Pelargonii radix\n\uf0a7analgesic, antifungal, antioxidant, choleretic, immunostimulating, anti-edema, sedative, spasmolytic, photosensitizing effectsCoumarins\n\u00a9 Blascchek (2016), p. 485\uf07a\nPhenylpropanoid pathway\nShikimic acidCoumarins\n\u00a9 in Lindequist et al. \n(2020), p. 275- 276Coumarin and derivatives \u2013biosynthetic pathway\nCinnamic acidPhenylalanine\uf07a\nMedical plants Pelargonium sidoides , Pelargonium reniforme\nHerbal drug Pelargonii radix\nFamily Geraniaceae\nConstituents \u2022Phenolic acids, phenylpropanoids and derivatives\n\u2022Coumarins\n\u2022Flavonoids\n\u2022Proanthocyanidins\nHerbal prep. liquid and dry extracts (solvent ethanol), special extract\nIndication Traditional herbal medicinal product for the \nsymptomatic treatment of common cold (HMPC, ESCOP , Ph. \nEur.)Coumarin and derivatives \u2013plant examples used for respiratory tract Coumarins\n\u00a9 Stickpen \n\u00a9 in Lindequist et al. (2020), p. 283\n\u00a9 Moyo et al. (2014) \uf07a\nCoumarinsKolodziej\n\u00a9 Kolodziej (2007)Coumarin and derivatives \u2013plant examples used for respiratory tract \nhigh degree of \naromatic \nfunctionalisation \n(OH; OCH3)\uf07a\nCoumarins\uf0a7Extracts of pelargonium root show antibacterial, antiadhesive, antiviral, \nimmunomodulating, secretolytic and secretomotoric activity \uf0e0not a \nsingle substance responsible for effects \n\uf0a7EPs\u00ae 7630 : special aqueous ethanolic (11% m/m) extract of P . sidoides \n(principal compounds: phenolic compounds and coumarins)\n\uf0a7Side Effects : \n\uf0a7Interactions with anticoagulants ?\n\uf0a7Hepatotoxicity?Coumarin and derivatives \u2013plant examples used for respiratory tract \uf07a\nTerpenoids \u2013chemistry, biochemistry and occurrence \nTerpenes\uf0a7isoprene rule (C5 rule) ,building blocks:\n\uf0a7dimethylallyl pyrophosphate ( DMAPP)\n\uf0a7isopentenyl pyrophosphate ( IPP)\n\uf0a72 metabolic pathways : the mevalonate \n(MVA) and the non-mevalonate (MEP) \npathway\n\uf0a7occur in all organisms, in the greatest variety in green plants\n\uf0a7classification based on the number of C \natoms\n\uf0a7largest group of natural products:  > 35 000\n\u00a9 in Heilmann et al. (2015), p. 515 and 517 \uf07a\nTerpenes\n\uf0a7type of monoterpenoids (cyclopentanopyrane) \nwith 2 O -Functions; precursor : Geranyl \npyrophosphate\n\uf0a7widespread in plants and some animals (Gentianaceae, Lamiaceae, Plantaginaceae and Caprifoliaceae) > 200 different \ncompounds\n\uf0a7antimicrobial (antibacterial, antifungal, antiviral), analgesic, antiphlogistic, choleretic, laxative, immunomodulating, hypotensive, antioxidant effects, bitter taste \n\uf0a7hydrolysis of intact iridoid glycosidesIridoid s\u2013chemistry, biochemistry and occurrence \n\u00a9 in Heilmann et al. (2015), p. 517 \uf07a\nTerpenes\uf0a73 classes: secoiridoids, \nglucosides or non -glycosides\n\uf0a7Verbenae herba, Agni casti \nfructus, Veronicae herba, Harpagophyti radix, \nPlantaginis lanceolatae \nfolium, \u2026.\n\u00a9 Hans \nHillewaertIridoid s\u2013chemistry, biochemistry and occurrence \n\u00a9 in Heilmann et al. (2015), p. 519\uf07a\nTerpenesMedical plants Plantago lanceolata\nHerbal drug Plantaginis lanceolatae folium\nFamily Plantaginaceae\nConstituents \u20222-3% iridoid glycosides with aucubin and Catalpol as main compounds\n\u20222\u20136% Mucilages \n\u2022Flavonoids: mainly apigenin and luteolin\n\u2022Phenylethanoids: acteoside\n\u2022Tannins\nHerbal prep. Tea drug, extracts\nIndication Traditional herbal medicinal product as a demulcent for the symptomatic \ntreatment of oral or pharyngeal irritations and associated dry cough (HMPC )Iridoid s\u2013plant examples used for respiratory tract \n\u00a9 in Heilmann et al. (2015), p. 521antibiotic effects\uf07a\nDiterpenoids \u2013chemistry, biochemistry and occurrence Terpenes\uf0a720 carbon atoms, 4 isoprene units\n\uf0a7Precursor : Geranylgeranyl pyrophosphate\n\uf0a7great structural diversity caused by \nsecondary modifications (ring extensions, narrowings, openings, \u2026) \n\uf0a7cytotoxic, antitumoral, antimicrobial, antifungal, antiparasitic, antiviral, anti -\ninflammatory, spasmolytic, cardiotonic, \nhypotensive, bitter or sweetening effect, \u2026\n\uf0a7> 3000 diterpenoids \n\uf07a\nTerpenesPrecursor : Geranylgeranyl \npyrophosphateDiterpenoids \u2013chemistry, biochemistry and occurrence \n\u00a9 in Lindequist et al. \n(2020), p. 376Bicyclic, tricyclic, \ntetracyclic compounds\nSteviosidTaxol A; Paclitaxel \nMarrubiin\uf07a\nTerpenesMedical plants Marrubium vulgare \nHerbal drug Marrubii herba\nFamily Lamiaceae\nConstituents \u2022Diterpenes of labdane -type with marrubiin \n(0.12- 1%) and its precursor pre -marrubiin \n(0.13%)\n\u2022Phenolic compounds (acteoside, chorogenic \nacid, caffeic acid, tannins, \u2026)\n\u2022Flavonoids\n\u2022Traces of essential oil (ca. 0,05 %)\nHerbal prep. Tea drug, expressed juice, liquid extracts\nIndication Traditional herbal medicinal product used as an expectorant in cough associated with cold; for symptomatic treatment of mild dyspeptic complaints and loss of appetiteDiterpenoids \u2013plant example used for respiratory tract \n\u00a9 Stefan.lefnaer\uf07a\nTerpenes\n\u00a9 in Lindequist et al. \n(2020), p. 376 Indication : Traditional \nherbal medicinal \nproduct used as an \nexpectorant in cough \nassociated with coldMode of \naction?\nMain active \nsubstance?Diterpenoids \u2013plant example used for respiratory tract \n\u00a9 Kurt St\u00fcber\uf07a\nLiteratureTerpenesBlaschek, W., Wichtl, M., Bauer, R., Buff, W., Classen, B., Heise, E. M., & Hensel, A. (Eds.) (2016). Wichtl -Teedrogen und \nPhytopharmaka: Ein Handbuch f\u00fcr die Praxis (6., vollst\u00e4ndig neu bearbeitete und erweiterte Auflage). Stuttgart: WVG \nWissenschaftliche Verlagsgesellschaft.\nLindequist, U., Melzig, M.F., & Teuscher, E. (2020). Biogene Arzneimittel Lehrbuch der Pharmazeutischen Biologie (8., \n\u00fcberarbeitete und erweiterte Auflage). Stuttgart: Wissenschaftliche Verlagsgesellschaft.\nSticher, O., Heilmann, J., & Z\u00fcndorf, I. (2015). Pharmakognosie -Phytopharmazie (10., v\u00f6llig neu bearbeitete Auflage). \nStuttgart: Wissenschaftliche Verlagsgesellschaft.\nEMA: Assessment report on Marrubium vulgare L., herba and Community herbal monograph on Marrubium vulgare L., \nherba\nEMA: Assessment report and Community herbal monograph on Plantago lanceolata L., foliumEMA: Assessment report and Community herbal monograph on Pelargonium sidoides DC and/or Pelargonium reniforme \nCurt., radix \nEMA: Assessment report on Sisymbrium officinale (L.) Scop., herba\uf07a\nLiteratureTerpenesConrad, A., Biehler, D., Nobis, T., Richter, H., Engels, I., Biehler, K., Frank, U. (2013). Broad spectrum antibacterial activit y of a \nmixture of isothiocyanates from nasturtium (Tropaeoli majoris herba) and horseradish (Armoraciae rusticanae radix). Drug Res \n(Stuttg) . 63(2):65 -8. doi: 10.1055/ s-0032 -1331754\nGoos, K.H., Albrecht, U., Schneider, B. (2012). Wirksamkeit und Vertr\u00e4glichkeit eines pflanzlichen Arzneimittels mit \nKapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentz\u00fcndung im Vergleich zu \nanderen Therapien unter den Bedingungen der t\u00e4glichen Praxis. Arzneimittelforschung. 62(12):e4. doi: 10.1055/s- 0033 -\n1351284\nKolodziej , H. (2007). Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and \nphytomedicinal sources of the herbal medicine Umckaloabo. Phytomedicine . 14 Suppl 6:9 -17. doi: \n10.1016/j.phymed.2006.11.021\nMoyo, M., Van Staden, J. (2014). Medicinal properties and conservation of Pelargonium sidoides DC. J Ethnopharmacol ., \n14;152(2):243 -55. doi: 10.1016/j.jep. 2014.01.009\nPrieto, M.A., L\u00f3pez, C.J., Simal -Gandara, J. (2019). Glucosinolates: Molecular structure, breakdown, genetic, bioavailability, \nproperties and healthy and adverse effects. Adv Food Nutr Res., 90:305 -350. doi: 10.1016/bs.afnr.2019.02.008\nTimmer, A., G\u00fcnther, J., Motschall, E., R\u00fccker, G., Antes, G., Kern, W.V. (2013). Pelargonium sidoides extract for treating a cute \nrespiratory tract infections . Cochrane Database Syst Rev. 22;(10). doi: 10.1002/14651858. CD006323\uf07aThank you for your \nattention!Mag. Gudrun Englmaier\nCenter for Traditional Chinese Medicine and Complementary \nMedicine, Donau- Universit\u00e4t, Krems\nSpring School\nFlorence, 5th -9th April 2022\nMarco Michelozzi\nFelicia Menicucci\nEleonora PalaganoUniversity of Florence\nHEALTHY HERBS\nPhytotherapy as a Strategy against Antimicrobial Resistances\nEcological roles of essential oil terpenes \nand their multiple applications\nEcological roles of essential oil terpenes \nSesquiterpenes C15\n\u03b2-Caryophyllene\n HumuleneMonoterpenes C10\nLimonene\n Thymol Carvacrol \nEssential oil\nResin essential oil components \nbelong mainly to the vast \nmajority of the terpene family\nResinTERPENES\nDiterpenes C20\nPimaric acid\n Abietic acidEcological roles of essential oil terpenes \nIsoprene and some monoterpenes are emitted in ambient air, \ninfluencing tropospheric atmospheric chemistry, including ozone \nlevels\nEcological roles of essential oil terpenes \nAttraction of pollinatorsEcological roles of essential oil terpenes \nTerpenes are sequestered in specific structures such as \nsecretory idioblasts , laticifers , and trichomesEcological roles of essential oil terpenes \nAlthough total quantities ofmonoterpenes areaffected byavailability of\nabiotic resources, therelative proportions (percentages) ofconstitutive\nmonoterpenes inmature tissues (which make upthe constitutive\nmonoterpene profile orthe constitutive mixture) have been shown to\nbeunder strong genetic control and little affected byabiotic factors\n(reviewed byLangheneim 1994 .Journal ofChemical Ecology, 20:1223 -\n1280 ).Monoterpenes C10\nb-pinene\n3-carene\nmyrcene\nb-phellandreneEcological roles of essential oil terpenes \nMichelozzi et al . 2008, iForest -\nBiogeosciences and Forestry, 1:65-74.Seasonal variations in monoterpene profiles in Mediterranean pine species of \ngroup \u201c halepensis \u201d\nNet photosynthesis (mmol m-2 s-1)\n02468101214161820\nPinus halepensis\nPinus brutia\nPinus eldaricaNeedle conductance (mmol m-2 s-1)\n020406080100120\naleppo\nbruzio\neldarica\nMonth\n1996                              1997                              1998AMJJASONDJFMAMJJASONDJFMAMJJASONDJFPredawn water potential (MPa)\n-3-2-10Ecological roles of essential oil terpenes \nb- Pinene (%)\n0255075\nP. brutia\nP. eldarica\nP. halepensisCamphene (%)\n02\nMonth\n1996                  1997                    1998AMJJASONDJFMAMJJASONDJFMAMJJASONDJF\uf061-Pinene (%)\n02550foliar tissueb-Myrcene (%)\n0204060 \uf064-3 Carene (%)\n020\nAMJJASONDJFMAMJJASONDJFMAMJJASONDJFSabinene (%)\n0510\nb - Caryophyllene (%)\n012Cineole (%)\n01\nAMJJASONDJFMAMJJASONDJFMAMJJASONDJFLimonene (%)\n020\nMonth\n1996                  1997                    1998Month\n1996                  1997                    1998\nMichelozzi et al . 2008, iForest -\nBiogeosciences and Forestry, 1:65-74.Seasonal variations in monoterpene profiles in Mediterranean pine species of \ngroup \u201c halepensis \u201dEcological roles of essential oil terpenes \nb- Pinene (%)\n0255075\nP. brutia\nP. eldarica\nP. halepensisCamphene (%)\n02\nMonth\n1996                    1997                    1998AMJJASONDJFMAMJJASONDJFMAMJJASONDJF\uf061-Pinene (%)\n02550cortical tissue b-Myrcene (%)\n0204060\uf064-3 Carene (%)\n020\nMonth\n1996                          1997                          1998AMJJASONDJFMAMJJASONDJFMAMJJASONDJFSabinene (%)\n0510\nb- Caryophyllene (%)\n012Col 43 vs b- caryoph-bruz \nCol 43 vs b caryophelda \nCol 43 vs b caryoph-ale Cineole (%)\n01\nMonth\n1996                           1997                           1998AMJJASONDJFMAMJJASONDJFMAMJJASONDJFLimonene (%)\n020\nMichelozzi et al . 2008, iForest -\nBiogeosciences and Forestry, 1:65-74.Seasonal variations in monoterpene profiles in Mediterranean pine species of \ngroup \u201c halepensis \u201dEcological roles of essential oil terpenes \nLavaronea-pinene\ncamphene\nb-pinene\nsabinene\nb-myrcene\nlimonene\ncineole\nAbetone\nGroup A\nGroup B\nNebrodi\nVendramin et al.1995. Forest Genetics , 2: 171 -175.Monoterpene profiles as biochemical markers in Abies nebrodensis and Abies albaEcological roles of essential oil terpenes \nTerpene profiles in the artificial hybride\nPinus Brutia Ten. \uf0b4Pinus halepensis Mill.\nHy br i d: P . br ut i a  x  P .  ha l e pe nsi s\n020406080100\nb-pinene b-myrcenecortical tissue\nfoliar tissue\nFemale  P. brutia\n050100\nb-pinene b-myrcenecortical tissue\nfoliar tissue\nMale P. halepensis\n0255075100\nb-pinene b-myrcenecortical tissue\nfoliar tissue\nMichelozzi et al.1990. J. Genet. & Breed. , 44: 241 -246.Ecological roles of essential oil terpenes \nPrimary and secondary metabolism: two functional levels \nwith entirely different characteristics\nPRIMARY METABOLISM\n\u2022Growth and development of the individual\n\u2022indispensable\n\u2022uniform\n\u2022universal\n\u2022conservativeSECONDARY METABOLISM\n\u2022Interaction of the individual with its \nenvironment\n\u2022dispensable for growth\n\u2022indispensable for survival of a    population\n\u2022unique\n\u2022diverse\n\u2022adaptive\nHartmann T. 1996. Entomologia Experimentalis et Applicata 80:177 -188Ecological roles of essential oil terpenes \nPlant genotype\nSynthesis of oleoresin terpenoids\nAbiotic \nresource Effects on total concentrations\nand variation in compositional profilesBiotic\nselection\npressures\nPrimary defensive \nchemicals\n(constitutive or \ninduced )Indirect defense\nvia attraction of\nentomophagesVolatilization\nStored in plant tissues\nAttraction of \npollinators\nSimplified scheme from Langenheim 1994. Journal of Chemical Ecology, 20:1223 -1280 Leaching, litter decompositionMajor ecological roles for plant terpenoidsEcological roles of essential oil terpenes \nMechanism of resin mobilization\nMonoterpenes Sesquiterpenes Diterpenes\nChemical defence system inpine trees include theconstitutive terpenoid -rich resin and theinduced resin which\nappear tobesynthesised denovo inresponse topest attack .This newly synthesised resin differs inits\nproportionate monoterpene composition compared tothat ofthe preformed resin .Some trees show an\naccumulation inthemost toxic concentration ofmonoterpenes inresponse topests .\nphytophagous\ninsect\nconstitutive resininduced resinEcological roles of essential oil terpenes \nFusiform Rust\nFusiform rust (Cronartium quercuum f.sp.fusiforme ),\nisthe most damaging disease ofslash and loblolly\npines throughout thesoutheastern United States .This\ndisease causes stem, branch and trunk cankers (galls)\ntoform oninfected trees\nMichelozzi et al. 1995. Can. J. For. Res., 25: 193 -197.Ecological roles of essential oil terpenes \nLoblolly pine clones  \n \nMonoterpene class  \n  \nNo. clones \nresistant   \nNo. clones  \nSusceptible  \n  \nPercent \nresistant   \nX2 \nHigh b-pinene  33 34 49.3  \nLow b-pinene  5 1 83.3 1.38 \nHigh myrcene  24 17 58.5  \nLow m yrcene  14 18 43.8 1.04 \nHigh limonene  5 2 71.4  \nLow l imonene  33 33 50.0 0.46 \nHigh  b-phellandrene  32 18 64.0  \nLow b-phellandrene  6 17 26.1 7.62**  \n \nMonoterpene profiles and fusiform rust resistance in loblolly pines\nChi-square test  of  independence for numbers of fusiform rust resistant and susceptible loblolly pine \nclones among clones classified as having high versus low content of  various monoterpenes . \n**Significant at  the  0.01 level\nMichelozzi et al.1995. Can. J. For. Res., 25: 193 -197.Ecological roles of essential oil terpenes \nLoblolly pine phenotype  \n \nItem Bmlp BMlp BmlP BMl P BmL P bMlP \n \nNumber  \nOf clones    9 10 16 26 5 3 \n \nMean level   \nof resistance  31.3 46.5 55.1 56.0 60.2 71.0 \n \n\uf061\uf02dpinene  70.3 61.3 60.3 43.6 42.3 57.6 \ncamphene  1.0 0.9 1.1 0.9 1.0 1.0 \nb-pinene  24.6 17.6 24.6 21.0 16.1 2.3 \nmyrcene  1.7 17.5 1.7 22.1   3.0 24.8 \nlimonene  1.2 0.7 1.1 1.0 22.6 0.8 \nb-phellandrene  0.9 1.8 10.9     11.4  14.4 12.9 \n \nMonoterpene profiles and fusiform rust resistance in loblolly pines\nB,M,L, and P represent high amounts of b-pinene, myrcene , limonene and b-phellandrene , \nrespectively , while lowercase letters represent lowamounts .\nMichelozzi et al.1995. Can. J. For. Res., 25: 193 -197.Ecological roles of essential oil terpenes \nVariations occurring in the constitutive and induced terpenoid mixtures provide \nenormous defensive potential within and among classes of these chemicals\nMixtures enhance additive and synergergistic effects and complexicity to defensive\ninteractions involving primary and secondary metabolites\nEcological roles of essential oil terpenes \nRelationtionships between terpenoid defenses and the attack of Heterobasidion\nspp. in Picea abies Picea sitchensis , and Abies alba\nHeterobasidion spp.  are \nrecognized as some of the most \ndestructive fungal pathogens of \nconifers worldwide. \nHeterobasidion species are \nresponsible for the root and \nbutt rot of several conifer \nspecies. Airborne spores of \nthese pathogens land either on \nfreshly cut stumps or fresh \nwounds (primary infection). \nHeterobasidion fungi infect \nuninjured trees by growth of \nthe mycelium through root \ncontacts or grafts (secondary \ninfection ). Ecological roles of essential oil terpenes \nMonoterpene responses to interacting effects of drought stress and infection by the \nfungus Heterobasidion parviporum in two clones of Norway spruce ( Picea abies )\nThe specific objective of this study was to \ncharacterize the effects of drought stress treatment \nand H. parviporum infection on defensive \nmonoterpenes in Norway spruce clones, exploring \nthe mechanisms of chemical resistance to the attack \nof this pathogenic fungus in plants under drought \nstress conditions.\nMadmony et al . 2018. Environmental and Experimental Botany , 152:137 -148. Ecological roles of essential oil terpenes \nConstitutive monoterpene profiles from two Norway spruce clones (bars indicate \nmeans \u00b1standard error) : \u201crelatively susceptible\u201d clone 171 and \u201crelatively \nresistant\u201d clone 386 to attack by Heterobasidion parviporum\nMadmony et al . 2018. Environmental and Experimental Botany , 152:137 -148. Ecological roles of essential oil terpenes \nChanges in total monoterpene \nconcentrations in the \u201crelatively \nsusceptible\u201d clone 171 (c171) and the \n\u201crelatively resistant\u201d clone 386 (c386)  \nto the attack of Heterobasidion\nparviporum . Treatments: drought -\nstressed plants (D); well -watered (W); \ncortical tissues from non -inoculated \nbranches (C) (white bar); wounded \nplus inoculated with H. parviporum\n(black bar); wounded only (grey bar). \nBars indicate means + standard \nerrors. Different minor letters on the \ntop of the bars indicate significantly \ndifferent disease treatment means \n(Mann -Whitney U test), while capital \nletters on the top of the bars indicate \nsignificant differences between \ndifferent sampling times (day0, \nday22, day44) in C samples (Friedman \ntest)\nMadmony et al . 2018. Environmental and Experimental Botany , 152:137 -148. Introduction\nBark beetle \u2013Fungus \u2013Conifer interaction\n5-6 mmSpruce bark beetle\n(Ips typographus)Ecological roles of essential oil terpenes \nTerpene Defenses\nphytophagous\ninsect\ncarnivorous\ninsect\nVolatile terpene \nsignals\nConstitutive and induced terpenes play the primary role of defence substances. However, through the course of evolution \nherbivores have been selected for their capability to circumvent plant chemical defences . Phytophagous beetles can be \nattracted by terpenes emitted by trees and, in addition, some monoterpene derivates have been reported as playing an \nimportant role in pheromonal communication. Insect predators of bark beetles are also attracted by volatile terpenes; \nthus, monoterpenes play a role in indirect plant defence at third -trophic -level interactions. Induced emission of volatile \nterpene signals warn neighbouring plants of beetle attack.Conclusion : essential oilapplications\nEssential oil\nAromatic medicines\nFood and liquor industry\nPerfumery cosmesy\nCultural heritage \npreservationPlant disease control\nEcological roles of terpene\nConclusion : essential oilapplications\nEssential oil\nAromatic medicines\nFood and liquor industry\nPerfumery cosmesy\nCultural heritage \npreservationPlant disease control\nEcological roles of terpene\nThank you for your attentionSpring School\nFlorence, 5th -9th April 2022\nMarco Michelozzi\nFelicia Menicucci\nEleonora PalaganoUniversity of Florence\nEssential oil terpenes in solid formulates \nfor paper items preservationHEALTHY HERBS\nPhytotherapy as a Strategy against Antimicrobial Resistances\nIntroduction : cultural heritage preservation\nDeterioration ofpaper items due tobiodeteriogens ,such asfungi, bacteria, rodents and insects\na) Conventional techniques based ontoxic chemicals (ethylene oxide )\nb) Essential oilsand terpenes forthecontrol ofpests and microbes\nStabilization of volatile terpenes into solid formulates\naDESSO project (Da ESsenziali a SOlidi ) supported by the Tuscany Region\u2022Plant -derived antimicrobials\n\u2022Insect -repellent properties\n\u2022Broad -spectrum of activity\n\u2022Low water solubility\n\u2022High volatility\n\u2022Short -term efficacyEOs & terpenes : pros and cons\nResults : cultural heritage preservation\nSolid formulates of \u03b2 -cyclodextrins and cocrystals\nSolvent -free synthesisSOLID TERPENE -BASED FORMULATES\nCocrystals \u03b2-Cyclodextrins\nPhenazine -thymol \u03b2-Cyclodextrin -thymol\nPhenazine -carvacrol \u03b2-Cyclodextrin -carvacrol\nPhenazine -eugenol \u03b2-Cyclodextrin -eugenola)\u03b2-Cyclodextrins :hydrosoluble ;provided with hydrophobic cavity\nb) Cocrystals :active ingredient +coformer ;high concentration ofactive ingredient\n\u03b2-cyclodextrin\nThymol Carvacrol Eugenol\nPhenazine\naDESSO project (Da ESsenziali a SOlidi ) supported by the Tuscany Region\nGC/MS analysis to quantify\nthe terpene content\nResults : cultural heritage preservation\nSampling and molecular identification of biodeteriogens\nFungi\nBacteria\naDESSO project (Da ESsenziali a SOlidi ) supported by the Tuscany RegionBiblioteca Nazionale Centrale \ndi Firenze (IT)\nResults : cultural heritage preservation\nAntimicrobial assays : indirect exposition of Cladosporium sp. (abbr . Cla) to the treatments\nCONTROL THYMOL CARVACROL EUGENOL\n\u03b2-CYCLODEXTRINS\nCOCRYSTALS\nPURE TERPENESa)\u03b2-cyclodextrins and cocrystals inihibited fungal proliferation\nb)Cocrystals were more effective than \u03b2-cyclodextrins\naDESSO project (Da ESsenziali a SOlidi ) supported by the Tuscany Region\nMenicucci et al. 2022 International Biodeterioration & Biodegradation \u2013Accepted with revision\nbba\ne      e edcc\ne      e e\nResults : cultural heritage preservation\nOn paper antimicrobial test: indirect exposition to phenazine -carvacrol cocrystal\nThe cocrystal significantly inihibited thefungal proliferation\nA. alternata A. alternata + phenazine -carvacrol\naDESSO project (DaESsenziali aSOlidi )supported bytheTuscany RegionRH~98%\nPhenazine -carvacrol cocristal\nMenicucci et al. 2022 International Biodeterioration & Biodegradation \u2013Accepted with revision\nTerpene -based solid\nformulates for the preventive \ntreatment of biodeteriogensFINAL INTENTa\nbR.L.U.\nA. Alternata + \nPhenazine -carvacrolA. Alternata\nFuture plans\nTo evaluate possible adverse effects of the terpene -based solid formulates on paper\nStructural analysis of treated and non -treated paper samples\n1)Tensile properties\n2)IR spectroscopy\n3)XRD analysis\nCellulose degree of polymerization\n1) pH variationsOptical parameters\n1)Yellowness index\n2)\u0394E Total colour difference\nFuture plans\nTo investigate theuse of terpene -based solid formulates in situ\nTheantimicrobial activity oftheformulates could beinvestigated on-siteunder controlled conditions\n1)RH%\n2)Temperature\n3)Time ofexposure\nOn-site treatment\nHistorical archive atForte Belvedere\n(Biblioteca Nazionale Centrale di Firenze, IT)\nLab experience with fungi\nLab experience with fungi\n2. Pure \ncultures\n3. Fungal\nsuspension\npreparation1. Sample \ncollection\nfrom paper1. Sample collection from paper\n2. Pure \ncultures\n3. Fungal\nsuspension\npreparation1. Sample \ncollection\nfrom paper1. Sample collection from paper\nBy sterile scalpel\nBy sterile swabs\nSuspending in physiological\nsolution\naDESSO project (Da ESsenziali a SOlidi ) \nsupported by the Tuscany Region\nLab experience with fungi\n2. Pure \ncultures\n3. Fungal\nsuspension\npreparation1. Sample \ncollection\nfrom paper2. Pure cultures\n2. Pure \ncultures\n3. Fungal\nsuspension\npreparation1. Sample \ncollection\nfrom paper2. Pure cultures\nCulturing on solid\nmedium \n(ex. PDA, NGA, YPD)\n27\u00b0C \n2-10 days\nMicrobial suspension\n2. Pure cultures\nEach fungal colony istranferred onto new \nPDA medium by using a sterile loopLab experience with fungi\n2. Pure \ncultures\n3. Fungal\nsuspension\npreparation1. Sample \ncollection\nfrom paper3. Fungal suspension preparation\n2. Pure \ncultures\n3. Fungal\nsuspension\npreparation1. Sample \ncollection\nfrom paper3. Fungal suspension preparation\nMaterial :\nFresh fungal culture                                                   PDB medium       \n1. Scrape the fungal culture with a \nsterile loop\n2. Suspend into PDB and \nhomogenize the suspension\n3. Pipette the suspension into the \nhemocytometer\nMethod:\nSterile loop Hemocytometer & glass coverslip3. Fungal suspension preparation\n20x 40xConidia are reproductive structures produced by fungi\nThe germination of conidia originates fungal mycelium\nFungal\nhyphae\nFungal\nmycelium3. Fungal suspension preparation\nAdjust the concentration of the suspension to about 1 x 106conidia/ mL.Under optical microscope itispossible to count the conidia within\nthe hemocytometer grid.\nCount theconidia within thesquares\nalong the two diagonals ofthe grid\ntocalculate theaverage value .\nConcentration (conidia/mL) = average number of conidia x 250.000Thank you\naDESSO project (Da ESsenziali a SOlidi ) \nsupported by the Tuscany Region\nState of the \nArt for the role \nof Essential \nOils in \nRespiratory \nSystem \nTherapy\nMaria do C\u00e9u Costa\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 20221\nwww.spfito.ptState of the Art for the role of Essential \nOils in Respiratory System Therapy\n2\n\u2022 well-established use (marketing authorisation , WEU): \ndemonstrated with sufficient safety and efficacy data \n\u2022 traditional use (simplified registration, TU): accepted \non the basis of sufficient safety data and plausible \nefficacy Monographs\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022EMA\nApplications for authorisation to place a \nherbal medicinal product on the market\n8\u00baCoNGReSo De FiToTeRaPia De La SEFIT 3http://www.ema.europa.eu/\n\uf0711999: Ad-HocWGHMP -\nWorking Group onHerbal\nMedicinal Plants na ex-\nEMA(EMEA)\n\uf071WGHMP\n\uf071HMPC\nDIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004, amending, as regards \ntraditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for \nhuman usewww.spfito.pt\nDIRECTIVE 2004 / 24 / EC ON \nTRADITIONAL HERBAL MEDICINAL \nPRODUCTS (THMPs) \n*   NEW LEGAL BASIS AND PROCEDURE\n\u2022   SIMPLIFIED REGISTRATION OF TRADITIONAL HERBAL MEDICINAL \nPRODUCTS (THMPs )\nunder  article 16a\ndoes not apply in case the \u201ctraditional\u201d herbal product \nfulfils the criteria for a full marketing authorisation\n\u2022   APPLICATION TO THE COMPETENT AUTHORITY OF THE ME  MBER STATE (MS)\nPROCEDURE\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nDIRECTIVE 2004 / 24 / EC ON \nTRADITIONAL HERBAL MEDICINAL PRODUCTS (THMPs) \n*   SCOPE\n\u2022  indication (s) exclusively appropriate to THMP and designed for \nuse without supervision of a medical practitioner for diagnosis, \nprescription or monitoring of treatment\n\u2022  specified strength and posology\n\u2022  only oral or external use and inhalation\n\u2022  period of traditional use : 30 years (15 years in and 15 years \noutside the eu)\n\u2022  vitamins and minerals may be added if their action is ancillary\nto the herbal constituent(s)\nanimal &  human products are not allowed                 \n info@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nEU/EMA\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 20226www.spfito.pt\nAssessment Report Finalised\n15/03/2022 \nRosmarinus officinalis L., aetheroleum\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 20227\nTherapeutic Area Indication Dosage form \nand method of \nadministration Target population\nAdults Paediatric\nCIRCULATORY DISORDERS For relief of minor \nmuscular and \narticular pain and \nin minor \nperipheral \ncirculatory \ndisorders. Herbal preparation in \nliquid or semi -solid \ndosage forms for : \ncutaneous use\nand \nas a bath additiveCutaneous use:  \n6-10% in semi -\nsolid and liquid \ndosage forms, \n2-3 times daily\nUse as bath \nadditive 10 -27 \nmg per litre\nOne bath every \n2 to 3 daysThe use is not \nrecommended \ndue to lack of \nadequate data. \nGASTRO -INTESTINAL DISORDERS\na-pinene\n1,8-cineoleFor symptomatic \nrelief of \ndyspepsia and \nmild spasmodic \ndisorders of the \ngastrointestinal \ntractHerbal preparation in \nliquid or semi -solid \ndosage forms for \noral use. Oral use: 2 \ndrops dailyThe use is not \nrecommended \ndue to lack of \nadequate data. \n2010\nwww.spfito.pt\nPimpinella anisum L., aetheroleum (anise oil)  \ninfo@spfito.pt\nSpring School -April 5th \u20139th, 20228\nTherapeutic Area  Indication  Dosage form \nand method of \nadministration  Target population  \nAdults  Paediatric  \n \nCOUGH AND COLD  \nCatarrh  \nTrans -anethole 75 -\n96.0%  \n Traditional \nherbal medicinal \nproduct used as \nan expectorant \nin cough \nassociated with \ncold. Solid or liquid \ndosage forms for \noral use.  \n \n50-200 microliters \nof anise oil, three \ntimes daily  \n Hypersensitivity to \nthe active substance \nand to other plants \nof the Apiaceae \n(Umbelliferae) family \n(fennel, caraway, \ncelery, coriander and \ndill) or to anethole  The use in children and \nadolescents under 18 \nyears of age is \ncontraindicated due to \nlack of adequate data \nand the presence of \nestragole  \n \nGASTRO -\nINTESTINAL \nDISORDERS  \n \n Traditional herbal \nmedicinal \nproduct for \nsymptomatic \ntreatment of \nmild, spasmodic \ngastrointestinal \ncomplaints \nincluding bloating \nand flatulence  Solid or liquid \ndosage forms for \noral use.  \n \n \n50-200 \nmicroliters of \nanise oil, three \ntimes daily  idem \n idem \n \n \n2013\nwww.spfito.pt\nEucalyptus globulus Labill ., Eucalyptus\npolybractea R.T. Baker and/orEucalyptus\nsmithii R.T. Baker , aetheroleum\n92014\nwww.spfito.pt\nTherapeutic Area Indication Dosage form and method of \nadministration Target population\nAdults Paediatric\nCOUGH AND COLD\n(\u00b1)-EucalyptolTraditional herbal \nmedicinal product \nused for relief of \ncough associated \nwith cold.Herbal \npreparation in \nsolid or liquid \ndosage forms \nfor oral use . \nHerbal preparations in \nLiquid dosage forms for \ninhalation \nor as bath additives. \nHerbal preparations in \nLiquid or semi \n-solid dosage \nforms for cutaneous use. Oral use and inhalation: \nAdolescents, adults and elderly \nCutaneous use \nUse as Bath additive:\nSingle dose: 1.5 -6 g essential oil/100 \nl water, 3 to 4 times a week .\nE.g.: Children between 4 and 12 \nyears of age Single dose: 0.5 -3 g \nessential oil/100 l water, 3 to 4 times \na week Recommended bath \ntemperature is 35 -38\u00b0C for 10 -20 \nminutes.Children older than 4 \nyears \nAdolescents \nChildren younger than \n30 months: the use is \ncontraindicated \nbecause there is a risk \nthat 1,8 -cineole \ncontaining \npreparations, \ncan induce \nlaryngospasm. \nChildren older than 30 \nmonths: the use is \nnot \nrecommended due to \nlack of adequate data. PAIN AND \nINFLAMMATION \nAntinociceptive effects of \n(+)-\u03b2-PineneTraditional herbal \nmedicinal product \nfor the \nsymptomatic \nrelief of localised\nmuscle pain.Herbal preparations in \nLiquid dosage forms \nas bath additives. \nHerbal preparations in \nLiquid orsemi\n-solid dosage\nforms for cutaneous use. Adults \nUse as bath additive Children \nbetween 4 and 12 years of age, \nadolescents, adults and elderly \nSingle dose: 1.7 -4 g essential oil/100 \nl water, 3 to 4 times a week. \nRecommended bath temperature is \nat 35-38\u00b0C for 10 -20 minutes.\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022Foeniculum vulgare Miller subsp . vulgare var. \nvulgare , aetheroleum (Bitter fennel fruit, oil) \ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022102007\nTherapeutic Area Indication Dosage form \nand method of \nadministration Target population\nAdults Paediatric\nCOUGH AND COLD\nanethole (55.0 -75.0%) \nfenchone (12.0 -25.0%)\nnot more than 6% of \nestragole\nCatarrh of the upper \nrespiratory tract [Brand 2007; \nBrayfield 2014].Traditional \nherbal medicinal \nproduct used as \nan expectorant \nin cough \nassociated with \ncold.\nDyspeptic \ncomplaints \nsuch as \nmild, \nspasmodic \ngastro -\nintestinal \nailments, \nbloating \nand \nflatulence \n[Brand \n2007]Solid or liquid \ndosage forms for \noral use. Adults\nHypersensitivity \nto the active \nsubstance or to \nApiaceae\n(Umbelliferae ) \n(aniseed, \ncaraway, celery, \ncoriander, dill) \nor to anethole .The use is not recommended due \nto lack of adequate data. \nContraindicated for children and \nadolescents under 18 years of age \nbecause of the lack of data and \nbecause of the presence of \nanethole (weak mutagenic \nactivity) and  estragole\n(carcinogenic effects). \nNote onthesafety ofestragole [ESCOP monograph , 2016]: flavonoids able to inhibit \nthe formation of 1\u2019 -sulfooxyestragole from 1, -hydroxyestragole\n[Iten 2004; Alhusainy 2010; Alhusainy 2012]www.spfito.pt\nMentha x piperitae L., aetheroleum\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022112008\n Therapeutic Area  \n TU Indications  Dosage form \nand method of \nadministration  Target population  \nAdults  Paediatric  \n COUGH AND COLD  \n \nmenthol (30 -55%)  \n \nmenthone (14 -32%)  \n Traditional herbal \nmedicinal product  \n \u2022 Cutaneous and \ntransdermal use  \n. For the relief of \nsymptoms in coughs \nand colds  \n \n\uf0b7 Inhalation  \n. For the relief of \nsymptoms in coughs \nand colds  \n \n \u2022 Oromucosal use  \n For the relief of \nsymptoms in coughs \nand colds   \nTraditional use  \nIn liquid or \nsemi-solid \npreparations  \n \u2022 For \ncutaneous and \ntransdermal use  \n\u2022 For inhalation  \n \u2022 For \noromucosal use  Adults  \nAdolescents  \n \nmenthofuran (1 -9%) \n \npulegone (< 4%)  \n \nNOEL 20mg/kg bw/day  \n  Children older \nthan 4 years  \n(Except for \ninhalation) . \n \nChildren \nyounger than 2 \nyears: the use \nis \ncontraindicated.  \n \nChildren older \nthan 2 years: \nThe use is not \nrecommended \ndue to lack of \nadequate \nexperience.  \n \n www.spfito.pt\nMentha x piperitae L., aetheroleuminfo@spfito.pt\nSpring School -April 5th \u20139th, 2022\n122008\nPublic statement on the use of herbal medicinal products containing pulegone and menthofuran 31 Marh 2015 EMA/HMPC/138386/2005 Rev. 1 (HMPC )  Therapeutic Areas Dosage form and \nmethod of \nadministration Target population\nWEU Indications\nGastro intestinal \ndisorders &\nPain and inflammationTU Indications\nSkin disorders and \nminor wounds\n&\nPain and inflammationAdults Paediatric\n\u2022 Oral use\nHerbal medicinal product \nfor the symptomatic relief \nof minor spasms of the \ngastrointestinal tract, \nflatulence and abdominal \npain, especially in patients \nwith irritable bowel \nsyndrome. \n\u2022 Cutaneous use \nHerbal medicinal \nproduct for the \nsymptomatic relief of \nmild tension type \nheadache.Traditional herbal \nmedicinal product\n\u2022 Cutaneous and \ntransdermal use \n. For the symptomatic \nrelief of localised muscle \npain \n. For the symptomatic \nrelief of localised pruritic \nconditions in intact skin Well-established use\nIn gastro \u2013resistant \ncapsules (for oral use) or \nIn liquid or semi -solid \npreparations  (for \ncutaneous use). \nTraditional use\nIn liquid or semi -solid \npreparations\n\u2022 For cutaneous and \ntransdermal use \n\u2022 For inhalation\n\u2022 For oromucosal useAdults\nAdolescents\nThe acceptable \nexposure is 0.07 \nmg/kg bwper d ay, \nwhich is close to the \ncurrent ADI value of \n0.1 mg/kg bwper day .\nThe daily dose for an \nadult of 50 kg body \nweight is thus 3.5 \nmg/person/day.Children older \nthan 8 years \nThe use is not \nrecommended \ndue to lack of \nadequate \nexperience. www.spfito.pt\nThymus vulgaris L., Thymus zygis Loefl . ex L., \naetheroleum\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022132010\nTherapeutic Area  \n TU Indications  Dosage form and \nmethod of \nadministration  Target population  \nAdults  Paediatric  \n COUGH AND COLD  \n \nThymol: 36.0 - \n55.0%  \n \n Indication 1)  \n \nTraditional herbal \nmedicinal product \nused as an \nexpectorant in \ncough associated \nwith cold.  \n \nIndication 2)  \n \nTraditional herbal \nmedicinal product \nfor the relief of \nsymptoms in \ncoughs and colds.  Indication 1) Adults and \nelderly  \nOral use: 4 -5 drops \n(single dose), 3 -5 times \ndaily.  \n \nHypersensitivity  to \nactive substance.  \n  \nUse as bath additive : \n Full baths are \ncontraindicated in cases \nof open wounds, large \nskin injuries, acute skin \ndiseases, high fever, \nsevere infections, severe \ncirculatory disturbances \nand cardiac \ninsufficiency.  Indication 2) \nAdults and \nelderly  \n \nCutaneous use: \nin liquid and \nsemi-solid \ndosage forms in \nconcentrations \nup to 10%; \napply up to 3 \ntimes daily.  \n \n Use as bath \nadditive: 0.007 \u2013 \n0.025 g per litre.  \n \n  Indication 2)  \nThe oral use in children and \nadolescents under 18 years \nof age is not recommended  \n \nAdolescents  \n Use as bath a dditive: 0.007  \n0.025 g per litre.  \nChildren 6 -12 years : Use \nas bath additive: 0.0035 \u2013 \n0.017 g per litre.  \n Children 3 -6 years : Use as \nbath additive: 0.0017 \u2013 \n0.0082 g per litre. One bath \nevery day or every second \nday. The cutaneous use in \nchildren and adol escents \nunder 18 years of age is not \nrecommended .  \nThe use as bath additive in \nchildren under 3 years of age \nis not recommended  \n \n www.spfito.pt\nOriganum dictamnus L., herba\n(Dittany of Crete herb)\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022142014\nTherapeutic Areas Dosage form and method \nof administration Target population\nAdults Paediatric\nCough and Cold\n&\nGastro intestinal disorders \nTUIndicationsSkin disorders and minor \nwounds\nTU Indications\n\u2022 Oral use\n1)Traditional herbal \nmedicinal product used \nfor the relief of cough \nassociated with cold.\n2)Traditional herbal \nmedicinal product used \nfor the relief of mild \ngastrointestinal \ndisorders. Traditional herbal medicinal \nproduct\n\u2022 Cutaneous use \nIndication 3) Traditional \nherbal medicinal product \nused for the relief of minor \nskin inflammations and \nbruises.Oral  use\nComminuted herbal \nsubstance as herbal tea \nCutaneous use\nComminuted herbal \nsubstance for infusion or \ndecoction preparation: 30 \n\u201375 g of comminuted \nherbal substance in 1 l of \nwater. Apply on the \naffected area, 2 to 5 \ntimes daily, in the form of \na wet, impregnated \ndressing.p-coumaric acid\n(13.9%)\nCarvacrol\n(44.6 + 25.8%)\nHigher thymol\n(29.0 + 13.1)Adolescents \nChildren \nOral use:\nThe use in \nchildren and \nadolescents \nunder 18 years \nof age is not \nrecommended\nCutaneous use:\nThe use in \nchildren under \n12 years of age \nis not \nrecommended\nwww.spfito.pt\n152020\nTherapeutic Area  \n TU Indications  Dosage form and method \nof administration  Target population  \nAdults  Paediatric  \n Pain nd \ninflammation  \n \n \nEugenol  \nCAS 97 -53-0 \n \nequivocal results in \nseveral test systems \nfor genotoxicity and \ncarcinogenicity.  \n 1) for the  \nsymptomatic \ntreatment of \nminor \ninflammatio\nns in the \nmouth or \nthe throat.  \n \n2) for the  \ntemporary \nrelief of \ntoothache \ndue to a \ndental  \ncavity.   Ind 1  \u2013 Oromucosal  \nMouth washes \ncorresponding to 1 \u20135% \nessential  oil. \n Apply several times \ndaily.  \n \nInd 2 - Dental use  \nUndiluted essential oil \nor solutions in a \nstrength of  \nminimum 50% or gels \nin a strength of 20%.  \n \nNot to be used for \nmore than 1 week.  Adults (oral use)  \n \nRepeat \nadministration \nafter 20 minutes, \nthen \nevery 2 hours if \nnecessary.  \n \nThe relief of \ntoothache by clove \nessential oil is \nonly a provisional \nmeasure. Dental \nattention should \nbe sought as soon \nas possible .  \nThe use in \nchildren and \nadolescents \nunder 18 years \nof age is not \nrecommended  \n \ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nCaryophylli floris aetheroleum\nSyzygium aromaticum (L.) Merr . et L.M. Perry (syn. Eugenia \ncaryophyllus (Spreng .) Bullock et S.G. Harrison clove oil\n2021\n75-80%162020\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nSyzygium aromaticum (L.) Merill et L. M. Perry, \nfloris aetheroleum\nOverdose :\n\uf0d8After oraladministration of5-10mlofclove oilinchildren below 2\nyears ofage,lifethreatening conditions were observed .\n\uf0d8Overdose may lead toCNS depression, urinary abnormalities, anion\ngapacidosis, deterioration ofliver function, coma, seizure andlow\nblood glucose levels .Treatment should besupportive and\nsymptomatic ;there have been reports intheliterature that N-\nacetylcysteine hasbeen successfully used asanantidote .\nPrecautions foruse:Dental use\n\uf0d8Asmall piece ofcotton wool should besoaked intheundiluted oilor\ninadiluted solution ;semisolid dosage forms should beplaced ona\ncotton bud.Cotton bud orcotton wool should beaccurately\ndirected tothedecayed part ofthetooth .\n\uf0d8Avoid contact withgums .Carum carvi L., aetheroleum\n172015\nTherapeutic Area  \n TU Indications  Dosage form \nand method of \nadministration  Target population  \nAdults  Paediatric  \n Gastro -intestinal \ndisorders  \n \n \n(+)-(S)-Carvone:  \n 50-65 %  \n For the \nsymptomatic \nrelief of \ndigestive \ndisorders such \nas bloating \nand \nflatulence.  Herbal \npreparation in \nliquid dosage \nforms for oral \nuse.  \nHerbal \npreparation in \nsemi-solid \ndosage forms \nfor cutaneous \nuse.  Adults (oral use)  \n \nThe use in patients \nwith liver disease, \ncholangitis, \nachlorhydria, \ngallstones and any \nother biliary \ndisorders is not \nrecommended.  \n \n (cutaneous use)  \n \nCutaneous use  \nThe product should \nnot be used on \nbroken skin, around \nthe eyes or on \nmucous membranes.  \n \n Infants, Children, \nAdolescents  \n \nThe oral use  in children \nand adolescents under 18 \nyears of age is not \nrecommended .  \n \n Cutaneous use  \n \nInfants, children, \nadolescents, adults and \nelderly  \n \nDaily dose: 2 % semi -solid \npreparations to be applied \nonce daily as a thin layer \non the abdominal area.  \n \ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nCarum carvi L., fructus\n182015\nTherapeutic Area  \n TU Indications  Dosage form \nand method of \nadministration  Target population  \nAdults  Paediatric  \n Gastro -intestinal disorders  \n \n3-7% EO  \n \n10-18% fixed oil, o f which the main \ncomponents are:  \npetroselinic acid (30-43 %)   \n \n \nLinoleic  acid (34-37 %)  For the \nsymptomatic \nrelief of \ndigestive \ndisorders such \nas bloating \nand \nflatulence.  Herbal \nsubstance or \ncomminuted \nherbal \nsubstance as \nherbal tea for \noral use.  Adults  \n \n  \nThe use in \nchildren and \nadolescents \nunder 18 \nyears of age is \nnot \nrecommended  \n \n \ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nChamaemelum nobile (L.) All., flos\n192011\nTherapeutic Area  \n TU Indications  Dosage form \nand method of \nadministration  Target population  \nAdults  Paediatric  \n Gastro -intestinal disorders  \n \nDried flowers of the cultivated double \nflowered variety of Chamaemelum \nnobile  (L.) All. (syn. Anthemis nobilis \nL.) [Fam. Asteraceae]. It contains not \nless than 7 ml/kg of essential oil. (Ph. \nEur. 6, 2008)  \n \n36.0-25.85% iso -butyl angelate  \n For the \nsymptomatic \ntreatment of \nmild, \nspasmodic \ngastrointestin\nal complaints \nincluding \nbloating and \nflatulence.  Herbal \nsubstance and \ncomminuted \nherbal  \nsubstance as \nherbal tea for \noral use.  \nHerbal \npreparations \n(liquid extract) \nin liquid dosage \nforms for oral  \nuse. Adults  \n  \n \n Adolescents  \n \nThe use in \nchildren under \n12 years of \nage is not  \nRecommended\n. \n \ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nCinnamomum verum J.S. Presl , \ncorticis aetheroleum & cortex\n202011\nTherapeutic Area  \n TU Indications  Dosage form \nand method of \nadministration  Target population  \nAdults  Paediatric  \n Gastro -intestinal disorders  \n \n\uf0b7 Cinnamomum verum  J.S. Presl, \ncortex - Essential oil obtained \nby steam distillation from the \ncortex  \n \n\uf0b7 Cinnamomum verum  J.S. Presl, \ncorticis aetheroleum  \n \ncinnamaldehyde (60 -75%)  \n \uf0b7 For the \nsymptomatic \ntreatment of \nmild diarrhoea.  \n \n\uf0b7 For the \nsymptomatic \ntreatment of \nmild, \nspasmodic \ngastro -\nintestinal \ncomplaints \nincluding \nbloating and \nflatulence.  \n Herbal preparation \nin liquid dosage \nforms for oral use.  \n \n \nComminuted \nherbal substance \nas herbal tea for \noral use. Herbal \npreparation in \nliquid dosage \nforms for oral use.  \n \n \n \n Adults  \nAdolescents  \n \n \nEO: 50 to 200 mg \ndaily, in 2 to 3 \ndoses. In order to \navoid local \nirritation, the use of \nthe undiluted oil is \nnot recommended.  \n  \n \n  \nThe use in \nchildren under \n12 years of \nage is not  \nRecommended  \n \ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nJuniperus communis L., aetheroleum\n212011\nTherapeutic Areas Dosage form and method of \nadministrationTarget population\nGastro -intestinal \ndisorders\n&\nUrinary tract and \ngenital disorders \nIndicationsPain and\ninflammation\nIndicationsAdults Paediatric\nTU\n\u2022 Oral use\n1)For symptomatic relief \nof digestive disorders \nsuch as dyspepsia and \nflatulence.\n2)Used to increase the \namount of urine to \nachieve flushing of \nthe urinary tract as an \nadjuvant in minor \nurinary tract \ncomplaints.TU\n\u2022 Cutaneous use \nIndication 3) \nUsed as adjuvant \nin the relief of \nminor muscular \nand articular \npain.\n\u03b1-pinene (20-\n50%)Essential oil obtained by steam \ndistillation from the ripe, non -\nfermented berry cones \nOral  use\nComminuted herbal substance \nas herbal tea \nCutaneous use\nComminuted herbal substance \nfor infusion or decoction \npreparation -Apply on the \naffected area, 2 to 5 times daily, \nin the form of a wet, \nimpregnated dressing.Adults Adolescents \nChildren \nOral use:\nThe use in children \nand adolescents \nunder 18 years of \nage is not \nrecommended\nCutaneous use:\nThe use in children \nunder 12 years of \nage is not \nrecommended\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nLavandula angustifolia Miller, aetheroleum\n222012\nTherapeutic Areas Dosage form and method \nof administration Target population\nAdults Paediatric\nMental stress and mood \ndisorders \nIndicationsSleep disorders and \ntemporary insomnia \nIndications\nFor relief of mild symptoms \nof mental stress and \nexhaustion and to aid sleep. \nlinalool (20 -50%)For relief of mild \nsymptoms of mental \nstress and exhaustion and \nto aid sleep. \nlinalyl acetate (25 -46%)Herbal preparation in liquid \ndosage form for oral use \nand as a bath additive. \nOral  use\nComminuted herbal \nsubstance as herbal tea \nCutaneous use\nUse as bath additive: \nrecommended temperature \nof bath: 35 \u201338 \u00b0C -10-20 \nmin.Adults\nFull baths are \ncontraindicated in cases \nof open wounds, large \nskin injuries, acute skin \ndiseases, high fever, \nsevere infections, severe \ncirculatory disturbances \nand cardiac insufficiency.\nReports oncontact\ndermatitisAdolescents \nChildren \nThe use in \nchildren \nunder 12 \nyears of age \nis not \nrecommende\nd\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nMatricaria recutita L., aetheroleum\n23201\nTherapeutic Area  \n TU Indications  Dosage form \nand method of \nadministration  Target population  \nAdults  Paediatric  \n Skin \ndisorders &  \nminor  \nwounds  \n \nThere are 2 types of matricaria oil \nwhich are characterised as rich in \nbisabolol oxides, or rich in (\u2212) -\u03b1-\nbisabolol.  \n \nMajor constituents of the essential \noil: sesquiterpenes: azulenes (2 -\n18%), especially chamazulene ( -)-\nalpha -bisabolol (up to 50%)  \nbisabolol oxides A and B  \ntrans-\u03b2-farnesene (up to 45%) \nspiroethers (20 -30%) (cis - and \ntrans-en-yn-dicycloethers  For adjuvant \ntherapy of irritations \nof skin and mucosae \nin the anal and \ngenital region, after \nserious conditions \nhave been excluded \nby a medical doctor.  \n Herbal preparations \nin liquid dosage \nforms for use as a \nbath additive.  \nCutaneous use as \nbath additive: \nRecommended \ntemperature of bath: \n35 \u2013 38 \u00b0C  \nDuration of bath: 10 \n\u2013 20 minutes  \n Adults  \n  \n \n Adolescents  \n \nThe use in \nchildren under \n12 years of \nage is not  \nrecommended.  \n \ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nMelaleuca alternifolia (Maiden andBetch ) Cheel , \nM. linariifolia Smith, M. dissitiflora F. Mueller\nand/orother species ofMelaleuca, aetheroleum\n242015\nTherapeutic Areas Dosage form and method ofadministration\nThe European Pharmacopoeia and the \nInternational Standard ISO 4730 require TTO \nto have a minimum content of 30% of \nterpinen -4-ol and a maximum content of \n15% of 1,8 -cineoleTarget population\nTU Indications\nMouth and throat disordersTU Indications\nSkin disorders and minor\nwoundsAdults Paediatric\n\u2022 Oromucosal use \nTraditional herbal medicinal \nproduct for symptomatic \ntreatment of minor inflammation \nof the oral mucosa.\nSingle dose 0.17 \u20130.33 ml of \nessential oil to be mixed in \n100 ml of water for rinse or \ngargle several times daily.\u2022 Cutaneous use \n1) THMP for treatment of small \nsuperficial wounds and insect \nbites. \n2) THMP for treatment of small \nboils (furuncles and mild acne). \n3) THMP for the relief of \nitching and irritation in cases of \nmild athlete \u00b4s foot.1) Herbal preparation in liquid and semi -solid\ndosage forms for cutaneous use ( ind1-3) or\nin liquid dosage form for oromucosal use ( ind\n4).\n2) 0.7 -1 ml of EO stirred in 100 ml of \nlukewarm water to be applied as an \nimpregnated dressing to the affected areas \nof the skin / Undiluted EO to be applied to \nthe boil using a cotton bud 2 -3 times daily.\n3) Undiluted EO to be applied to the affected \narea using a cotton bud 2 -3 times daily.Adults\nAdolescents\nEEElderly\nPreparations \ncontaining 0.5% \nto 10% of \nessential oil to \nbe applied to the \naffected area 1 -3 \ntimes daily.The use in \nchildren under \n12 years of age is \nnot \nrecommended \n1,8-cineol \nallergen\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nMelaleuca alternifolia (Maiden andBetch ) Cheel , \nM. linariifolia Smith, M. dissitiflora F. Mueller\nand/orother species ofMelaleuca, aetheroleum\n252017\nAvailable information on repeated dose systemic toxicity of TTO constituents:\n\uf0fcBased on repeated -dose toxicity data in literature, the SCCP in 2008 has established \nNOAEL values in animals of six main components in Tea Tree Oil. \n\uf0fcThese NOAEL's have been summarized in the table below (Norwegian Food Safety \nAuthority ( Matthylsyne ) 2012):\n& the International Standard ISO 4730 \ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nHMP containing EO registered and\nmarketed in  Portugal, April 2022\n262014Thymus vulgaris aetheroleum + Benjoim\ntincture + Eucalypt ustinctureVaporilInhalation \nSolution by \nvaporizationWEUR07A OTHER RESPIRATORY \nSYSTEM PRODUCTS\n14.1.1 Descongestant drugs\nEucalyptus EO + Camphor + Menthol + \nTurpentine EOVicks Vaporub Ointment WEUR05 COUGH AND COLD \nPREPARATIONS\n5.2.3 Associations and\ndecongestant drugs\nThymi herba , Dryextract , \n59.5 mg (DER = 7 -13 : 1; H2O)Phytosun\nBronchodual\nPastilhasSoft Tablets TUR05CA \nExpectorants\nMarsh -mallow, liquid extract , 829.56 mg\nThymus vulgaris , extract , 117.08 mgPhytosun \nBronchodual \nSolu\u00e7\u00e3o OralOral Solution TU R05CA Expectorants\nThymus vulgaris , extract , 22 gPulmocap\nThymusSyrup TUR05CA10 combinations\n5.2.2 Expetorants info@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\n\uf0a7notfulfilled :therequirement laiddown inArticle 16a(1)(b)ofDirective 2001/83/EC\nthattheherbal substance orherbal preparation is\u201cexclusively foradministration\ninaccordance with aspecified strength and posology \u201d,because adequate\ninformation onposology onmonotherapy fortraditional useasanantiseptic andas\nanaidinhealing ofminor wounds isnotavailable intheliterature\n\uf0a7notfulfilled :therequirement laiddown inArticle 10aofDirective 2001/83/ECthat\ntheactive substance hasarecognised efficacy andanacceptable level ofsafety and\nthattheperiod ofwell-established medicinal usehaselapsed .Non-clinical and\nclinical studies are not sufficient tosupport any well-established use\nindication andnosingle preparation medicinal product isauthorised inthe\nEuropean CommunityPublic statement\non Citrus bergamia Risso et \nPoiteau , aetheroleum\n27info@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\n\uf0a7Acantholippia deserticola used\ninfolkmedicine inTarapaca ,Chile\nasawomen aphrodisiac agent\n\uf0a7\u03b1- and \u03b2-Thujone were\ncharacterized as the main\nconstituents, 10.5%and77.9%,\nrespectivelyOutside EU\nEthnopharmacology in Chile\nRica-rica \n28\nLeonel Rojoand Julio Benites , MC Costa et al., Composition and \nAntimicrobial Screening of the Essential Oil of Acantholippia deserticola\n(Phil.ex F. Phil.) Moldenke . J. Essent . Oil Res., 18, , 695 -697, 2006\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nIndustry is foreseen to play a \nbigger and better part \u2026\n29\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nSBS TM: Safety Band System\n30Special Sealing Technology\nforhard capsules perband\napplication system, making\nthecapsules tight.\nApplication oftwo ormore\nlayers ofthesame material\nused inthemanufacture of\nthecapsule, atthejunction of\nthetwohemi-receptacles .\nPurpose : Ensure sealing of the \ncapsules in order to avoid spilling\nitscontent .\nResult: Improve the product \nstability \u2013increasing itsshelf life.\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nQNPTM: Quantified Nitrogen Protection\n31Technology QNP was\nentirely developed by\nLabialfarma ,tocreate a\nprotective atmosphere of\nnitrogen properly dosed\nandquantified .QNP\u2122 technology ensures that the\nright amount ofnitrogen isinjected to\neffectively protect the active\ningredients and that levels are\nmeasured after the capsule, vial,\nsachet, ampoule orblister aresealed .\nAdvantages\n\uf0a7To ensure greater stability of active \nsubstances\n\uf0a7To effectively prevents oxidative \ndegradation\n\uf0a7Offering guarantees to preserving the\norganoleptic characteristics\n\uf0a7To increase product\u2019s half -life, thereby \nextending shelf -life, reproducibly in all \nbatches\n\uf0a7Preserves long -term efficacy of the \nactive substances\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022www.spfito.pt\nESCOP | European Scientific \nCooperative on Phytotherapy\n\u2022SPFito isamember ofESCOP ,an\numbrella organisation representing national\nphytotherapy orherbal medicine associations\nacross Europe ,especially intheir discussions\nwithEUmedicines regulators .\n32\nwww.escop.comwww.spfito.pt\nQuestions ?\ninfo@spfito.pt\np1658@ulusofona.pt\n33\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 202234www.spfito.pt\ninfo@spfito.pt\nSpring School -April 5th \u20139th, 2022June 18th, 2020OLD and NEW prescriptions forrespiratory tract infections\nA multidisciplinary overview\nChristine Schauhuber\nDonau \u2013Universit\u00e4t Krems\nDanube University Krems, April 2022www.donau -uni.ac.at\nANTIMICROBIAL RESISTANCE\nand \nHEALTHY HERBS Danube University Krems, April 2022www.donau -uni.ac.at\n\u00a9 CDC\nDanube University Krems, April 2022www.donau -uni.ac.at\nRESISTANCE \nDanube University Krems, April 2022www.donau -uni.ac.at\nEVIDENCE BASED MEDICINEDanube University Krems, April 2022www.donau -uni.ac.at\n\u00a9 2022 Academia Nacional de Medicina\nDanube University Krems, April 2022www.donau -uni.ac.at\nEBMClinical \nexpertise\nBest research\nevidencePatients ` \nvaluesDanube University Krems, April 2022www.donau -uni.ac.at\n\u00a9 Acharya & WilsonEBMClinical \nexpertise\nBest \nresearch\nevicence\nTeachingPatient \nvaluesDanube University Krems, April 2022www.donau -uni.ac.at\nHISTORYDanube University Krems, April 2022www.donau -uni.ac.at\n\u2022Records of the use of medicinal plants can be found in all \nearly advanced civilization\n\u2022medicinal plants were used in medical applications as early as \n3000 BC\n\u2022IMHOTEP\n\u2022Papyrus Ebers\n\u00a9pixabay, free, wikilmagesDanube University Krems, April 2022www.donau -uni.ac.at\nCHINA\n\u2022SHENG NONG BEN CAO Sheng nung pen ts'ao king\n\u2022Silk manuscripts  in Ma Wang Tui's tomb in Hunan\n\u2022I GING \n\u2022Huang Di NeiJing \n\u2022SHANG HAN LUN\n\u2022WEN BING\n\u00a9pixabay, free, auillauDanube University Krems, April 2022www.donau -uni.ac.at\n\u27a2Yin and Yang BALANCE\nYIN YANGDanube University Krems, April 2022www.donau -uni.ac.at\n\u27a2Yin and Yang IMBALANCE\nDanube University Krems, April 2022www.donau -uni.ac.at\nClassification ofDisease and Diagnostics\n-Ba GANG \n-Yin  -Yang\n-Inner -Outer  \n-Weakness -Fullness\n-Cold  -Heat \n-SI ZHEN Danube University Krems, April 2022www.donau -uni.ac.at\nClassification ofHerbs \n-Temperature\n-Taste \n-Interaction \n-HierachyDanube University Krems, April 2022www.donau -uni.ac.at\nEUROPE \n\u2022HIPPOKRATES (460 -370 BC)\n\u2022PLINIUS (Naturalis Historica ) (24 -79)\n\u2022DIOSCORIDES \u201cDe Materica medica\u201d (40 \u201390)\n\u2022GALENOS of Pergamon \u201c Methodus medendi \u201d \n(~ 200)\n\u2022HILDEGARD von BINGEN (1098 \u20131179) > Causae et Curae\n\u2022Henri Leclerc (1870 \u20131955) \u201cPrecis de Phytotherapie \u201d\n\u00a9komarnytsky, S. Danube University Krems, April 2022www.donau -uni.ac.at\n\u27a2RECEIPE \nANCIENT MODERN \nEmperor Remedium cardinale\nMinister Remedium adjuvans\nAssistent/adjudant Remedium adjuvans\nHelper -messenger Remedium corrigens ; (constituens )Danube University Krems, April 2022www.donau -uni.ac.at\n\u27a2Glycyrrhiza Radix\n\u27a2Glycyrrhiza glabra L.; Glycyrrhiza inflata Bat.; \nGlycyrrhiza uralensis Fisch.\n\u27a2GAN CAO \n\u00a9Fuchs \n \u00a9Dungl, C. \n\u00a9Hager\n \u00a9Madaus Danube University Krems, April 2022www.donau -uni.ac.at\nLatin name Liquititiae radix\nEnglish common\nname Liquorice Root\nBotanical nameGlycyrrhiza glabra L.; Glycyrrhiza inflata Bat.; \nGlycyrrhiza uralensis Fisch.\nTherapeutic area Cough and cold; Gastrointestinal disordersDanube University Krems, April 2022www.donau -uni.ac.at\n\u27a2Glycyrrhiza Radix\n\u27a2Glycyrrhiza glabra L.; Glycyrrhiza inflata Bat.; \nGlycyrrhiza uralensis Fisch.\n\u27a2CAN GAO \n\u27a2Shen Nong\n\u27a2Theophrastus\n\u27a2Dioscorides\n\u27a2Pliny\n\u27a2Galen\n\u27a2Culpepper \n\u27a2Hildegard von Bingen\n\u27a2Linn\u00e9\n\u27a2Madaus\n\u27a2\u2026\u2026Danube University Krems, April 2022www.donau -uni.ac.at\nFlavonoids\nCumarins \nOthersSaponins\n\u00a9 EMADanube University Krems, April 2022www.donau -uni.ac.at\n\u2022Traditional herbal medicinal product for the relief\n\u2022of digestive symptoms including burning sensation\n\u2022and dyspepsiaTraditional herbal medicinal product used as an\n\u2022expectorant in cough associated with cold\nhttps://www.ema.europa.eu/en/documents/herbal -report/final -\nassessment -report -glycyrrhiza -glabra -l/glycyrrhiza -inflata -\nbat/glycyrrhiza -uralensis -fisch -radix -first-version_en.pdfDanube University Krems, April 2022www.donau -uni.ac.at\nRECIPES Danube University Krems, April 2022www.donau -uni.ac.at\nZHI GAN CAO  TANG \nZhiGan Cao Glycyrrhizae, Rx. Praep. Emperor\nRen Shen Gingeng, Rx. Minister\nGui Zhi Cassiae, Ram. Assistant\nSheng Di Huang Rehmanniae , Rx. Minister\nMai Men Dong Ophiopogonis, Tb. Minister\nE Jiao Gelatinum Corii Asini Minister\nHuo Ma Ren Canabis, Sm. Minister\nSheng Jiang Zingiberis Recens, Rhz. Assistant\nDa Zao Jujubae, Fr. MinisterDanube University Krems, April 2022www.donau -uni.ac.at\nGUI ZHI TANG \nGui Zhi Cassiae, Ram. \nBai Shao Paeoniae alb. Rx. \nSheng Jiang Zingiberis Rec. Rhz. \nDa Zao Jujubae, Fr. \nZhiGan Cao Glycyrrhizae Ural., Rx. Danube University Krems, April 2022www.donau -uni.ac.at\nGan Cao Gan Jiang Tang\nZhiGan Cao Glycyrrhizae Ural., Rx. \nGan Jiang Zingiberis Off., Rhz. \nChronic respiratory Ling Gan Wu Wei Jiang Xin Tang \ninfections\nFu Ling Poria Cocos, Sc. \nGan Cao Glycyrrhizae Ural., Rx. \nGan Jiang Zingiberis Off., Rhz. \nXi Xin Asari, Hb. [Original]\nWu Wei Zi Schisandrae , Fr. Danube University Krems, April 2022www.donau -uni.ac.at\nLatin name of herbal plant Name of drug EuAB\nGlycyrrhiza glabra Liquiritiae radix\nFoeniculum vulgare Foeniculi fructus\nLinum usitatissimum Lini semen\nTussilago farfara Farfare folium\nPolygonum aviculare Polygoni avic. Herba\nValeriana officinalis Valerianae radix\nThymus vulgaris Thymi herba \nVeronica officinalis Veronicae herba\nC.m.f . species\nMadaus, 1938Mixture \u201eFinsterw\u00e4lder \u201cDanube University Krems, April 2022www.donau -uni.ac.at\nLatin name of herbal plant Name of drug EuAB\nDrosera rotundifolia Droserae herba\nCastanea sativa Castaneae folium*\nEucalyptus globulus Eucalypti folium\nThymus vulgaris Thymi herba \nGlycyrrhiza glabra Liquiritiae radix\nPlantago lanceolataPlantaginis lanceolatae \nfolium\nC.m.f . species\nMadaus, 1938Danube University Krems, April 2022www.donau -uni.ac.at\nExpektorans (nach Fischer) g\nLatin name of herbal plant Name of drug EuAB\nGlycyrrhiza glabra Liquiritiae radix\nAlthaea officinalis Althaeae radix\nPlantago lanceolataPlantaginis lanceolatae \nfolium aa25,0\nToprepare aninfusion, use 4.5goffinely comminuted\nherbal substance for150 mlofboiling water incase of\ngastrointestinal disturbances, 1.5gin150 mlforbronchitis\norcough .Tobetaken 2to3times daily .Infusion time :10-\n15minuteDanube University Krems, April 2022www.donau -uni.ac.at\nBronchitis  (F.M. Germ)\nLatin name of herbal plant Name of drug EuAB\nLinum usitatissimum Lini semen toto\nPimpinella anisum Anisi fructus\nFoeniculum vulgare Foeniculi fructus\nGlycyrrhiza glabra Liquiritiae radix\nC.m.f . species\nMadaus, 1938Danube University Krems, April 2022www.donau -uni.ac.at\nIrritant Cough (nach Ulrich)\nLatin name of herbal plant Name of drug EuAB\nVerbascum densiflor., V. \nphlomoidesVerbasci flos\nAlthaea officinalis Althaeae herba\nGlycyrrhiza glabra Liquiritiae radix\nC.m.f . species\nMadaus, 1938Danube University Krems, April 2022www.donau -uni.ac.at\nBronchal Tea -Solubifix\nLicorice root dry extract, Water 3 -4:1\nMarshmallow root dry extract, Water 7 -9:1\nPrimrose root dry extract, 60% Ethanol, 5 -7:1\nThyme Oil Danube University Krems, April 2022www.donau -uni.ac.at\n\u27a2Expectorans\nWith kind permision Drogistenmuseum Wien; Deutsches Arzneibuch 1910Danube University Krems, April 2022www.donau -uni.ac.at\nTake home message\nisas old as mankind and closely linked toits\ndevelopment and evolution .Indifferent eras, different\nviews ofhealth and disease were given, which found\nexpression inthecreation ofcombinations ofmedicinal\nplants .The aim ofthe conception ofthese mixtures,\nwhich wecall recipes, formulations and prescriptions,\nwas always the restoration ofinner balance .This basic\nconcept isstill used today inmodern phytomedicine,\nwhere supporting and balancing combinations inthe\nsense ofhomeostasis also play arole and find their way\ninto modern science and phytopharmacy .Danube University Krems, April 2022www.donau -uni.ac.at\n\u27a2Thank You forYour attention ! \n\u00a9pixabay, free, wikilmagesDanube University Krems, April 2022www.donau -uni.ac.at\nReferences\nAcharya , K. & Wilson, R. (2019). Antimicrobial resistance in Nepal : a review. Frontiers ofMedicine.6. doi:10.3389/fmed. 2019.00105\nBasar , N, Oridupa , OA, Ritchie, KJ, Nahar, L, Osman, NMM, Stafford, A, Kushiev , H, Kan, A and Sarker , SD. (\u2026). Comparative Cytotoxicity of Glycyrrhiza glabra Roots from \nDifferent Geographical Origins Against Immortal Human Keratinocyte ( HaCaT ), Lung ,Adenocarcinoma (A549) and Liver Carcinoma (HepG2) Cells. Retrieved from: \nhttp://researchonline.ljmu.ac.uk/id/eprint/830/ (March 5th, 2022)\nBensky , D. (1996). Chinesische Arzneimittelrezepte und Behandlungsstrategien . Bad K\u00f6tzting:Verlag Ganzheitliche Medizin W\u00fchr\nChen, J.K (1012). Chinesische Pharmakologie, (Band I ). Bad K\u00f6tzting:Systemische Medizin\nChen, J.K. (2012). Chinesische Pharmakologie, (Band II ). Bad K\u00f6tzting: Symstemische Medizin\nEuropean Medicines Agency, retrieved from : https://www.ema.europa.eu/en/medicines/herbal/liquiritiae -radix\nFiore C, Eisenhut M, Ragazzi E, Zanchin G, Armanini D. A history ofthetherapeutic useofliquorice . Europe. J Ethnopharmacol 99(3):317 -24. doi: 10.1016/j.jep.2005.04.015. \nPMID: 15978760; PMCID: PMC7125727.\nKozlowska , W., Wagner, CH., Moore Erin. M., Matkowski , A., Komarnytsky , S. (2018). Provenance of Traditional Medicines From Carpathian Mountains at the Ukrainian -Polish \nBorder. Frontiers in Pharmacology. DOI=10.3389/fphar. 2018.00295\nMadaus, G. (1938). Lehrbuch der biologischen Heilmittel (Bd. II) .Leipzig:Thieme\nMarti\u00ed -Carvajak , A. (2020). What isEvidence -Based Medicine? ClientMed 1(23), 01 -07.Doi.org/10.47449/CM.2020.1.1.21\nMessetler -Steiner, S. (2016). Westliche Kr\u00e4uter in der TCM . (Master -Thesis) Danube University Krems, Austria\nSackett D, Rosenberg W, Gray J, Haynes R, Richardson W. (1996). Evidence based medicine: what it is and what it isn\u2019t .BMJ. 312:71 -2.\nPictures -free access byPixabay\nAMR: Source CDC, (2019). ID Breeding like bacteria \u2013the spread of antibiotic resistance [Blog post] \nhttps://www.lgcstandards.com/US/en/Resources/Blogs/Antibiotic_resistance . \nGlycyrrhizae sp.: Dungl, C. (2021); K\u00f6hler (1890); Madaus (1938)\nCulpepper , N.(1850). The Complete Herbal . InThe Project Gutenberg EBook of The Complete Herbal, by Nicholas Culpeper http://www.gutenberg.org/files/49513/49513 -\nh/49513 -h.htmHealthy Herbs Spring School     \nFirenze,  Italy Tuesday, April 5th, 2022\nPhytotherapy for infectious diseases -an introduction\nRainerStange\nDepartment ofNatural Medicine \u2013\na joint venture of\nCharit\u00e9 -medical faculty ofHumboldt and Free universities\nand Immanuel Hospital, Berlin, Germany\nConflict ofinterest (I):\nCommercial partners\nWithin thelast three years , thepresenter hasrecieved honoraries forthe\nconduct ofclinical trials , consulting and lectures by:\nRepha GmbH Biologische Arzneimittel, Langenhagen, Germany\nmanufacurer ofANGOCIN \u00ae  Anti -Infekt N\nClinica Holistica Engiadina, Susch , Switzerland\nA. Vogel, Roggwil, SwitzerlandPresident of\nZentralverband der \u00c4rzte f\u00fcr \nNaturheilverfahren und \nRegulationsmedizin e.V. ( ZAEN )\nVice -president of\nGesellschaft f\u00fcr Phytotherapie e.V. ( GPT)\nConflict ofinterest (II):\nScientific societies\nMemberships:\nBerufsverband Deutscher Internisten BDI\n\u00c4rztegesellschaft f. Naturheilverfahren (Physiotherapie) \nBerlin -Brandenburg\n\u00c4rztegesellschaft Heilfasten und Ern\u00e4hrung \u00c4GHEOutline\n\u2022history and problems ofuseofconventional\nantibiotics\n\u2022basic chemistry ofplant -derived antimicrobial extracts\nand substances\n\u2022pre-clinical assays\n\u2022clinical trialsSir\nAlexander \nFleming\n(1881 -1955)\nDiscovery of\npenicilline 1928\nby\u201aaccident \u2018\nFirst treatment\n1941\nNobel price for\nphysiology 1945History and common useofantibiotics \u2013\n94 years from Fleming\u2018s discovery tonow\n\u2022many substances in use, almost all derived from fungi\n\u2022in spite oftremendous research very few with pure \nsynthetic background\n(most important : sulfonamides , gyrase inhibitors )\n\u2022today noplant -based extract orsingle substance\nin wide -spread use (judged byanycriterium , e.g. \nCOCHRANE recommandation , guidelines , sales figures )Problems with useofantibiotics today\n\u2022in spite ofnumerous (!) declarations still increasing per \ncapita usein most countries, only few decreasing\n\u2022increasing rates ofresistances forseveral bacteria , eg. \nStaph . a. (MRSA), Enterocci , E. coli, Clostridium diff.\n\u2022little secure knowledge about longterm effects on \nhuman body and environment\n\u2022e.g. in Natural Medicine in Europe assumption of\nunfavourable longterm interaction with microbiotaWorld average consumption in 2015 ( weigthed bypopulation ) : \n15.7 DDD per 1,000 persons per day, resp.\n5.7 DDD per person per yearBetween 2000 and 2015, antibiotic consumption\nincreased by65% from 21.1 billion defined daily doses\n(DDDs) \u2013e.g. a single antibiotic capsule orinjection \u2013of\nantibiotics to34.8 billion DDDs. \nThe antibiotic consumption rate increased by39% \nfrom 11.3 to15.7 DDDs per 1,000 inhabitants per day.Outline\n\u2022history and problems ofuseofconventional antibiotics\n\u2022basic chemistry ofplant -derived antimicrobial\nextracts and substances\n\u2022pre-clinical assays\n\u2022clinical trialsPrinciples ofconventional antimicrobi als\n-naturally occurring aswell aschemically defined substances -\n\u2022bacteriostatic\n\u2022bactericide\n\u2022virustatic\n\u2022virucide\n\u2022\n\u2022fungistatic\n\u2022fungicide\n\u2022\u2026Principles ofantimicrobials derived from plants\n\u2022bacteriostatic (asdefined forconventional antibiotics )\n\u2022bactericide (asdefined forconventional antibiotics )\n\u2022virustatic (asdefined forconventional virustatics )\n\u2022inhibition ofbiofilm formation oradherence\n(nocorresponding properties for\nconventional antimicrobiotic agents )\n\u2022effects on immune system ofhost (dto.)Important properties ofgrowth ofmicroorganisms\n\u2022bacteria : intracellular vs. extracellular\n\u2022bacteria extracellular : planctonic vs. biofilm\n\u2022viruses : almost only intracellularGroups ofphytochemicals with known\nantimicrobiologic action -a selection\n\u2022polyphenoles : in anyplant, e.g. flavonoids , phenolic acids\n\u2022saponines : in many plants\n\u2022terpenes : in many plants, e.g. in etheric oils\n\u2022isothiocyanates : in fewer plants, e.g. from mustard glycosides\n\u2022alliine /allinin derivates : so faronly in onion plantsEucalyptus\nLinalool from\nmany plants,\ne.g. laurel leavesMost common etheric oil\nfrom citrus fruit peels\neUto T et al. Advances in Pharmacological Sciences 2012 \nOutline\n\u2022history and problems ofuseofconventional antibiotics\n\u2022basic chemistry ofplant -derived antimicrobial extracts\nand substances\n\u2022pre-clinical assays\n\u2022clinical trialsLooking fornew candidates totreat MRSA infections\nSystematic research of168 plants from Southern Italy\n25 traditionally used forinflammatory skin diseases\n28 forother indications\n\u2022Black horehound (Ballota nigra L.)\n\u2022Giant cane (Arundo donax L.)\n\u2022Walnut tree, resp. walnuts (Juglans regia L.)\n\u2022Tassel grape hyacinth (Hyacinthus comosus L.)\n\u2022White, resp. common horehound ( Marrubium vulgare L.)\n\u2022Elmleaf blackberry ( Rubus ulmifolius SCHOTT) Arundo donaxArundo donax (aequous\nextract ofnodes )\nJuglans regia L.\n(ethanolic extract of\nimmature walnuts )\nSelected results : Growth inhibition by2 ofthe6 plants\u30ef\u30b5\u30d3 or\u5c71\u8475\nWasabi ( Eutrema japonicum Miq.Koidz ., resp.  Wasabia japonica )\nCruciferae family\nUto T et al. Advances in Pharmacological Sciences 2012 \nUto T et al. Advances in Pharmacological Sciences 2012 \nUto T et al. Advances in Pharmacological Sciences 2012 \nLu Z et al. Frontiers in Microbiology 2016\nLu Z et al. Frontiers in Microbiology 2016\nPlankton (Greek \u03c0\u03bb\u03b1 \u03b3\u03ba\u03c4\u03cc\u03bd \"the wandering\", \"the drifting\") is \nthe name for the totality of organisms that live in free water \n(\"floating\", with little or no movement of their own) and whose \nswimming direction is dictated by water currents.\nwikipedia\nDifferentiation: Zooplankton vs. Phytoplankton\nBacteria were not originally included in this conceptPlanktonic bacteria\nBiofilms are characterized by the fact that \ncells are surrounded by a microbially \ninduced matrix mostly of polysaccharides \nthrough which an aqueous solution flows. \nThey may be composed of individuals of a \nsingle species or of mixed populations of \ndifferent species of organisms.In biofilms , microorganisms find nutrients\nand favorable conditions forreproduction .\nThey provide protection against natural\nand artificial chemical and physical\nenvironmental influences , e.g. pH \nenvironment , ionizing such asUV radiation , \ndisinfectant solutions , antibiotics .Biofilms of\nPseudomonas aeruginosa:\nRod-shaped cells are embedded in a three -\ndimensional structure (matrix)Polymicrobial biofilms ofPseudomonas aeruginosa ( green ) and \nStaphylococcus aureus (red)biofilms are ubiquitously distributed in our environment\nevidence in fossils about 3.5 billion years old\nthe majority of microorganisms on earth (99%) live in biofilms \n(Costerton et al.1987 )\nunder suitable conditions they colonize almost all surfaces, \nbecause the conditions for the formation of a biofilm are rather low\nas soon as boundary surfaces, microorganisms, abundant nutrients \nand sufficient moisture are present, they are colonized by a biofilm \n(Flemming , 1991)EPS  = extracellular polymer substance , main componnent ofbiofilmsBacterial proliferation (left) and formation ofEPS\n(extracellular polymer substance , right ) aresuppressed\nbyincreasing concentrations ofITCMSito9 stain (green ) \ndetects bacteria in biofilmsProprium iodide staining (red) \ndetects bacterial celldeath or\ndefective bacterial cellintegrityOverlay ofboth stainings\n(yellow ) detetcts\nmostly dead bacteriaBiofilm degradation and bacterial killing after 60min exposure ofPseudomonas aeruginosa\ntoa mixture ofisothiocyanates (ITCM) asshown by2 different stains and their overlayOutline\n\u2022history and problems ofuseofconventional antibiotics\n\u2022basic chemistry ofplant -derived antimicrobial extracts\nand substances\n\u2022pre-clinical assays\n\u2022clinical trialsAsif HM, Zaidi SF, Sugiyama T, Akhtar N, Usmanghani K\nPhytomedicine -based and Quadruple Therapies in \nHelicobacter pylori Infection : A Comparative , \nRandomized Trial\nAltern Ther Health Med. 2015;21 Suppl 2:33 -9.\n.Composition ofone capsule ofPylorex Plus: \nTumeric rizomes (Curcuma longa rhizomes ) 150 mg\nFruits ofkamala, or red kamala or kumkum tree\n(Mallotus phillipenensis ) 150 mg\nLiquorice (Glycyrrhiza glabra L.) 100 mg\nGinger roots (Zingiber officinale rhizomes ) 100 mgDesign ofRCT: \ngroup 1  quadruple therapy -20 mg ofomeprazole , 1g ofamoxicillin , \n500 mg ofmetronidazole , and 400 mg ofbismuth compound for7 d\ngroup 2 phytomedicine -based , quadruple formulation -500 mg of\nPylorex Plus-for15 d.\nOUTCOME:\neradication rate forH pylori asprimary outcome (C-urea breath test\nand negative stool antigen test at 4 wkafter treatment ) was similar for\nstandard eradication scheme (62.2%, ITT) ascompared tophytotherapy\n(55.8%, ITT) with better safety profile forphytomixture .VERUM\ndestilled rectified oilsin a mixture of66:32:1:1\nin capusles 3x2 daily\nEucalyptus\nOrange\nMyrtle\nLemon\nin Germany licensed drug formany years\nNeed foradditional treatment with antibiotics as\nsecondary endpoint\nVerum 6 of35 pat. (17%),\nmedian duration oftreatment 5.5d ( 5-14)\nPlacebo 10 of29 pat. (34%)\nmedian duration oftreatment 10.0d (9-12)\nHorseraddish (Amoraciae rusticanae L.)\nOriginally found around Danuve and Volga rivers in \nEastern Europe, now ubiquitous\nCruciferae familyTropaeolum maius L.\nOriginally coming from Peru, now asgarden flower ubiquitous\nPhytotherapy AntibioticPrimary Outcome: Response (bacterial count < 10\u00b3 CFU/ml at day 7)days oftreatment\n__________ phytodrug ----------antibiotic+ censored\nLogrank p=0.0046Results :  First dayofcontinuous absence ofsymptoms\nN= phytodrug\nN= antibioticprobability6 capsules a dayofa Japanese green tea\npreparation\naltogether\n378 mg ofcatechins\n270mg ( -)-epigallocatechin gallate\n210mg theanine\nIncidences ofproven flue\n(antigen test, clincial symptoms ) \nwithin 5 months of\nprevention bystandardized\ngreen teapowderConclusions\n\u2022numerous plants contain phytochemicals with anti-\nmicrobial properties (anti-bacterial , anti -viral, \nanti-fungal , maybe anti-helimintic , anti -protozoic )\n\u2022abundant knowledge on preclinical effects\n\u2022little knowledge on clincial effects /effectiveness\n(e.g.bioavailability , demands on extracts , dosage , \noutcome combined /uncombined with conventional\nanti-infectious agents )Abteilung und Zentrum f\u00fcrNaturheilkunde\nam Immanuel Krankenhaus Berlin\nLehrstuhl f\u00fcr Klinische Naturheilkunde der Charit\u00e9 Berlin\nStation\u00e4re Therapie\n60 Betten\nTagesklinik f\u00fcr Naturheilkunde und  \nMind -Body Medizin\n10 Betten\nHochschulambulanz f\u00fcr  \nNaturheilkunde der Charit\u00e9 /  \nAmbulanzen f\u00fcrchinesische  \nMedizin undAyurveda\nForschungszentrum f\u00fcr  \nNaturheilkunde und  \nErn\u00e4hrungsmedizin\nUniv. -Prof. Dr. med.  \nAndreas Michalsen\nCharit\u00e9 Berlin und  \nImmanuel Krankenhaus Berlin\nPhytotherapy in clinical mangement\nPhyt otherapy\n\u2022Disease treatment with plants, plant formulations and their  \npreparations. Mainly self-medication (with medical advice)\n\u2022Main indications\n\u2013Common cold and infections (respiratory, urinary)\n\u2013Gastro -intestinal inflammation and functional disorders\n\u2013Gynecological /urinary inflammatory/ functional disorders\n\u2013Psychiatric indications (mild to moderate severity)\n\u2013Osteoarthritis, musculo -scelettal pain\n\u2013Wound healing\nOnly rarely applied in: cardiovascular diesease,  \noncological disease management\nChallenges of phytotherapy in clinical practice\n\u2022Abundance of available plants, preparations and  \nproducts\n\u2022Different ethnopharmaceutical pharmacopoes:  \nEuropean rationale phytotherapy; Monastery Medicine  \nAyurveda, Chinese Medicine, Tibetan Medicine, Kampo  \na.o.\n\u2022Few knowledge of physicians about specific effects,  \nsafety and interactions\n\u2022In outpatient setting mostly no reimbursement by  \ninsurances (Germany: OTC exception list: mistletoe, St.  \nJohns wort, Psyllium husks, Gingko biloba \u2013and herbs  \ninchildren\nPhytotherapy in German S -3Guidelines\n\u2022Ca.30% (n=40) of AWMF guidelines contain recommendations of phytotherapy,  \nof which about 30% are positive\nPositive Recommendations :\n\u2022Urinary tract infections :u.a.horseradish, cress, bearberry leaves\n\u2022Respiratory infections :Thyme, Ivy,Primrose (primula), Plantain (Plantao,\nSpitzwegerich), Cetraraia islandica (island moss), Marshmallow (Althaea,\nEibisch), Essential oils,Salvia, Echinacea, Myrte (Myrtus)\n\u2022Sore throat : lime -tree blossoms (Lindenbl\u00fcten), Plantain, Arnica, Cetraria,  \nThyme, Pelargonium,\n\u2022Sinusitis : essential oils\n\u2022Colitis : psyllium seed husk, myrrh tree\n\u2022Irritable bowel syndrome: Peppermint oil, bitter preparations (\u201eIberogast\u201c a.o.)\n\u2022Obstipation : psyllium husks, Aloe Vera, Senna\n\u2022Depression : St. Johns wort\n\u2022Sleep disorders : Valerian root, hops, lemon balm (Melisse),\n\u2022Cancer : mistletoe; green tea\nKlose P et al, Forschende Komplement\u00e4rmedizin 2015\nModul 38 Seminar Komplement\u00e4rmedizinRespiratory tract infections: viral orbacteria?\n\u25aaMore than 90 % of respiratory tract infections are  \ncaused by viruses\n\u25aaIn less than 10 % bacterial infection\n\u25aaNo effective antiviral medication so far available.  \nCurrent situation: symptomatic therapy\nModul 38 Seminar Komplement\u00e4rmedizinThe challenge of treating respiratory tract  \ninfections\n\u25aaNo effective antiviral medications, but  \noverprescription of antibiotics\n\u25aaIncreasing resistance of baceteriae against current  \nantibiotics\n\u25aaOnly few new antibiotics in the pipeline\n\u25aaAntibiotics damage the microbiome and immune  \ndefense\nHealthy herbs in respiratory tract infections \u2013\nMany choices\n\u25aaThyme\n\u25aaPrimrose -Primula\n\u25aaMarshmallow -Eibisch -Althaea officinalis\n\u25aaIsland moss -Cetraria islandica\n\u25aaIvy -Efeu -Hedera\n\u25aaEukalyptus -Cineol\n\u25aaLicorice -S\u00fcssholz -Glycyrrhica\n\u25aalime tree blossoms \u2013Lindenbl\u00fcten \u2013\nTiliacordata\n\u25aaLavender\n\u25aaFennel \u2013Fenchel \u2013Foeniculum\n\u25aaPlantain -Spitzwegerich -Plantago\n\u25aa\u25aaGeranium -Pelargonie\n\u25aaMyrtle -Myrte -Myrtol\n\u25aaRock rose -Cistus incanus\n\u25aaElderberryHolunder-Sambucus\n\u25aaSage \u2013Salbei \u2013Salvia\n\u25aaGinger -Ingwer \u2013Zingiber\n\u25aaHorseraddish -Meerrettich\n\u25aaCress -Kresse\n\u25aaOnion -Zwiebel -Allium cepa\n\u25aaMustard -Senf -Sinapis\n\u25aaBasil -Basilikum\nPhytotherapie \u2013Overview ofmechanisms\n\u25aaPflant extracts and their effects in respiratory tract  \ninfections\nanti-\nviralsekreto -\nmotoricsekreto -\nlyticanti-\nbacterialbroncho -\nspasmolyticMucos -\nirritatinganti-\nphlogisticMucosa -\nprotetive\nIvy\nAlthaea\ncrees/\nraddish\nMyrtol\nPelargonium  \nsidoides\nPrimula\nPlantain\nThymie\nAntiviral Herbs\n\u25aaPlant extracts with antiviral efficacy in -vitro (selection)\nThymus vulgaris (Thymiankraut)  \nHSV-1, HSV -2, Aciclovir -resistente  \nViren\nPropolis (Bienenkittharz)  \nInfluenza Virus A (H3N2),  \nAciclovir -resistentes HSV-1,  \nAdenovirus Typ 1, VSV, Polio\nCistus incanus (Zistrose)\nHIV-1, HIV -2, Ebola -,Marburg -Virus\nJustitia adhatoda (Indisches\nLungenkraut)\nInfluenza -Viren\nPlantago major (Breitwegerich)\nAdenovirus -Typ 3, 8 und 11\nBasilicum (Basilikum)\nAdenovirus -Typ 3, 8 und 11\nPelargonium sidoides (Kapland -\nPelargonie)\nInfluenza Virus A H1N1 / H3N2, RSV,  \nHCoV -229E, Parainfluenza 3,  \nCoxsackie A9\nExample: Best efficacy against Klebsiella  \npneumoniae in-vitro (MIC<0.01)\n\u25aaFennel\n\u25aaBasil\n\u25aaPeppermint\n\u25aaOregano\nSummarized best antiviral efficacy invitro\n\u2022Lavender\n\u2022Peppermint\n\u2022Thyme\n\u2022Ginger\n\u2022Lemon\n\u2022Elderberry\nElderberry in acute vital respiratory tract infections :  \na rapid review of clinical studies\nHarnett J et al: Advances in Integrative Medicine (2020), 08.001Collectively the evidence obtained from across five  \nclinical studies involving 936 adults indicate that  \nmono -herbal preparations of Sambucus nigra L.berry  \n(S.nigra ), when taken within 48 hours of onset\nof acute respiratory viral infection, may reduce the  \nduration and severity of common cold and  \ninfluenza symptoms in adults.\nPelargonium against acute bronchitis in  \nchildren\nSymptome gebessert\nComparative effectiveness of herbs in  \nrespiratory tract infections\n\u25aa> 60 Plants scientifically proven and at least experimentally  \nefficacious\n\u25aaBut: comparative clinical studies with head -to-head\ncomparison are lacking\n\u25aaCombination preparations common: over 500 evaluated\n\u25aaSynergistic effects likely\n\u25aaMulti Target appraoch versus Single Target approach\n\u25aaClinical comparative judgement with caution\nOther Clinical indications  \nexamples\n-Psychiatry -\nPhytotherapy in depression  \nSt. Johns wort -Johanniskraut -\n\u2022Robust efficacy and safety inmeta -analyses\n\u2022However: Interaction with increased effect of  \nantidepressants of SRI-bzw. SSRI -Typ as  \nParoxetine, Sertraline undTrazodon\n\u2022+:induction ofenzym CYP 450 3a4:  \nInteraction with a.o. Simvastatin, Omeprazole,  \nPhenprocoumon, Ciclosporine, Tacrolimus,\nGliacides and several chemotherapeutics like Irino -\ntecan\nPhytotherapy in depression and anxiety\n-Safran (Crocus sativus) -\nT\u00f3th B et al., Planta Med. 2019; 85:24 -31\n\u2022For1gofextracts about 150blossoms needed .\nDaily dose =30g\n\u20224systematic reviews (23studies with 1237 patients :\nSafran formoderate depression superior toplacebo\nandequivalent toFluoxetine, Imipramine, Citalopram\n\u2022Effective also asadd-onwithconcomittant medication\nwithCitalopram, Sertraline andFluoxetine\n\u2022Anxiety disorders: no consistent effect in different  \nassessment questionnaires (systmatic review of 21  \nstudies)\nPhytotherapie\n-Curcuma longa -\nFusar -Poli L et al., Crit Rev Food Sci Nutr. 2020; 60:2643 -2653\n\u2022Effective ingredient = polyphenol curcumin, main substance\nrelated to pharmacological effects of Curcuma (turmeric)\n\u2022Current meta -analysis of 10 clinical studies: significant effect  \nof Curcumin on depressive symptoms (531 Patienten) and  \nangst (284 Patienten); good effect sizes\n\u2022All studies done in Asia: Evaluation in Europe needed\n\u2022Further evidence for osteoarthritis, rheumatic disease,  \nMorbus Crohn ,Hypercholesterolemia\n\u2022Enhancement ofpoor bioavailability byconcomittant intake\noffatandpepper .Pharmacy -sold products useresorption -\nenhancers\nPhytotherapy\n-Lavender -\nM\u00f6ller HJ et al., Eur Arch Psychiatry Clin Neurosci. 2019; 269:183 -193\n\u2022Signifikant beneficial effects on anxiety, tension and sleep with dosage  \nof 1x 80mg/day and good tolerability/safetyLavendel\u00f6lextrakt\nFavours  \nLavendel\u00f6lextrakt\nClini calindication and practice-\nexamples:\n-Rheumatology and Autimmune  \nDisease -\n\u2022Curcuma\n\u2022Devil\u00b4sclaw\n\u2022Stinging nettle\n\u2022TCM: Trypterigium wilfordii Hook  \n(thundergod wine)\n\u2022Ayurveda: Withania somnifera, Ashwaghanda and  \nYogaraja Guggulu\n\u2022Frankincense (Boswellic acid)\n\u2022Tree bark(\u201ePhytodolor\u201c)\n\u2022RosehipOsteoarthritis and Rheumatic disease\nCurcuma longa\n(Turmeric, Gelbwurzextrakt) in osteoarthritis\nWang Z et al: Ann Intern Med 2020; 15. Sept\nSelf-help: Cabbage wraps in osteoarthritis\nLauche et al., Clin J Pain 2016;32:961 -7311\nOther Clinical indications\nexamples\n-Gastroenterology -\nBlueberries -Heidelbeeren\nOsman N et al. Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS) -induced colitis.  \nDig Dis Sci. 2008\nTormentil \u2013Blutwurz\nHuber R et al. Tormentil for active ulcerative colitis: an open -label, dose -escalating study. J Clin Gastroenterol.  \n2007\nVermouth \u2013Absinth\nOmer B et al. Steroid -sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double -blind  \nplacebo -controlled study. Phytomedicine. 2007\nMyrrhe \u2013Baumharze\nLanghorst J et al. RCT, 94 Pat. Alim Pharmacol Ther 2013\nPsyllium husks\nPhytotherapy in chronic inflammatory bowel disease\nMyrrhe, Chamomille, coffee coal versus Mesalazine in Remission  \nmaintainement of Colitis ulcerosa\nPhytotherapeutic self -help strategies in  \nIBS and CED:\nCaraway Oil wraps of the abdomen\nConclusion\n\u2022Numerous herbs in various indications available with  \nproven efficacy\n\u2022Effcacy underrated in conventional medicine today\n\u2022Effect magnitude is mostly mild to moderate:\n\u2022Use is reasonable in self-medication for non -severe  \ndisease and as supportive therapy in severe disease\n\u2022Better education about effects, differential therapy,  \nsafety, interactions isneeded\nTraditionelle Anwendung,  \nklinische Evidenz und  \nStudien zu Mentha, Thymian  \nund Eukalyptus\nBernhard Uehleke\nAbt. Naturheilkunde der Charit\u00e9, Berlin  \nForschergruppe Klostermedizin GmbH, W\u00fcrzburg  \nClinical Evidence Evaluations UG, BerlinPfefferminze EMA\n\u2022Mentha x piperita L., folium\n\u20131. Revision 2020\n\u2013Traditional herbal medicinal product for the  \nsymptomatic relief of digestive disorders such as  \ndyspepsia andflatulence.\n\u2022Mentha x piperita L.,aetheroleum (1.R 2020)\n\u2013Indication 1) Traditional herbal medicinal product  \nused for the relief of symptoms in coughs andcolds.\n\u2013Auch well established use, jedoch nicht Atemwege\nBernhard Uehleke(Pfeff er)Minz\u00f6l\n\u2022Menthol 30-50 %\n\u2022K\u00e4lterezeptoren -Stimulation =  \nreflektorische Atemwegsdilation\n\u2013Nebenh\u00f6hlen -Nase\n\u2022Cave: Kratschmer -Reflex?\n\u2013V orsichtige Anwendung bei Kleinkindern\n\u2013EMA: Children under 2 years of age, because  \nmenthol can induce reflex apnoea and  \nlaryngospasm.\n\u2022Daher Eukalyptus\u00f6l sicherer bei KindernK\u00e4lte- Wirkung\nBernhard Uehleke\u2022The effects of inhalation of L-menthol, D -isomenthol and  \nD-neomenthol, upon nasal resistance and sensation to  \nairflow were investigated in 40 subjects. L-menthol caused  \na highly significant enhancement of nasal sensation of  \nairflow but despite their great similarity in structure and a  \nsimilar peppermint smell the isomers D -isomenthol and D -\nneomenthol had no effect on nasal sensation of airflow.  \nThese findings show that L-menthol has a specific  \npharmacological action on nasal sensory nerve endings  \nwhich is not related to its peppermint smell. It seems that  \nmenthol acts upon trigeminal sensory nerve endings within  \nthe nose (Eccles et al., 1988).Pers\u00f6nliche Empfehlungen:  \nSymptomlindernder Soforteffekt bei  \nverstopfter Nase/Nebenh\u00f6hlen  \nKopfschmerzen  Krankheitsgef\u00fchl/Mattigkeit:\nBernhard Uehleke\u2022Pfefferminzbl\u00e4tter: Tee, Kopfdampf\n\u2022Minz\u00f6l: alkoholisch verd\u00fcnnt f\u00fcr  \nErk\u00e4ltungsbalsam\n\u2022Erk\u00e4ltungslutschpastillen\n\u2022Minz\u00f6l \u2013Aromatherapie 1 Tropfen reicht  \nauf Taschentuch zum Inhalieren\n\u2022Nicht : Badezusatz oder SaunaaufgussEMA Thymian\nThymus vulgaris L. and Thymus zygis L., herba\nTraditional herbal medicinal product used in productive cough\nassociated with cold.\nThymus vulgaris L., Thymus zygis L.,  \naetheroleumDraft 1 Rev: 2017\nTraditional herbal medicinal product used as an expectorant in  \ncough associated with cold.\nCutaneous use, use as bath additive Traditional herbal  \nmedicinal product for the relief of symptoms in coughs and  \ncolds\nEMA Kombinationsmonographie mit Primel  \nwellestablished and traditional useThymian \u00f6l\n\u2022Thymol 30-50 %\n\u2022Keimhemmend\n\u2022Neu: Anti-biofilm -activity\n\u2022Pharmakologische Eigenschaften\n\u2013Atemwegsdilation im Bronchiolen und  \nBronchialbereich\n\u2013Reflexexpektoration\n\u2013Oberfl\u00e4chenspannung- senkend\n\u2022Unsch\u00f6nes Aroma\n\u2022EMA Monog 1 Rev. draft: Thyme oil should not be applied to the face  \nparticularly in the nasal area of babies and infants under the age of 2  \nyears because of the risk of a laryngospasm.Pers\u00f6nliche Empfehlungen:\n=\u201eeurop\u00e4isches Teebaum\u00f6l\u201c\nBernhard Uehleke\u2022Thymiankraut: Tee(-mischung)\n\u2022Erk\u00e4ltungslutschpastillen\n\u2022Badezusatz (Phytobalneologie) (2g \u00d6l/100L)\n\u2013Resorption, Keimhemmung, ExhalationEMA Eukalyptus\nBernhard UehlekeEucalyptus globulus Labill., folium 2013  \nTraditional herbal medicinal product used for  \nrelief of cough associated with cold.\nEucalyptus globulus Labill., Eucalyptus  \npolybractea R.T. Baker and/or Eucalyptus  \nsmithii R.T. Baker, aetheroleum 2014\nTraditional herbal medicinal product used for  \nrelief of cough associated with cold.\nWirksamkeitsmitbestimmend 1,8 CineolEukalyptus\u00f6l\nBernhard Uehleke\u20221,8 Cineol 50-60 %\n\u2022Keimhemmend (schwach?)\n\u2022Reflexexpektorierend\n\u2022Aromatherapie\n\u2013sch\u00f6nes, frisches, angenehmes Aroma\n\u2013(beruhigend, entspannend)?\n\u2022Oberfl\u00e4chenspannung- senkendPers\u00f6nliche Empfehlungen:  \nMilderer Soforteffekt (als Minz\u00f6l)  \nbei verstopfter Nase/Nebenh\u00f6hlen  \nKopfschmerzen\nBernhard Uehleke\u2022Eukalyptusbl\u00e4tter: Tee, Kopfdampf\n\u2022Eukalyptus\u00f6l: alkoholisch verd\u00fcnnt f\u00fcr  \nErk\u00e4ltungsbalsam\n\u2022Erk\u00e4ltungslutschpastillen\n\u2022Eukalyptus\u00f6l \u2013Aromatherapie 1 Tropfen  \nreicht auf Taschentuch zum Inhalieren\n\u2022Badezusatz oder SaunaaufgussInhalation Eukalyptus\n\u2022Droge: Inhalation \u20263 g of the comminuted  \nherbal substance in boiling water, up to 3  \ntimes daily. Daily dose 3 - 9 g of the  \ncomminuted herbal substance\n\u2022EMA Droge und \u00d6l: Children under 30months  \nof age, because there is a risk that cineole  \ncontaining preparations, like other essential oils,  \ncan induce laryngospasm.\n\u2022Kratschmer -Holmgren- Reflex\n\u2022Jorch G. Ausl\u00f6sungsmechanismus des Kratschmer -Reflexes.  \nArzneimittel -, Therapie- Kritik & Medizin und Umwelt 2009, 41:384  \n[German]\nBernhard UehlekeEntwicklungen f\u00fcr Mentha,  \nThymian und Eukalyptus\n\u2022Kratschmer -Reflex: Ein theoretisch  \nkonstruiertes und falsch rezipiertes Risiko  \nwird zum Ausschluss von Kleinkindern  \nherangezogen und ungerechtfertigt auf  \nimmer weitere Heilpflanzen \u00fcbertragen.  Wird das dann zuk\u00fcnftig auf \u00e4ltere Kinder  \nausgeweitet und schlie\u00dflich auf  Erwachsene?\n\u2022DasVerleugnen vonpharmakologischen\nWirkungen er\u00f6ffnet Zulassungsm\u00f6glich-\nkeiten alsMediziBnerpnhrarodUdehulekket\u2026??EMA monographs\nExamples of Plants for Respiratory Disorders\nDezs\u0151 Csupor\nDepartment of Clinical Pharmacy\nDepartment of Pharmacognosy\nUniversity of Szeged, Hungary\nRespiratory diseases \u2013phytotherapeutic options\n\uf06eHome remedies , tisanes , herbal extracts\n\uf06eNon-specifical tools\n\uf06eLess serious upper respiratory tract infections\n\uf071Common cold, acute bronchitis\n\uf06eGoals : \n\uf071Relieve symptoms\n\uf071Shorten theperiod of illnness\n\uf071Decrease antibiotic use\n\uf06ePharmacons of herbal origin\n\uf071Beta2-agonists: Ephedra\n\uf071Methilxantin derivatives : Coffea , Camellia\n\uf071Anticholinergic compounds : Atropa\n\uf071Sodium chromogycate : Ammi visnaga\nCommon cold, flu, Covid-19?\n\uf06ePhytotherapy : only common cold\n\uf06eCold\n\uf071Picorna , rhino, ECHO stb.\n\uf071Symptom relief:\n\uf06eSore throat , blocked nose , cough etc.\n\uf071Prevention: immune modulations ?\n\uf06eFlu\n\uf071Influenza virus A/B\n\uf071Less remarkable respiratory symptoms\n\uf071High fever (39 oC)\n\uf071No place forphytotherapy\n\uf06eCovid -19\n\uf071No herbal remedy has established effect\nEMA herbal monographs\n\uf06eEU monographs provide all information necessary for the use of a \nmedicinal product :\n\uf071what the herbal product is used for;\n\uf071who the herbal product is intended for;\n\uf071safety information such as information regarding undesirable effects and \ninteractions with other medicines.\n\uf06eMonographs form the basis for thesummary of product characteristics \n(SmPC) and the package leaflet. \n\uf06eTwo types of indications /products\n\uf071Well-established use (marketing authorisation) :sufficient safety and efficacy data\n\uf071Traditional use (simplified registration) : sufficient safety data and plausible \nefficacy , no proof of efficacy\n07:49EMA herbal monographs\n\uf06eBased onassessment reports: collections of scientific data and \ntraditional use\n\uf071Prepared byexperts\n\uf06eAccepted bytheCommittee on Herbal Medicinal Products \n(HMPC) of theEMA\n\uf06ePreparation of monographs is intended tosupport the \nharmonisation of the European market: national competent \nauthorities are able to refer to one unique set of information on a \nherbal substance or preparation when evaluating marketing \napplications.\n\uf071165 monograps\n\uf07114 listentries\n07:49What is theoffer of theEMA monographs ? \n\uf06eGeneral relief of symptom\n\uf071Effect notspecified\n\uf06eCough\n\uf071Productive\n\uf071Dry\n\uf06eWell established useand traditional use\n\uf06eIndication (seemingly) notalways in line withclinical evidence\n\uf06eThe drawback of standard terms: disappearing differences\n07:4907:49Cough\n\uf06eReaction totheirritation of mucosa\n\uf06eMechanoreceptors of throat/pharynx\n\uf06eDrycough : relieve cough, decrease irrittation\n\uf06eProductive cough: expectoration\n\uf071Direct\n\uf071Indirect\n\uf06eDecrease theviscosity of mucus \u2013 teas (non- specific)\n\uf06eTrough gastropulmonal reflex \u2013 saponin- containing drugs\nMedicinal plants forcough in EMA monographs\n\uf06eUsed as an expectorant in cough \nassociated with cold.\n\uf071Anisi aetheroleum : \n\uf071Anisi fructus\n\uf071Foeniculi amari fructus aetheroleum\n\uf071Foeniculi amari fructus\n\uf071Foeniculi dulcis fructus\n\uf071Liquiritiae radix\n\uf071Primulae flos\n\uf071Primulae radix\n\uf071Thymi aetheroleum\n\uf071Thymi herba \n\uf071Polypodii rhizoma\uf06eUsed as an expectorant in case of productive cough.\n\uf071Hedera helicis folium\n\uf071Marrubii herba\n\uf06eFor relief of cough associated with cold.\n\uf071Eucalypti aetheroleum\n\uf071Origani dictamni herba\n\uf071Sideritis herba\n\uf06eFor the relief of symptoms in coughs and colds.\n\uf071Menthae piperitae aetheroleum\n\uf06eTo relieve symptoms of sore throat associated with \ndry cough and cold.\n\uf071Verbasci flos\n\uf06eDemulcent for the symptomatic treatment of oral or \npharyngeal irritations and associated dry cough.\n\uf071Plantaginis lanceolatae folium\n\uf071Althaeae radix \n07:49Expectorants\n\uf06eEssential oil-containing\n\uf071Aniseed\n\uf071Fennel\n\uf071Thyme\n\uf071Eucalyptus\n\uf071Oregano\n\uf071Peppermint\n\uf06eExpectorant + antimicrobial\uf06eSaponin- containing\n\uf071Primula\n\uf071Liquiritiae radix\n\uf071Ivy\n\uf06eSecretolytic\n\uf071+broncodilator (ivy)\n07:49 Side effects : mainly gastrointestinal07:49\n07:49\nWhat is behind?\n\uf06e101- page assessment rceport\n\uf06eDozens of clinical studies\uf06e\u201eIn summary, the data from numerous \nclinical trials and the existing medicinal \nproducts fulfil the requirements of a \nwell-established medicinal use with \nrecognised efficacy and are eligible for \na marketing authorisation with the \nindication herbal medicinal product \nused as an expectorant in case of productive cough associated with \nacute respiratory infection. This \nindication considers as well the data on improvement of symptoms by preparations of ivy as the limitations by current guidance on COPD.\u201d\n07:4907:49\nPolipodii rhizoma -thepower of tradition\n\uf06e\u201eThe traditional medicinal use of \npolypody rhizome as a remedy for diseases of the air passages, \nsuch as coughs, colds, adenoids \nand a multitude of other purposes has been documented in handbooks such as The Swedish Pharmacopeia (1849), Madaus (1938), Frerichs et al. \n(1938), H\u00f8eg (1975) and Nielsen \n(1977). \u201d\n\uf06eNo market data onproducts\n07:49\nPolipodii rhizoma -thepower of tradition\n\uf06eChemistry\n\uf071Ecdysteroids\n\uf071Sugars\n\uf071Essential oil\n\uf071Saponins\n\uf06eOsladin (500x sucrose )\n\uf06eGlycyrrizic acid? \u201eonly mentioned in \nold handbooks and journal, and not \ncited in newer literature. \u201d\uf06ePharmacology\n\uf071In vitro: antiviral, moulting\n(insects)\n\uf071In vivo: CNS, antipyretic, \nanalgetic , cardiovascular\n\uf071Clinical: no data\n\uf06eEfficacy : no data\n\uf06eDosage: mainly textbooks\n07:49\nMarrubii herba\n\uf06eChemistry\n\uf071Diterpenes\n\uf071Tannins\n\uf071Essential oil\n\uf06ePharmacology\n\uf071Antispasmodic , anti-inflammatory effects , \nanalgesic , antmicrobial\n\uf06eClinical: none\n\uf06eTradition :\n\uf071Catarrhs of the respiratory tract \n\uf071Acute bronchitis, non-productive coughs\n\uf071Symptomatic treatment of coughs\n\uf071To support the secretolytic activity in the \nrespiratory tract\n\uf06eAccepted indication\n\uf071Used as an expectorant in case of \nproductive coughSideritis herba\n\uf06eChemistry\n\uf071Essential oil\n\uf071Diterpenes\n\uf071Flavonoids\n\uf071Phenylpropanoids\n\uf06ePharmacology\n\uf071Antispasmodic , antmicrobial, antioxidant\n\uf06eClinical: none\n\uf06eTradition :\n\uf071No registered or authorised medicinal \nproducts in the EU / EEA Member States\n\uf071\u201ehas been traditionally used to aid digestion, strengthen the immune system and \nsuppress common cold, the flu and other viruses, allergies and shortness of breath, \nsinus congestion, even pain and mild anxiety \u201d\n\uf06eAccepted indication\n\uf071For relief of cough associated with cold\n07:49\nAnd what about \u2026?\n\uf06eAlthaeae radix\n\uf071Used as a demulcent preparation \nfor the symptomatic treatment of oral or pharyngeal irritation and associated dry cough. \n\uf071Used as a demulcent preparation for the symptomatic relief of mild gastrointestinal discomfort. \uf06eLichen islandicus\n\uf071Used as a demulcent for the symptomatic treatment of oral or pharyngeal irritation\n\uf071Used in temporary loss of appetite.\n07:49\nNon-specific relief of symptoms\n\uf06eFor the relief of early symptoms of common cold.\n\uf071Sambuci flos\n\uf06eFor the symptomatic treatment of common cold.\n\uf071Pelargonii radix\n\uf06eFor the relief of symptoms of common cold. \n\uf071Polygoni aviculare herba\n\uf071Tiliae flos\n\uf071Echinaceae purpureae radix\n\uf071Matricariae flos\n\uf06eFor the relief of symptoms in coughs and colds.\n\uf071Thymi aetheroleum\n07:49\nPelargonii radix\n07:49\nAgbabiaka 2008, adults\nEfficacy assessed : Bronchitis Severity Score\nSeifert , 2019, child\u0171ren, time torecoverySupportive treatment & fever\n\uf06eFor supportive treatment of common cold.\n\uf071Echinaceae angustifoliae radix\n\uf071Echinaceae pallidae radix\n\uf071Filipendulae ulmariae flos\n\uf071Filipendulae ulmariae herba\n\uf06eUsed for the relief of fever associated with common cold.\n\uf071Salicis cortex\n07:49One rareand special example: \nfixed combination of \nThymi herba and Primulae radix\n\uf06eTraditional herbal medicinal product \nused as an expectorant in cough associated with cold.\n07:49Summary\n\uf06eEMA monographs : based onscientific evidence ortradition\n\uf071Sometimes lacking pragmatism\n\uf06eLage limit usually high (asolescents and adults)\n\uf071Chamimile : 6 years\n\uf071Ivy: 2 years\n\uf06eNotalways in line withmarketed products\n07:49Workshop 1\nWie man eine Monographie und  \neinen Assessment Report der EMA\nliest\nBernhard Uehleke\nAbt. Naturheilkunde der Charit\u00e9, Berlin  \nForschergruppe Klostermedizin GmbH, W\u00fcrzburg  \nClinical Evidence Evaluations UG, Berlin\nEMA Thymian\n\u2022GebenSiedie St ichworteEMA und  \nThymian ein oder so \u00e4hnlich!\n\u2022Finden Sie die \u00dcbersichtsseite\u00dcbersic htsseite\nBernhard Uehleke  \nBernhard Uehlekewww.ema.euro pa.eu/en/ medicines/ herbal/ thymi-\nherba\n\u00dcberfliege die Infos und komme zuden  \nangegebenen Dokumenten\nklicke die aktuelle Monographie an\n\u2026.finalEMA -Mon ographie\nBernhard Uehleke  \nBernhard Uehleke\u2022Beachten Sie dieAufteilung rechts links\n\u2022Schauen Sie die Herbal preparations an  \nunter 2\n\u2022Und die Dosierungen unter Posologie 3\nBerechnen Sie die \u201eDosierung entsprechend  \nDroge\u201cZubereitungsformen und  \n\u00e4quivalente Dosierung\n\u2022DROGE\n\u2013Tee 2g3xt\u00e4glich =6g\n\u2013Droge in festen oralen Formen 3 x 4 Drgs.\u00e1 500 mg\n\u2013Extrakt D:E -Verh\u00e4ltnis!!!\n\u2013Tinktur 1:1 3x 20 Tropfen\n\u2022FRISCHPFLANZE\n\u2013Saft 3x 20 ml\n\u2013Gem\u00fcse? mind. 3x 20 g\n\u2022\u00c4therisches \u00d6lca. 3 x 20-100mgDosieru ngsber echnung\nZubereitungen Entspricht Droge\na)Liquid extract (DER 1:1): Single dose: 1-2\nml, 3-4 times daily\nb)Liquid extract (DER 1:1.16): Single dose  \n1.2-2.4 ml, 3-4 times daily\nc)Liquid extract (DER 1:2 -2.5): Single dose 1-\n4 g, 1 -7 times daily, maximum daily dose 14 g\nd)Tincture (1:10): Single dose 40 drops, 3  \ntimes daily\ne)Tincture (1:5): Single dose 2 -6 ml, 3times\ndaily\nf)Soft extract: Single dose 50 mg, 6times  \ndaily\nBernhard Uehleke  \nBernhard UehlekeDosieru ngsber echnung\nZubereitungen\ng) Liquid extract (DER 1:1.5 -2.4) Single dose\n10 ml, 3-4 times daily\nh) Dry extract (DER 6 -10:1): Single dose 75-\n200 mg, 3 times daily\ni) Dry extract (DER 1.6 -2.4:1) Single dose 135\nmg, 1-3 times daily\nj)Liquid extract (1:4.5) Single dose 480 \u2013960  \nmg, 3-4 times daily\nk)Dry extract (DER 7 -13:1) Single dose 100 \u2013\n200 mg, 3-4 times daily\nl) Comminuted herbal substance Herbal tea: 1-\n2 g of the comminuted herbal substance in 150  \nml of boiling water as a herbal infusion 3-4  \ntimes dailyEntspricht Droge\nBernhard UehlekeVergleichen Sie die Dosierungen  \nzur Kommission E\nBernhard Uehleke  \nBernhard Uehleke\u2022https://ar zneipflanzen lexikon.i nfo/thymian. \nphp\n\u2022?Kinderdosierungen\nBernhard Uehleke  \nBernhard Uehleke\u2022Suchen Sie die Kinderdosierungen\n\u2022Auch unter 4.4\n\u2022Formale Ablehnung von  \nPhytotherapiebehandlung f\u00fcr KleinkinderWeitere Info\nBernhard Uehleke  \nBernhard Uehleke\u2022SchauenSieunterNebenwirkungen 4.8Assessment report\nBernhard Uehleke  \nBernhard Uehleke\u2022https://www .ema. europa.eu/en/ docum ents/h \nerbal -report/final -assessment -report -\nthymus -vulgaris -l-vulgaris -zygis -l-\nherba_en.pdf\n\u2022Siehe L\u00e4nderliste S 5. (1.2)Assessment report II\nBernhard Uehleke  \nBernhard Uehleke\u20222.2.1Indications nach L\u00e4ndern\n\u20222.2.2 ff Blumenthal ist die amerikanische  \n\u00dcbersetzung der E-Monographien\n\u2022S. 12f. Studien bei Kindern\n\u20223 Non -clinical Data S.14-20:\n\u20223.15. conclusion\n\u20224 Clinical data S. 23-25\n\u2022Studien mit Kombinationen\n\u20226 Overall conclusionForschung und Zukunft\nBernhard Uehleke  \nBernhard Uehleke\u2022Viel pr\u00e4klinische Forschung mit Einzelsubstanzen\n\u2013\u00dcbersch\u00e4tzung pr\u00e4klinischer Ergebnisse weltweit!!\n\u2022Kaum klinische Forschung \u00fcberhaupt\n\u2022Patentierbarkeit vonPflanzen?\n\u2022Kombinationsprodukte mit starkem Branding\n\u2013Mit dem leichtesten Zulassungsweg\u2026\n\u2022Vielleicht sp\u00e4ter doch (verkaufsf\u00f6rdernde)  \nklinische Evidenz gew\u00fcnscht?How to find HMPC \nMonographs easily\nMINI -GUIDE\nSUMMERSCHOOL HEALTHY HERB S1.\n3.2.Start with the EMA main page: https://www.ema.europa.eu/enThis overview page offers lots of information about guidelines, regulatory pathways, etc. Scroll down \nand click on Find herbal medicines and you will come directly to the search fields. Or click on the left \nside on EU monographs and list entries and you will find again general information about the \nmonographs. \n4.Search fields \u2192\nimportant for the \nSummer School: \nTherapeutic area\n5.Example Thymi aetheroleum:\nhttps://www.ema.europa.eu/en/medicines/herbal/thymi -\naetheroleum\nScroll down to \ndocuments and open \nthe monograph (pdf)6.Content of HMPC Monograph: \n\u2022Name\n\u2022Qualitative and quantitative composition\n\u2022Pharmaceutical form\n\u2022Clinical particulars\n\u2022Pharmacological properties\n\u2022Pharmaceutical particulars \n\u2022Date of compilation/last revision Workshop 1\nWie man eine Monographie und  \neinen Assessment Report der EMA\nliest\nBernhard Uehleke\nAbt. Naturheilkunde der Charit\u00e9, Berlin  \nForschergruppe Klostermedizin GmbH, W\u00fcrzburg  \nClinical Evidence Evaluations UG, Berlin\nEMA Thymian\n\u2022GebenSiedie St ichworteEMA und  \nThymian ein oder so \u00e4hnlich!\n\u2022Finden Sie die \u00dcbersichtsseite\u00dcbersich tsseite\nBernhard Uehleke  \nBernhard Uehlekewww.ema.euro pa.eu/en/ medicines/ herbal/ thymi-\nherba\n\u00dcberfliege die Infos und komme zu den  \nangegebenen Dokumenten\nklicke die aktuelle Monographie an\n\u2026.finalEMA -Mon ographie\nBernhard Uehleke  \nBernhard Uehleke\u2022Beachten Sie dieAufteilung rechts links\n\u2022Schauen Sie die Herbal preparations an  \nunter 2\n\u2022Und die Dosierungen unter Posologie 3\nBerechnen Sie die \u201eDosierung entsprechend  \nDroge\u201cZubereitungsformen und  \n\u00e4quivalente Dosierung\n\u2022DROGE\n\u2013Tee 2g3xt\u00e4glich =6g\n\u2013Droge in festen oralen Formen 3 x 4 Drgs.\u00e1 500 mg\n\u2013Extrakt D:E -Verh\u00e4ltnis!!!\n\u2013Tinktur 1:1 3x 20 Tropfen\n\u2022FRISCHPFLANZE\n\u2013Saft 3x 20 ml\n\u2013Gem\u00fcse? mind. 3x 20 g\n\u2022\u00c4therisches \u00d6lca. 3 x 20- 100mgDosieru ngsbere chnung\nZubereitungen Entspricht Droge\na)Liquid extract (DER 1:1): Single dose: 1-2\nml, 3- 4 times daily\nb)Liquid extract (DER 1:1.16): Single dose  \n1.2-2.4 ml, 3- 4 times daily\nc)Liquid extract (DER 1:2 -2.5): Single dose 1-\n4 g, 1- 7 times daily, maximum daily dose 14 g\nd)Tincture (1:10): Single dose 40 drops, 3  \ntimes daily\ne)Tincture (1:5): Single dose 2 -6 ml, 3 times\ndaily\nf)Soft extract: Single dose 50 mg, 6 times  \ndaily\nBernhard Uehleke  \nBernhard UehlekeDosieru ngsbere chnung\nZubereitungen\ng) Liquid extract (DER 1:1.5- 2.4) Single dose\n10 ml, 3- 4 times daily\nh) Dry extract (DER 6 -10:1): Single dose 75-\n200 mg, 3 times daily\ni) Dry extract (DER 1.6 -2.4:1) Single dose 135\nmg, 1-3 times daily\nj)Liquid extract (1:4.5) Single dose 480 \u2013960  \nmg, 3-4 times daily\nk)Dry extract (DER 7 -13:1) Single dose 100 \u2013\n200 mg, 3-4 times daily\nl) Comminuted herbal substance Herbal tea: 1-\n2 g of the comminuted herbal substance in 150  \nml of boiling water as a herbal infusion 3-4  \ntimes dailyEntspricht Droge\nBernhard UehlekeVergleichen Sie die Dosierungen  \nzur Kommission E\nBernhard Uehleke  \nBernhard Uehleke\u2022https://ar zneipflanzen lexikon.i nfo/thymian. \nphp\n\u2022?Kinderdosierungen\nBernhard Uehleke  \nBernhard Uehleke\u2022Suchen Sie die Kinderdosierungen\n\u2022Auch unter 4.4\n\u2022Formale Ablehnung von  \nPhytotherapiebehandlung f\u00fcr KleinkinderWeitere Info\nBernhard Uehleke  \nBernhard Uehleke\u2022SchauenSieunterNebenwirkungen 4.8Assessment report\nBernhard Uehleke  \nBernhard Uehleke\u2022https://www .ema. europa.eu/en/ docum ents/h \nerbal -report/final- assessment -report -\nthymus -vulgaris -l-vulgaris -zygis -l-\nherba_en.pdf\n\u2022Siehe L\u00e4nderliste S 5. (1.2)Assessment report II\nBernhard Uehleke  \nBernhard Uehleke\u20222.2.1Indications nach L\u00e4ndern\n\u20222.2.2 ff Blumenthal ist die amerikanische  \n\u00dcbersetzung der E-Monographien\n\u2022S. 12f. Studien bei Kindern\n\u20223 Non-clinical Data S.14-20:\n\u20223.15. conclusion\n\u20224 Clinical data S. 23-25\n\u2022Studien mit Kombinationen\n\u20226 Overall conclusionForschung und Zukunft\nBernhard Uehleke  \nBernhard Uehleke\u2022Viel pr\u00e4klinische Forschung mit Einzelsubstanzen\n\u2013\u00dcbersch\u00e4tzung pr\u00e4klinischer Ergebnisse weltweit!!\n\u2022Kaum klinische Forschung \u00fcberhaupt\n\u2022Patentierbarkeit vonPflanzen?\n\u2022Kombinationsprodukte mit starkem Branding\n\u2013Mit dem leichtesten Zulassungsweg\u2026\n\u2022Vielleicht sp\u00e4ter doch (verkaufsf\u00f6rdernde)  \nklinische Evidenz gew\u00fcnscht?From Galen to Galenics \u2013\nProperties of Herbal Drugs for the \nRespiratory Tract\nProf.Anna Rita Bilia\nDepartment of Chemistry \u201cUgo Schiff\u201d\nUniversity of Florence, Italy\nar.bilia@unifi.it \nHEALTHY HERBS -A STRATEGY AGAINST ANTIMICROBIAL \nRESISTANCE IN THE RESPIRATORY TRACT\nSUMMERSCHOOL\n08/09/2021 -12/09/20212AGENDA\n\uf075Historical overview\n\uf075Ancient galenic formulations\n\uf075The evolution from galenical to\nneogalenical formulations\n\uf075Herbal drugs fortherespiratory tract:\nclassification onthe basis oftheir\nmechanism ofactions\n\uf075Herbal drugs fortherespiratory tract:\ntypical formulations3AGENDA\n\uf075Historical overviewAncient archeological  records of medicinal plants\n\uf0d8Neanderthal burial with useful medical plants\nfrom Middle Paleolithic period, some 60,000\nyears ago.Shanidar Cave inIraq.Buried with 8\nplant species, 7ofwhich have medicinal uses.\n\uf0d8Otzi the Iceman, who died about \n5200 years ago and was preserved in \na glacier in northern Italy, carried \ntwo lumps of birch fungus, which \ncan be used as both a laxative and an \nantibiotic.  He had intestinal \nparasites.  \nThe Greek s\u2026\nPythagoras of Samos (570 -495 B.C.) used drugs as Mustard and \nSquill\nHippocrates of Kos (460 -370 B.C.) \nThe father of Western medicine was familiar with numerous drugs, \nand wrote \"Corpus Hipocraticum \". \nHe used ginger (warm herb) for cold. \nHe described many plants: thyme, fennel, caraway, cinnamon, \nclove, anise, frankincense, myrrh, garlic, opium, mandrake, \nbelladonna\nTheophrastus of Eressus (370 \u2013286 B.C.) \nFather of Botany . \nBotanical Gardens in Athens.\nAuthor of the oldest treatise on botany , \u201cHistoria Plantarum \u201d,in \nwhich he described about 480 kinds of plants from the Atlantic to \nIndia.\n\u2026 and  the Romans\nPedacious Dioscorides (40-90AD)\nofAnazarbos ,who was aGreek by\nbirth hewas thefirst todescribe\ndrugs and hiswork \u201cDe Materia\nMedica \"a5-volumes encyclopedia\nwhich included 600medicinal plants\ninaddition toanimal and mineral\ndrugs (more than 1,000\nmedications) and represented the\nleading pharmacological textinthe\nnext 1,500 years .Cannabis, water\nhemlock, colchicum, pomegranate,\nRhodiola ,Milkthistle\n\u2026 and  the Romans\nPliny theElder (23-79AD) who lived\nabout thesame time asDioscorides ,\nwas also an eminent author of\n\u201cNaturalis Historiae \u201d.About 900 plants\nare named, among others lemon,\nsilphium ,garlic, hops, cucumber,\nmustard, horseradish, lycium ,turnip\n\u2026 and  Galen\nGalen ofPergamum was born 129 AD, now\nBergama, Turkey .Physician, philosopher, and\nwriter, Galen revolutionized medical theory inthe\nByzantine world, Islamic middle east, andEurope .\nGalen\u2019s medical teachings and theories would\ndominate and influence Western medical science\nforthenext 1,700years .\nPassionate about treatments, hestudied andtravelled\nextensively and long distances, inparticular inAsia\ninvestigating and collecting plants foruse as\nmedicines .Hebecame legendary inhisday, aprolific\nwriter, andthephysician toseveral Roman Emperors .\n5thto 12thcentury: Monastic Pharmacy\n\uf075Monasteries\n\uf075Centers of intellectual life\n\uf075Remnants of the Western knowledge of Pharmacy and Medicine\n\uf075Monks\n\uf075Exotic spices from the East were rare and Europeans had to rely on \nnative temperate herbs and many valued for medicinal uses \n\uf075Monks collect and cultivate medicinal plants\n\uf075They distill aromatic and cordial flowers\n\uf075They prepare herbs according to the art of the apothecary for the \nbenefit of the sick and injured\nclaustrum sine armario\nest quasi castrum sine \narmamentario\n9thto 15thcentury: Medical School of Salerno\nSchola Medica Salernitana had a great impact on the revival and development of Italian and \nWestern medicine inspired to Hippocrates\u2019 and Galen\u2019s writing s and strongly influenced by the \nArabic medicine with the introduction or reconsideration of numerous plants from East. One of the \ncrowning achievements of the school was a poem on health, \u201c Regimen Sanitatis Salernitanum .\u201dPietro Andrea Mattioli, 1500 -1577\nPetri Andreae Matthioli senensis medici : commentarij\nin sex libros Pedacij Dioscoridis Anazarbei De medica\nmateria .Venetiis : Ex Officina Valgrisiana , 1565.Castor Durante, da Gualdo , \nMedico, & Cittadino \nRomano,1529 -1590\nHerbario novo 1585\n15\nth\n-\n16\nth\ncenturies: The Age of Herbals\u2026\nand of  first Pharmacopoeias\nRicettario Fiorentino ,1496\nbytheMedical Council ofFlorence\nItwas thefirst Pharmacopoeia inEurope .Every\nspice seller was obliged toprepare herb medicines\nfollowing theprescriptions :heavy sanctions were\nadopted against violators ofnorms .The Ricettario\nindicated thequality ofspices formedicines ,and\nthisinfluenced thecommerce .\nTeatro Farmaceutico , Dogmatico , \nSpagirico by Donzelli , 1611\u201cSemplici \u201d\nAlmonds (sweet and  bitter) \nAsa-foetida\nBlack pepper\nCardamom\nCinnamon species\nCubebe pepper\nDragon\u2019s blood (P. drago , P. \nsantalinus , D. drago , C. \nrotang )\nGarlic\nGinger\nGinsengJujube \nLaurel \nMacys\nOlibanum\nOnion\nOrange\nPomegranate\nRhubarb \nSaffron\nTea (T. bohea and \nT. viridis )  \nDragon\u2019s blood : against haemorrhage, especially epistaxis \nGinger : Stimulant as pepper, in colic with flatulence, against weakness of intestines\nSaffron : narcotic and depriment, hemmenagoghe, colic of uterous\nTea: diuretic, expectorant, exhilarating, pectoral and sweating \u201cMedicamenti composti \u201d\nChapter on \nBotanical  \u201cMateria Medica\u201d\n\u2022Exotic Stimulant Aromatic Plants\nCardamom, Ginger (digestive), Turmeric (different sp., as \na tonic, stimulant and against scorbutus)\n\u2022Iris Plants\nSaffron (tonic, stomachic, nerving, excitant)\n\u2022Pepper Plants\nBlack or white  pepper (stimulant, stomachic, against \nfever), Cubebe pepper  (treatment of gonorrhoea, of \npathologies of urethra and vagina, blennorrhoea), P. \nlongum (in the theriac)\n\u2022Apiaceae Plants\nAsa-foetida ( \u201cstercus diaboli\u201d), Hydrocotile asiatica \n(poisonous as haemlock, narcotic, against  leprosy, \nscabies, syphilis,  as pills, syrup and hydro alcoholic \nextract)\n\u2022Laurus Plants\nCinnamon ( Laurus cinnamomum , excitant and digestive), \nChina cinnamon ( L. cassia , its substitution is  trivial), \ncamphor ( L. canfora )\n\u2022Plants with astringent , tonic and stimulant \nproperties\nCloves ( Myrtus cariophyllata, as stimulant and aromatic), \nPomegranate (the drug is represented by the bark root as \nalready reported by Plinius and Dioscorides, as a \nfebrifugal, the decoction is used for taenia expulsion\n\u2022Polygonaceae  RhubarbTeriaca orTheriac :medical\nconcoction originally formulated\nbytheGreeks inthe1stcentury\nADand widely adopted inthe\nancient world asfaraway as\nPersia, China andIndia.Itwasan\nalexipharmic, or antidote,\nconsidered apanacea .The word\ncomes from the Greek term\n\u03b8\u03b7\u03c1\u03b9\u03b1\u03ba\u03ae (th\u0113riak\u0113), afeminine\nadjective signifying \"pertaining to\nanimals \"\nElettuario (or elettovario ,\nelettovaro ,lattovaro )indicates an\nancient pharmaceutical\npreparation composed ofadense\nmixture ofactive principles,\npowders, parts andplant extracts\nmixed with sweeteners such as\nhoney orsyrups tomask its\nunpleasant taste .1892: first Italian Pharmacopoeia\nAlmonds (sweet and  bitter) \nAsa-foetida\nCinnamon species (Ceylon or Queen, as distilled water, syrup, \nessence, hydro alcoholic solution)\nCubebe pepper\nGalbanum (mollis, i.e. G. levanticum or  siccum, i.e. G. \npersicum; Ferula rubricaulis )\nGinger, Lemon, Orange, \nMyrrh (as a tincture)\nPeach (Amigadalus persicus)\nPomegranate (Granati radicis cortex)\nRhubarb (as syrup, aqueous extract, infusion, pills, tincture \nand wine)\nSaffron  (Croci stigmata)1902: second edition \nDecoction of pomegranate, bitter orange tincture, asafoetida tincture (1:5, alcohol 80 v/v )\n1909: third edition \nSaffron tincture (1:10, alcohol 70 v/v )\n1892: first Italian Pharmacopoeia\nHerbal Drugs and their preparations\nAsa foetida (as tears or tincture)\nBlack pepper (in Pills with arsenic , Pillulae acidi\narsenicosi )\nCardamon (fruit or tincture)\nCubebe pepper\nCinnamom (cassia or queen, as oleum, spirit, tincture)\nCloves (as ingredient of  laudano and aqua melissae )\nGalbanum ( Ferula galbanifera Boisser et Buhse , as  a \nplaster  with trementine and yellow wax))\nMhyrr (tincture)\nNutmeg (as ingredient of aqua melissae )\nPomegranate (as decoction)\nSaffron\n1940: sixth EditionPreparations\nAromatic vinegar (Acetum aromaticum)\nLaudanum tinctura opium crocata\nRhubarb pills and rhubarb pills with arsenicum and iron \nlactate \nRhubarb syrup and rhubarb wine with Marsala  and \nbitter orange tincture\n20AGENDA\n\uf075Historical overview\n\uf075Ancient galenic formulations Claudius Galen  (129-201 AD)\nThe father of galenic pharmacy\nToday areavailable 83books, ofwhich themost\nfamous is Claudii Galeni de simplicium\nmedicamentorum facultatibus libri XIwhich\nincluded 473medicinal plants\nGalenic isthe process that turns anactive\ningredient intoaready -to-usemedicine thatcan\nbedosed asrequired .A\u201cgalenic formulation\u201d\ndeals with the principles ofpreparing and\ncompounding medicines inorder tooptimize\ntheir absorption\u201d .\nToday ,galenic formulation isapart of\npharmaceutics, the discipline (orscience) of\ndosage form design, and itisrecognised to\nprofoundly affect pharmacokinetics,\npharmacodynamics andsafety profile ofadrug.Galenic formulations were prepared almost\nexclusively from plants by squeezing,\ndigesting, and other simple methods and\nwere widely used fortherapeutic purposes\nuntil theendofthe15thcentury .Claudius Galen  (129-201 AD)\nThe father of galenic pharmacy\nHefirstly described theprocesses ofcreating extracts containing theactive\nprinciples ofmedicinal plants within thefollowing phases :\n1-Comminution(reducing themedicinal substance tosmall size\n2-Penetration bythemenstruum inthemedicinal substance\n3-Dissolition oftheactive principles bythemenstruum\n4-Diffusion ofthedissolved active principles through thecell wall tothe\nsurrounding \u201cmestrum \u201d\n5-Separation ofthedissolved active principles from the\u201cmarc\u201d bystraining,\nfiltration orexpressionV: Pharmacy\nOn the Powers (and Mixtures) of Simple remedies (Drugs) De Simp . \nMedicament. Facultatibus (SMT )\nOn Remedies Easy to Prepare: \u03a0\u03b5\u03c1\u03b9 \u03b5\u03c5\u03c0\u03bf\u03c1\u03b9\u03c3\u03c4\u03c9\u03bd (Peri euporiston); De Remediis \nParabilibus\nOf medicinal substitutes (On Substitute Drugs) De Substitutis Medicinis (Suc.)\nOf the faculty or power of purgative remedies (On the Power of Cleansing \nDrugs) De Purgantium Medicamentorum Facultate (Purg . Med. Fac. )\nWhom, with which, and at what time to purge (Whom to Purge, with what Cleansing Drugs and \nWhen) Quos Purgare Conveniat , Quibus Medicamentis , et Quo Tempore (Cath. Med. Purg .)\nOf the theriaca (On Theriac to Piso)De Theriaca , ad Pisonem (Ther. Pis.)\nOn the use of the theriaca (On Theriac to Pamphilianus )De UsuThericae , ad Pamphilianum\nOn Antidotes De Antidotis (Ant.)\nOf the composition of local remedies De Compositione Medicamentorum Localium\nOn the Composition of Drugs (Medical Compounds) according to Places De Compositione\nMedicamentorum Secundum Locus (Comp. Med. (Sec.) Loc. )\nOf the compounding of remedies in relation with their genera (On the Composition of Drugs \naccording to Kind) De Compositione Medicamentorum per Genera (Comp. Med. per Gen. )\nOf weights and measures De Ponderibus et Mensuris LibellusPHARMACEUTICAL PREPARATIONS (Pharmaceutica )\nPharmaceutical preparations are defined asmedicinal products generally\nconsisting ofactive substances that may becombined with excipients, formulated\ninto adosage form suitable for the intended use, where necessary after\nreconstitution, presented inasuitable and appropriately labelled container .\nPharmaceutical preparations may belicensed bythe competent authority, or\nunlicensed and made tothe specific needs ofpatients according tolegislation .\nUnlicensed medicines are extemporaneous preparations, i.e.pharmaceutical\npreparations individually prepared foraspecific patient orpatient group, supplied\nafter preparation, and stock preparations, i.e.pharmaceutical preparations\nprepared inadvance and stored until arequest forasupply isreceived .\n[Eur.Pharm .04/2019 :2619 PHARMACEUTICAL PREPARATIONS Pharmaceutica ]Ceratum galeni recipe\nIngredients: plant oil, flower water, and beeswax\nTo treat dry, cracked skin. \nClaudius Galen  (129-201 AD)\nThe father of galenic pharmacy\nHefirstly described theprocesses ofcreating extracts containing theactive\nprinciples ofmedicinal plants within thefollowing phases :\n1-Comminution (reducing themedicinal substance tosmall size)\n2-Penetration bythemenstruum inthemedicinal substance\n3-Dissolition oftheactive principles bythemenstruum\n4-Diffusion ofthedissolved active principles through thecell wall tothe\nsurrounding \u201cmenstruum\u201d\n5-Separation ofthedissolved active principles from the\u201cmarc\u201d bystraining,\nfiltration orexpression\n\u201cMenstruum\u201d : solvent used for the \nextraction (water, wine, vinegar, oils and \nfats)\n\u201cMarc\u201d : the inert fibrous and other insoluble \nmaterials remaining from the extractionMethods to obtain extracts\nMACERATION\nComminuted herbal drug isplaced inacontainer with thesolvent, until\nthecellular structure issoftened and penetrated bythesolvent and\nsoluble matter isdissolved (3-7days ).Themarc ispressed .\nDIGESTION\nThis process isamodified form ofmaceration where thedrug is\nextracted byheating .This willincrease thepenetration power ofthe\nmenstruum, sothat there iscomplete extraction ofthedrug.Insome\ncases itisaprocess before themaceration .\nINFUSION\nComminuted herbal drug isplaced inacontainer .Boiling water is\nadded and poured over theherb.After theherb hasbeen allowed to\nsteep intheliquid foranappropriate period oftime, itisremoved\n(possibly bystraining) leaving aninfusion .\nDECOCTION\nComminuted herbal drug isboiled withwater for10to15minutes .\nAfter boiling, theliquid iscooled andfiltered .\nFrom the \n first Pharmacopoeias\nRicettario Fiorentino ,1496\uf0d8List ofmedicinal species (plants and\nanimals)\n\uf0d8How toprepare \u201csimple medicines\u201d :\ndrugs ofanimal origin aresalted, while\nplants having lowcontent ofwater are\nmoisten etc..,howtomake extractions of\nmucilage\n\uf0d8How toprepare \u201ccomposite medicines\u201d,\nincluding their conservation\n\uf0d8Different solvents arereported, including\nthe \u201cagresto \u201d,anacidic condiment\nobtained from thecooking ofthemust of\nunripe grapes andtheaddition ofvinegar\nandspices .FIRST PARTFrom the \n first Pharmacopoeias\nRicettario Fiorentino ,1496\uf0d8\u201cDeRobbi ,Giulebbi andSciroppi \u201d\nGiulebbi :very sweet syrup obtained with\nflowers andfruits ,from thePersian \u00abgulab \u00bb\nwich means rosewater, transformed bythe\nArabic as\u00abgiuleb \u00bb.\n\uf0d8\u00abLocchi\u00bb from theArabic ,\u00abEclemi \u00bbor\n\u00abElecta \u00bbfrom theGreek ,\u00abLincti \u00bbfrom\nLatin aremore dense syrups .Theterm\n\u00abLinctus syrup \u00bbused today means\nmedicated syrup\n\uf0d8\u00abLattuari from thegreek which means\nantidotesRicettario Fiorentino ,1496 SECOND PART: LIST OF RECIPES\nFrom the \n first Pharmacopoeias\nTeatro Farmaceutico , Dogmatico , \nSpagirico by Donzelli , 1611\uf0d8Terminology :Decoctions ,Distillation ,\u00abDel\nbagno maria \u00bbetc..FIRST PART\nSECOND PART\n\uf0d8Description of terms : \u00abElettuari ,\nConfezioni ,Conserve, Locchi (Loch),\nTabelle ,Orbicole eMorfelli \u00bb\nElettuari are obtained from powerful\n\u00absemplici \u00bbmixed with sugar orhoney\nTabelle ,Orbicole ,Morselli :solid forms made\nwith thepowders and sugar syrup .Tabelle\nhave asquare form, orbicole arespherical and\nmorselli areelongated ones.\nSORBET :sugar 1pound ,lemon juce 30ounces ,spirito divetriolo\n(sulphoric cid)1drachma ,ambra grigia 10grams ,muschio 4gramsFrom the \n first Pharmacopoeias\nTeatro Farmaceutico , Dogmatico , \nSpagirico by Donzelli , 1611\uf0d8Among others, syrups, \u00abgiulebbi \u00bb,\n\u00absape\u00bb(fruit orherb juce concentrated\nbyexposition tothesunorbyfire, \u00abrob\u00bb\nisthe Arabic term), \u00abapozeme \u00bb\n(decoctions plus sugar inthe same\nquantity, cooked until hard consistency),\n\u00abfoti\u00bbor\u00abfomenti \u00bb(from thelatin word\n\u201cfovere \u201dwhich means heating, fomenti\naredried herbs orplant parts oreven\nhumidified which areapplied locally in\nthebody after heating), boli,pillole ,\ngargarismiTHIRD PARTINDICE DEI MORBI CON I LORO RIMEDITeatro Farmaceutico , Dogmatico , Spagirico by Donzelli , 1611\n\u201cAsma , Catarri ,  Glandule nella Gola gonfie , Infiammazione del \nPolmone , Ostruzione di Polmone , Pettorali , Pleuritide e dolore nel\nCostato , Polmone giovare , Raucedine , Tosse \u201d  \nAsthma, Catarrhs,\nSwollen Throat\nGlandules, Lung\nInflammation, Lung\nObstruction, Pectorals,\nPleuritis andPain inthe\nRib, Lung Benefit,\nHoarseness, Cough\n33AGENDA\n\uf075Historical overview\n\uf075Ancient galenic formulations \n\uf075The evolution from galenical to neogalenical\nformulations34\uf071Historical galenic : \nfrom the \u201c Ceratum Galeni \u201d until 18 century\n\uf071Galenic : \nfrom 18 century up to 1990\n\uf071Neo-galenic : \nFrom 1990 modern technologies and innovative \nexcipients gave new smart formulationsEVOLUTION OF GALENICAL PREPARATIONS\n\uf071Historical galenic : \nfrom the \u201c Ceratum Galeni \u201d until 18 century\n%\nBEESWAX  20,00\nVEGETAL OIL 60,00\nROSE WATER 20,00EVOLUTION OF CERATUM GALENI\nThe beeswax isessential toasuccessful\ncream, asitistheemulsifying ingredient,\nbutitisextremely inefficient compared to\nmodern emulsifiers .Chemically, beeswax\nconsists mainly ofesters offatty acids and\nvarious long-chain alcohols .The poor\nemulsifying properties areduetothefatty\nalcohols contained inbeeswax and\nphytosterols present intheunsaponifiable\nfraction ofvegetal oil.EVOLUTION OF CERATUM GALENI\n\uf0d8Theformulation persisted \u2013generally using rose-water and/or oilofroses asa\nperfume \u2013and was included inthefirst edition ofthe\u2018Pharmacop\u0153a\nLondinensis \u2019in1618.Inlater formulations, sweet almond oilreplaced the\nolive oil.\n\uf0d8Acopy oftheLondon Dispensatory ,edited byNicholas Culpeper and\npublished intheyear1650 included thefollowing formula forthissubstance :\nTakeofwhite wax four ounces ,oylofroses omphacine apound ;melt inadouble\nvessel ,then powr itoutinto another ,bydegrees putting incold water, and often\npowring itoutofonevessel into another ,stirring ittillitbewhite ;lastofallwash it\ninrosewater, adding alittle rosewater androsevinegar .\nNicholas Culpeper (1650),London Dispensatory\n\uf0d8Starting from 1850 there areseveral kinds ofcold cream, distinguished by\ntheir odour, such asthat ofcamphor, almond, violet, roses, etc.Inaddition\nBeeswax wassubstituted with White Wax, Benzoated Lard, Spermaceti, while\nalmond oilwas substituted bypetrolatum and mineral oil.Afurther\nadvancement wastheinclusion ofborax (sodium borate) .EVOLUTION OF CERATUM GALENI\n\"cold cream \"\nfrom the\ncooling feeling\nthat the\ncream leaves\nontheskin.\n%\nBEESWAX 18.00\nVEGETAL OIL 60.00 (or less)\nWATER 20.00 (o more)\nBORAX 2.00\nROSE ESSENCE 30 dropsCOLD CREAM\nCreams made with only beeswax require extensive mixing and can separate upon\nstanding .Thus, small quantities ofborax were later added inaddition tothebeeswax .\nBorax isthesodium tetraborate decahydrate (Na2B4O7\u00b710H2O)that, when dissolved\ninwater, ishydrolyzed toboric acid andOH\u2212 anions, yielding apHofabout 9.13.\nBorax saponifies fatty acids inthebeeswax andoilallowing toamore stable cream,\nusing thesmall quantities ofsoap created astheemulsifying agent .Inthenineteenth century, borax wasalso introduced intocold creams .In1890 ,aformula\nforaborax cold cream was incorporated intotheU.S.Pharmacopoeia andthen intothe\nBritish Pharmacopoeia in1914 (deNavarre ,1941 ).However, records goback earlier\nthan this.In1844 ,Lawrence Turnbull published arecipe foracold cream made with\nborax inthe\u2018American Journal ofPharmacy\u2019 .Soft Paraffin, white 12.50\nWhite Beeswax 12.50\nAlmond Oil 50.00\nBorax 1.00\nOil of Rose 0.10\nRose Water \n(undiluted)25.00\nThe British Pharmaceutical Codex, 1911, was \npublished by direction of the Council of the \nPharmaceutical Society of Great Britain.In 1869, Robert Chesebrough extracted petrolatum from crude petroleum and began selling it under the \ntrade name Vaseline Petroleum Jelly. Once established, Chesebrough produced a range of products \nmade with petrolatum including Vaseline Cold Cream, developed in 1876. Petrolatum had a much longer \nshelf life than almond oil and was a good deal cheaper. As well as reducing the cost of making cold \ncream it extended its shelf life. \nEVOLUTION OF CERATUM GALENI\n%Almond cold cream\n5 gr Borax\n300 gr Water ( Distilled )\n100 gr White beeswax\n100 gr Spermaceti \n200 gr Almond Oil\n300 gr Lanolin\n30 drops of Rose oilCold cream\nA classic recipe.\n250 gr Spermaceti \n25 gr White beeswax\n250 gr Olive oil\n150 gr Rose water\n2 drops of Rose or Lavender oil\n7 pinches of BoraxRecipes  from a Swedish beauty book from 1946 ,Sk\u00f6nhet by \nVivan Huber. EVOLUTION OF CERATUM GALENI\nAlmost allmodern cold creams have replaced theplant\noilswith mineral oiland have added alcohol, glycerin ,\nandlanolin .Beginning inthe1970 s,jojoba oilbecame a\ncommon ingredient, used as a substitute\nofspermaceti from whales .%\nCERA BELLINA 15.0\nCETIOL S 35.0\nWATER 50.0\nPRESERVATIVES          1.0Cera bellina is a modified beeswax (Polyglyceryl -3 \nbeeswax , \u201c the free fatty acids have been converted to \npolyglycerols esters \u201c) that thickens oils and butters into \nvery cool, glide -y oil gels.\nCETIOL\u00aeSis diethylhexylcyclohexane ,a medium \nspreading emollient. EVOLUTION OF CERATUM GALENI:NEOGALENC\nNEOGALENIC\n\uf0d8Emulsifiers : alkyl polyglucosides , polyglycerol esters (not \nethoxylated ) \n\uf0d8Lipophilic substances: saturated, unsaturated, cyclic, terpenic\nhydrocarbons; silicones : dimethylpolysiloxanes, cyclosilicones\n\uf0d8Rheological additives: acrylic polymers (acrylic acid, glyceryl \nacrylate, acrylamide), polyacrylamides, hydroxyethylcellulose41AGENDA\n\uf075Historical overview\n\uf075Ancient galenic formulations\n\uf075The evolution from galenical to\nneogalenical formulations\n\uf075Herbal drugs forthe respiratory tract:\nclassification on the basis oftheir\nmechanism ofactions42\nMarshmallow\nGrindeliaHerbal drugs for the \nrespiratory tract: \nclassification on the \nbasis of their \nmechanism of actions\nAntitussive\nMucolytics\nExpectorants43\nMarshmallow\nGrindeliaHerbal drugs for the \nrespiratory tract: \nclassification on the \nbasis of their \nmechanism of actions\nDemulcents\nAromatic \nExpectorantsDemulcents help tothin andliquefy mucus, which inturn canhelp support\nexpectoration (the removal ofexcess mucus) .Thisisparticularly supportive ina\ndrycough orwhen there isnocough present butafeeling ofthedesire tocough .\nInthese cases, mucus maybepresent though itistoothick, hardened, andinert to\nelicit acough, ortoothick andsticky toexpel effectively bycoughing .\nDemulcents arecharacterized byaslightly slippery texture andoften provide a\nthickening quality when infused inhotorcoldwater .\nExamples :marshmallow (Althaea officinalis )root, plantain (Plantago spp.)leaf,\nflower, andseed husk, licorice (Glycyrrhiza glabra )root (though contraindicated\nwith highblood pressure), mullein (Verbascum thapsus )leaforroot, violet (Viola\nspp.)leafandflower, linden (Tilia spp.)bract andflower, andoat(Avena sativa )\nseed/grain etc\u2026.DemulcentsTheterm \u201caromatic\u201d isreferred toherbs which boast spicy, minty, citrusy, orcamphorous scents .This\nisduetosmall molecules thatcanbeeasily sensed (smelled) andthatcreate abitofmovement in\ntheGItract andrespiratory tract when tasted orinhaled .\nHerbs witharomatic properties tend tobestimulating andcanbecharacterized aswarming orcooling .\nThe warming aromatics ,such asthyme (Thymus vulgaris ),oregano (Origanum vulgare ),and bee balm\n(Monarda fistuloso ,M.didyma ),canhelp support damp orcold conditions andencourage expectoration .\nCooling aromatics ,such asspearmint (Mentha spicata )andpeppermint (Mentha xpiperita ),canhelp soothe\nhotconditions while relaxing spasms .\nBoth warming andcooling aromatics willencourage movement, sothere aremany possibilities here.Because\nmany aromatics arealittle bitdrying ontheir own, pairing them with demulcents isagood idea toencourage\nsoothing movement instead ofdryirritation .\nMost demulcents are best used as infusions, with some opinions on \nthat to follow! Some observe that you can experience the most \nslippery, demulcent properties when you infuse these herbs over a \nlong period of time. First, infuse in hot or warm water, then let it cool \nto room temperature, extending the length of the infusion. Demulcents\nAromaticsExpectorants\nExpectoration describes theaccelerated removal ofsecretions from thebronchi andtrachea .\nThis canwork byasimple combination ofdemulcent andaromatic qualities .Thedemulcency\ncanboth thinandaddtothevolume ofmucus, thereby aiding theexitofmucus .Thinning the\nmucus makes iteasier forourbody toclear iteffectively and comfortably .Adding tothe\nvolume encourages reflexes thatwillpropel mucus outoftherespiratory tract.\nExpectorants can work bystimulating secretions ofmucus (slightly different than\ndemulcents, but toasimilar effect) therefore adding tothe volume, encouraging\nelimination, orsupporting secretion ofathinner mucus .\nExpectorants canbewhat conventional pharmacy refers toas\u201cmucolytic,\u201d orasubstance\nthatthins orbreaks upthephysical structure ofmucus, making iteasier forthebody toexpel .\nSome plant alkaloids have this effect, forexample .Ofcourse plants often possess a\ncombination ofallofthese actions andrelated constituents, soasyoulearn about herbs for\nlungs andrespiratory support, don\u2019t count onbeing able tocategorize each herb ashaving\njustoneofthese actions!\nWhen demulcent and aromatic actions arecombined, themild expectorant\naction ofdemulcents isaccentuated, asthearomatic action can stimulate\nmovement, while thedemulcent action thins mucus, soothes tissues, and\nprovides aslippery path forstuck mucus toexit.Expectorants are a\ncategory ofherbs that combine demulcent andaromatic actions prettily .47AGENDA\n\uf075Historical overview\n\uf075Ancient galenic formulations\n\uf075Theevolution from galenical toneogalenical\nformulations\n\uf075Herbal drugs for the respiratory tract:\nclassification onthebasis oftheir mechanism\nofactions\n\uf075Herbal drugs fortherespiratory tract:typical\nformulationsMARSHMALLOW\n(Althaea officinalis L.) \n\uf0d8Liquid extract (DER 1:19.5 -23.5), extraction \nsolvent water \n\uf0d8Macerate for preparation of syrup (2 g \nHD/150 ml of water)\n\uf0d8Dry extract (DER 3 -9:1), extraction solvent \nwater \n\uf0d8Liquid extract (DER 1:1), extraction solvent \nethanol 25% (V/V)\nEuropean Union herbal monograph on \nAlthaea officinalis L., radix (europa.eu )Differences in procedures for the preparation of marshmallow \nsyrup in the pharmacopoeias/handbooks of the EU member \nstates are summarised below: \nThe macerate is prepared in accordance with the \npharmacopoeial monographs for Sirupus althaeae in \n\u00d6sterreichisches Arzneibuch 1981, \u010ceskoslovensk\u00fd\nl\u00e9kopis 1954, Farmakopea Polska 1970 and 2002 or \nwith the monograph Eibischsirup in Deutscher\nArzneimittel -Codex 1979. \nMARSHMALLOW\n(Althaea officinalis L.) \nAlthaea syrup as defined \nin the British \nPharmaceutical Codex \n1949 is considered \nobsolete due to \nchloroform content and its \npotentially carcinogenic \neffect. Chloroform content \nin this product is ca 2500 \nppm.\nCold macerates in \nsyrups correspond to \n0.21\u20130.58 g of \nmarshmallow root in 10 \nml of syrup.\nOverview of data obtained from marketed medicinal productsMARSHMALLOW\n(Althaea officinalis L.) Overview of data obtained from marketed medicinal products\nMARSHMALLOW\n(Althaea officinalis L.) Overview of data obtained from marketed medicinal products\nMacerate\nFor syrup \npreparation\nThefollowing relevant combination product\nis registered in in the EU/EEA\nAnoral solution containing 0.83gofliquid\nextract (DER 1:12-14)oftheroot ofAlthea\nofficinalis L.,extraction solvent water and0.12g\nofdryextract (DER 7-13:1)ofThymus vulgaris\nL./Thymus zygis L.(leaves and flowers)\nextraction solvent water in15mlisregistered in\nseveral member states (Croatia ,Spain, Ireland,\nAustria, Bulgaria, Italy, Hungary, Portugal,\nSweden, Slovenia andUK)andinNorway .\nIndication :Traditional herbal medicinal product\nused inproductive cough associated with cold,\nandtorelief pharyngeal irritation andassociated\ndrycough .\nPosology :Adults andadolescents :15mlevery\n4hours (4times perday).Ifneeded the\nmaximum daily dose is90ml(6doses perday).\nChildren 6-12years ofage:7.5mlevery 3-4\nhours (4times per day).Ifneeded the\nmaximum daily dose is45ml(6doses perday).LIQUORICE ROOT\n(Liquorice root consists ofthedried\nunpeeled orpeeled, whole orcutroot\nand stolons ofGlycyrrhiza glabra L\nand/or ofGlycyrrhiza inflata Bat.\nand/or Glycyrrhiza uralensis Fisch .\n).\nAssessment report onGlycyrrhiza glabra L.and/or\nGlycyrrhiza inflata Bat.and/or Glycyrrhiza\nuralensis Fisch.,radix (europa .eu)\nSoft extract (1:0.4-0.5),extraction\nsolvent water\nSoft extract (3:1),extraction solvent\nwater\nDry extracts that correspond to\npreparations mentioned under soft\nextractsTheEuropean Pharmacopoeia reports thefollowing liquid anddry\nextracts :\n\uf0d8Liquorice ethanolic liquid extract, standardised (Liquiritiae\nextractum fluidum ethanolicum normatum ),which isproduced\nfrom theherbal drug byasuitable procedure forliquid extracts\nusing ethanol (70percent V/V) andcontains 3to5%of18\u03b2-\nglycyrrhizic acid.Theextract isaclear liquid, dark brown, with\nafaint characteristic odour andasweet taste .\n\uf0d8Liquorice dry extract for flavouring purposes (Liquiritiae\nextractum siccum adsaporandum )produced from the cut\nliquorice rootbyasuitable procedure using water, andcontains :\n5to7%of18\u03b2glycyrrhizic acid.Thedryextract isayellowish -\nbrown orbrown powder with averysweet taste .LIQUORICE ROOT\n).\n\uf0d8In Germany , Liquiritiae radix soft extract (DER 1:0.4 -0.5, extraction \nsolvent water) is on the market as an oral liquid to support gastric \nfunction, based on traditional use. Liquiritiae radix dry extract (DER 3 -\n4:1, extraction solvent water) in combination with Althaeae radix, \nPrimulae radix and Thymi aetheroleum is traditionally used in Germany \nto support the fluidification of mucous of the airways; in combination \nwith ammonium chloride it is traditionally used as an expectorant of \nthe airways. Medicinal products containing liquorice juice and liquorice \nextract with different DER were on the German market with indications \nrelated to the expectorant activity and/or to the gastric function, but \nthe 30 years criterion for the traditional use is not sufficiently \ndocumented.\n\uf0d8In Denmark ,two oral liquids containing Liquorice soft extract (DER \n3:1, extraction solvent water) are authorised for more than 70 years as \nexpectorants for use in cough in shorter periods. One product contains \n98.5 mg/ml soft extract corresponding to 4.64 mg glycyrrhizic acid. \nThe other contains 80.9 mg/ml soft extract corresponding to 3.92 mg \nglycyrrhizic acid. \n\uf0d8Magisterial preparations traditionally used inNorway ascough\nremedies, refer totheposology oftheESCOP monograph forcough and\nbronchial catarrh :1.5-5gGlycyrrhiza glabra ,radix equivalent to60-\n200mgglycyrrhizic acid.ZhiGan Cao (Honey fried liquorice)\nTHYME\n(Thymus vulgaris L., T. zygis L.,herba )\n\uf0d8Liquid extract (DER 1:1),extraction solvent ethanol 24%(v/v)\n\uf0d8Liquid extract (DER 1:1.16),extraction solvent glycerol 85%(m/m) :ethanol\n25%(m/m) (0.1:2)\n\uf0d8Liquid extract (DER 1:2-2.5),extraction solvent ammonia solution 10%\n(m/m) :glycerol 85%(m/m) :ethanol 90%(v/v) :water (1:20:70:109)\n\uf0d8Tincture (1:10),extraction solvent ethanol 70%(v/v)\n\uf0d8Tincture (1:5),extraction solvent ethanol 70%(v/v)\n\uf0d8Softextract (DER5-8:1),extraction solvent ethanol 25%-30%(v/v)\n\uf0d8Liquid extract fresh herb (DER 1:1.5-2.4),extraction solvent water\n\uf0d8Dryextract (DER 6-10:1),extraction solvent ethanol 70%(v/v)\n\uf0d8Dryextract (DER 1.6-2.4:1),extraction solvent ethanol 96%(v/v)\n\uf0d8Liquid extract (DER 1:4.5),extraction solvent ammonia solution 10%(m/m)\n:glycerol 85%(m/m) .ethanol 96%(v/v) :water (1.2:25:112:113)\n\uf0d8Dryextract (DER 7-13:1),extraction solvent water\nAssessment report on Thymus vulgaris L., \nvulgaris zygis L., herba (europa.eu)THYME\nMedicinal products in Europe \nTHYME\nMedicinal products in Europe \nTHYME\nHerbal preparations\nPELARGONIUM\n(Pelargonium sidoides DC and/or \nPelargonium reniforme Curt., radix .) \n\uf0d8Liquid extract (DER 1:8-10),\nextraction solvent ethanol 11%(m/m)\n\uf0d8Dryextract prepared from theliquid\nextract described above\n\uf0d8Dryextract ofPelargonii radix (DER\n4-25:1),extraction solvent ethanol\n11%(m/m)\n\uf0d8EPs7630 (EPs\u00ae 7630 )solution isan\nethanolic (11%(m/m)) extract ofP.\nsidoides roots\n\uf0d8EPs7630 film-coated tablet contains\nthedryextract prepared from the\nliquid extract described above .\nAssessment report on Pelargonium \nsidoides DC and/or Pelargonium \nreniforme Curt., radix (europa.eu)Information about products on the market \nAustria: \n1)Dry extract prepared from the liquid extract described below \n2)Liquid extract (1:8 -10), extraction solvent: ethanol 11% (m/m) \n3)Pharmaceutical form: a) Film-coated tablet b) Oral liquid (1 ml=21 \ndrops )\nBelgium:\n1) Liquid extract EtOH 11% (m/m) DER 1:8 -10 \n2) Dried extract EtOH 11% (m/m) DER 1:8 -10 \n3) Pharmaceutical form:a ) Oral solution: 8 g extract per 10 g solution, \nb) Tablets: 20 mg extract per tablet, c) Syrup 0.25 g extract per 100 g \nsyrup\nGermany:\n1) Dry extract prepared from the liquid extract described below \n2) Liquid extract (1:8 -10), extraction solvent: ethanol 11% (m/m)\n3) Dry extract (4-25:1), extraction solvent: ethanol 11% (m/m)\n4) Pharmaceutical form:a ) Film-coated tablet, b) Oral liquid 10 -12) \nSyrup\nItaly: \n1)Liquid extract (1 -8:10, ethanol 11% (w/w)) (EPs 7630) 80% oral \ndrops, solution (multiple application) \n2)Dry extract (1 -8:10, ethanol 11% (w/w)) (EPs 7630) 20 mg film \ncoated tablets (multiple application) PELARGONIUM\n(Pelargonium sidoides DC and/or \nPelargonium reniforme Curt., radix .) \uf0d8Marketing of the remedy as a treatment for bronchitis and \nsymptoms of common cold already started in the 1970\u2019s\n\uf0d8Pelargonium received a full market authorisation by the German \ndrug regulatory agency in 2005. Until this time, a tincture 1+10 \nfrom P . sidoides /reniforme was used, from 2005 the ingredients \nchanged to a solution of P . sidoides (Brendler and van Wyk, 2008 ).\n\uf0d8The monograph of Pelargonium sidoides /reniforme root ( Pelargonii\nradix) was introduced into the European Pharmacopoeia in 2008 \n(European Pharmacopoeia 9th ed. 2016). \n\uf0d8Outside Europe, various liquid and solid preparations are available \nas herbal supplements especially in North America and Mexico.\nTHMP\nHomeopathicFood Supplement\nBASIC FORMULATIONS RELATED TO GALENIC PREPARATIONS FOR\nRESPIRATORY TRACT\nSimple galenic preparations made ofsubstances ofplant oranimal origin include :infusions (infusa )\nand decoctions (decocta ).\nInfusions and decoctions arealways prepared from plant substances byinfusion .There arewater\ninfusions incold and boiling water .Acold infusion isobtained byinfusing theplant substance in\ndistilled water atroom temperature for4hours ;hot infusion -bypouring aherbal preparation\nwith boiling distilled water and immersing thevessel inasteam bath for5m.\nGenerally, formulations include: \n\uf0b7Solids (tablets , capsules, sachets, etc.)\n\uf0b7Liquids (suspensions, solutions, syrups , etc.).\n\uf0b7Semi -solids (gels, creams, ointments, etc.). \nIn the practical, the following preparations are used for respiratory tract:\n\uf0d8Liquid preparations for oral use (syrups, powders and granulates for syrups, solutions,\nemulsions, suspensions, powders forsolutions orsuspensions, drops, powder fordrops) .\n\uf0d8Solid preparation fororal use(powders, granules, capsules, tablets, cachet)\n\uf0d8Semi -solid preparations forcutaneous application (ointments, creams, pastes, cataplasms,\nmedicated plasters, hydrophilic and lipophilic gels)LIQUID PREPARATIONS FOR ORAL USE \nAccording toPharm .Eur.10thEdition,\u201cLiquid preparations fororaluse\u201d are usually solutions,\nemulsions orsuspensions containing one ormore active substances inasuitable vehicle ;they\nmay, however, consist ofliquid active substances used assuch (oral liquids) .Some preparations\nfororal use areprepared bydilution ofconcentrated liquid preparations, orfrom powders or\ngranules forthepreparation oforal solutions orsuspensions, fororal drops orforsyrups, using a\nsuitable vehicle .\nSeveral categories ofpreparations may bedistinguished :\n\u2013oral solutions, emulsions and suspensions ;\n\u2013powders and granules fororal solutions and suspensions ;\n\u2013oral drops ;\n\u2013powders fororal drops ;\n\u2013syrups ;\n\u2013powders and granules forsyrups .\nTests include :Uniformity ofdosage units ;Uniformity ofcontent ;Uniformity ofmass ;Dose and\nuniformity ofdose oforal drops ;Uniformity ofmass ofdelivered doses from multidose\ncontainers .\nThe label states thename ofanyadded preservative .Syrup\nA liquid dosage form in single phase , generally\nan aqueous preparation containing up to 85% \nsugars (including honey )\nOther components\n\u2022Actives\n\u2022Antimicrobial preservatives\n\u2022Viscosity modifier\n\u2022Flavouring agent\n\u2022Colorants\n\u2022Cosolvents and solubilizing agents\n\u2022Thickeners or Stabilisers\n\u2022MucoaodhesivesLiquid preparations for oral use Base Syrup\nHONEY\nOn the market itispossible to findspecial \nhoneys : thyme , rosmarinus , citrus , lavander , \neucaliptus , myrtle\nThe beach honey, both smell and taste \nremind us of the essential oils of the \nMediterranean Maquis \u2018, namely \nHelichrysum stoechas , achillea\nmaritima , Centaurea subciliata , \nSolidago litoralis , Greater \nKnapweed and the most widespread \ntypes of Cistus . Microscopic drops \nof essential oils collected by the bees \ngive the honey its particular aroma and \norganoleptic qualities.\nAntimicrobial preservatives and Flavouring agents: \nessential oils\nColorants\uf075Polyols (e.g. glycerin or sorbitol ) maybe added to retard \ncrystallization of sugars or  increase the solubility of added\ningredients.Alcohol often isincluded aspreservative and solvent\nfor volatile oils\n\uf075In particular , GLYCERIN hasplasticizing effect, to promote softness \nand flexibility, and a hydrating effect. It is a very useful solvent, is \nviscous and has a high viscosity and this makes it useful as a \nthickening or bodying agent. Glycerol is also a lubricant, \ndemulcent,  non -toxic and non irritating Other components\n\u2022Viscosity modifier\n\u2022Cosolvents and solubilizing agents\n\u2022Thickeners or Stabilisers\n\u2022Mucoaodhesives\nPharmacy 2017 , 5, 4; doi:10.3390/pharmacy5010004SOLID PREPARATION FOR ORAL USE\nPowders ,oral (Pulveres perorales ,including Effervescent powders)\nGranules (Granulata )\nCapsules (Capsulae )\nTablets (Compressi )\nCoated tablets aretablets covered with one ormore layers ofmixtures ofvarious substances such\nasnatural orsynthetic resins, gums, gelatin ,inactive and insoluble fillers, sugars, plasticisers,\npolyols, waxes, colouring matter authorised bythecompetent authority and sometimes flavouring\nsubstances and active substances .The substances used ascoatings areusually applied asasolution\norsuspension inconditions inwhich evaporation ofthevehicle occurs .When thecoating isavery\nthin polymeric coating, thetablets areknown asfilm-coated tablets .Coated tablets have asmooth\nsurface, which isoften coloured and may bepolished ;abroken section, when examined under a\nlens, shows acore surrounded byone ormore continuous layers with adifferent texture .Where\njustified, uniformity ofmass oruniformity ofcontent ofcoated tablets other than film-coated\ntablets may beensured bycontrol ofthecores .Film -coated tablets comply with thedisintegration\ntest.OROMUCOSAL PREPARATIONS ( Praeparationes buccales )\nOromucosal preparations aresolid, semi -solid orliquid preparations, containing one ormore active\nsubstances intended foradministration tothe oral cavity and/or the throat toobtain alocal or\nsystemic effect .Preparations intended foralocal effect may bedesigned forapplication toaspecific\nsite within the oral cavity such asthe gums (gingival preparations) orthe throat (oropharyngeal\npreparations) .Preparations intended forasystemic effect aredesigned tobeabsorbed primarily at\none ormore sites ontheoral mucosa (e.g.sublingual preparations) .Mucoadhesive preparations are\nintended toberetained inthe oral cavity byadhesion tothe mucosal epithelium and may modify\nsystemic drug absorption atthesite ofapplication .Formany oromucosal preparations, itislikely that\nsome proportion ofthe active substance(s) will beswallowed and may beabsorbed via the\ngastrointestinal tract .Advantages : \n1.Prolongs the residence time of the dosage form at the site of absorption \n2.Enhanced absorption increases the therapeutic efficacy of the drug . \n3.Increases drug bioavailability due to avoidance of first pass metabolism\n4.Protects drug from degradation in the acidic environment of GIT . \n5.Improves patient compliance & ease of drug administration. \n6.Faster onset of action due to mucosal surface. MUCOADHESION\nCYCLODEXTRINS INCLUSION COMPLEXES\nCyclodextrins are active ecipients\n1.Enhancement of solubility\n2.Enhancement of bioavailability\n3.Improvement of stability\n4.Reduction of irritation\n5.Prevention of incompatibility\n6.Odour and taste masking\n7.Material handling benefitsTypically chitosan and polymers possessing numerous carboxyl \ngroups such as carbopol and polycarbophilTo optimise the formulation \u2026..\nMICRO AND  NANOVECTORS\nPOLIMERIC MICROPARTICLES\nNANOCARRIERSLab experience of pharmaceutical technology : \nessential oilsloaded in vesicles and microemulsions\nGiulia Vanti, PharmD , PhD\nDepartment of Chemistry , University of Florence\nLipidand PolymericNanocarriers\nNANOCARRIERS\nLiposomes/ Vesicles\nMicelles\nPolymericnanocapsules/nanospheres\nMicro/Nano emulsions\nLipidnanoparticles(SLN and NLC)\nCyclodextrincomplexesNANOCARRIERS\nIncrease stability\nIncrease solubility\nEnhance permeation\nImprove bioavailability\nIncrease efficacy\nReduce toxicity\nControl release\nTarget deliveryAdvantagesof NanocarriersEssen8aloils\n\u00fcComplexmixturesofvolatile,liquid,odorous,andactivecompounds.\u00fcVariousbiologicalproperties,principallyantioxidantandantimicrobial.Theirhighvolatilityandlowstabilitytodirectexposuretolight,oxygen,heatandhumiditycanlimittheirpotentialuse.\nLipidVesicles\nSphericalsystemsmadeofoneormorebilayersofphospholipidsandlipidsandaninternalaqueouscavity.Edgeactivators(surfactants)andpenetrationenhancers(propyleneglycol,glycerol,ethanol,chargedlipids,PEG-lipidsetc.)canbeincorporatedinthebilayertoobtaindeformableandstablevesicles.\nPreparation of Lipid Vesicles\nPreparation method:Thin Layer Evaporation or Lipid Film Hydration\nLoadedEssentialoilMicroemulsions\nBicontinuousSystemOil in Water(O/W)\nWater in Oil(W/O)\nTransparent, monophasic, optically isotropic and thermodynamically stable colloidal dispersionsPreparationof MicroemulsionsOil in Water(O/W)\nPreparation methodAqueous titration: dropwise addition of water to the oil-surfactants mixture\nLoadedEssen6aloilFormulation\u2019sPhysicalCharacterizationLight ScatteringTechniques1.DynamicLight Scattering\u2022AverageHydrodynamicDiamater(Size, nm) \u2022PolydispersityIndex (PdI)\n\u0013\u0015\u0017\u0019\u001b\u0014\u0013\u0014\u0015\u0014\u0017\n\u0013\u0011\u0014 \u0014 \u0014\u0013 \u0014\u0013\u0013 \u0014\u0013\u0013\u0013 \u0014\u0013\u0013\u0013\u0013,QWHQVLW\\\u0003\u000b3HUFHQW\f6L]H\u0003\u000bG\u0011QP\f6L]H\u0003'LVWULEXWLRQ\u0003E\\\u0003,QWHQVLW\\\n5HFRUG\u0003\u0017\u0014\u001c\u001d\u0003.1/&\u00107\u0013\u0010'\u0003\u0014623\u00031DPH\u001d\u0003\n\u0013\u000f\u0013\u0014\u00136\\VWHP'XUDWLRQ\u00038VHG\u0003\u000bV\f\u001d\u0003$WWHQXDWRU\u001d\u00039LVFRVLW\\\u0003\u000bF3\f\u001d\u0003.\u00101/&\u0011GWV\u0013\u000f\u001b\u001b\u001a\u0015'LVSHUVDQW\u00031DPH\u001d\u0003PDQVHWWLQJV\u0011QDQR\n&HOO\u0003'HVFULSWLRQ\u001d\u00036DPSOH\u00031DPH\u001d\u0003\n5HVXOWVYHQHUGu\u0003\u0014\u001b\u0003JLXJQR\u0003\u0015\u0013\u0015\u0014\u0003\u0014\u0017\u001d\u0011\u0011\u0011\u0014\u0013)LOH\u00031DPH\u001d\u0003.1/&\u00107\u0013\u0010'\u0003\u0014:DWHU\n&RXQW\u00035DWH\u0003\u000bNFSV\f\u001d\u0003\u001b\u0013\u0014\u000f\u0018\u001c6DPSOH\u0003'HWDLOV*HQHUDO\u00031RWHV\u001d\u0003\n\u0017\u000f\u0019\u0018'LVSRVDEOH\u0003VL]LQJ\u0003FXYHWWH0DWHULDO\u0003$EVRUEWLRQ\u001d\u00035HFRUG\u00031XPEHU\u001d\u00030HDVXUHPHQW\u0003'DWH\u0003DQG\u00037LPH\u001d\u00030DWHULDO\u00035,\u001d\u00030HDVXUHPHQW\u00033RVLWLRQ\u0003\u000bPP\f\u001d\u0003'LVSHUVDQW\u00035,\u001d\u0003\n\u0014\u001a\u0013\u000f\u0013\u0014\u000f\u0016\u0016\u00137HPSHUDWXUH\u0003\u000b\u0083&\f\u001d\u0003\u0017\u0014\u001c\u0003\n\u0015\u0018\u000f\u0013\n\u0015\u0013\u001a\u000f\u001a\u0013\u000f\u00133HDN\u0003\u0015\u001d\u0013\u000f\u0013\u0013\u0013\u0013\u000f\u0015\u0017\u001b\u0014\u0015\u0017\u000f\u0017,QWHUFHSW\u001d\u0003\u0013\u000f\u0013\u0013\u000f\u0013\u0013\u00133HDN\u0003\u0016\u001d3HDN\u0003\u0014\u001d\u0014\u0013\u0013\u000f\u0013\u0015\u001a\u0018\u000f\u001c\u0013\u000f\u001c\u0014\u0015=\u0010$YHUDJH\u0003\u000bG\u0011QP\f\u001d\u0003\u0013\u000f\u0013\u0013\u00133G,\u001d\u0003\u0013\u000f\u0013\u0013\u0013\b\u0003,QWHQVLW\\\u001d*RRG5HVXOW\u0003TXDOLW\\\u001d\n6L]H\u0003'LVWULEXWLRQ\u00035HSRUW\u0003E\\\u0003,QWHQVLW\\Y\u0015\u0011\u0015\n6L]H\u0003\u000bG\u0011Q\u0011\u0011\u00116W\u0003'HY\u0003\u000bG\u0011Q\u0011\u0011\u0011\n\u0003ZZZ\u0011PDOYHUQ\u0011FRP0DOYHUQ\u0003,QVWUXPHQWV\u0003/WG6HULDO\u00031XPEHU\u0003\u001d\u00030$/\u0014\u0013\u0015\u001b\u001a\u0016\u0013=HWDVL]HU\u00039HU\u0011\u0003\u001a\u0011\u0013\u0015\u0014\u0013\u0003GLF\u0003\u0015\u0013\u0015\u0014\u0003\u0014\u0015\u001d\u0017\u001a\u001d\u0015\u00195HFRUG\u00031XPEHU\u001d\u0003\u0017\u0014\u001c)LOH\u0003QDPH\u001d\u0003.\u00101/&10,0001,000\n2.ElectrophoreticLight Scattering\u2022\u03b6-potential(mV)\n\u0013\u0018\u0013\u0013\u0013\u0013\u0014\u0013\u0013\u0013\u0013\u0013\u0014\u0018\u0013\u0013\u0013\u0013\u0015\u0013\u0013\u0013\u0013\u0013\u0015\u0018\u0013\u0013\u0013\u0013\n\u0010\u0014\u0013\u0013 \u0013 \u0014\u0013\u0013 \u0015\u0013\u00137RWDO\u0003&RXQWV$SSDUHQW\u0003=HWD\u00033RWHQWLDO\u0003\u000bP9\f=HWD\u00033RWHQWLDO\u0003'LVWULEXWLRQ\n5HFRUG\u0003\u0015\u001b\u001a\u001d\u0003.1/&\u00037(032\u0003=(52\u000367$%,/,7j\u0003\u00165HVXOWV$UHD\u0003\u000b\b\f3HDN\u0003\u0015\u001d=HWD\u00033RWHQWLDO\u0003\u000bP9\f\u001d\u00036W\u0003'HY\u0003\u000bP9\f\u0013\u000f\u0013\u0010\u0017\u001b\u000f\u001b\u0014\u0013\u0013\u000f\u0013=HWD\u0003'HYLDWLRQ\u0003\u000bP9\f\u001d\u00030HDQ\u0003\u000bP9\f3HDN\u0003\u0016\u001d\u0013\u000f\u0013\u0013\u0013\u000f\u0013\u0013\u0013\u000f\u0013\u0013&RQGXFWLYLW\\\u0003\u000bP6\u0012FP\f\u001d\u0003\u0013\u000f\u0013\u00133HDN\u0003\u0014\u001d\u0013\u000f\u0013\u001a\u000f\u0018\u00166DPSOH\u0003'HWDLOV623\u00031DPH\u001d\u0003\n=HWD\u00035XQV\u001d\u0003\u0003.\u00101/&\u0011GWV\n&HOO\u0003'HVFULSWLRQ\u001d\u0003\u001a\u001b\u000f\u0018JLRYHGu\u0003\u0015\u001a\u0003PDJJLR\u0003\u0015\u0013\u0015\u0014\u0003\u0014\u001b\u001d\u0016\u001b\u001d\u0011\u0011\u0011\u0014\u000f\u0016\u0016\u0013.1/&\u00037(032\u0003=(52\u000367$%,/,7j\u0003\u0016\n9LVFRVLW\\\u0003\u000bF3\f\u001d\u0003*HQHUDO\u00031RWHV\u001d\u0003\n\u0014\u0015\u0015\u000f\u0013\u00136DPSOH\u00031DPH\u001d\u0003:DWHU)LOH\u00031DPH\u001d\u0003\n$WWHQXDWRU\u001d\u0003\u0014\u0017\u0019\u000f\u00190HDVXUHPHQW\u00033RVLWLRQ\u0003\u000bPP\f\u001d\u0003\u0013\u000f\u001b\u001b\u001a\u0015\n&OHDU\u0003GLVSRVDEOH\u0003]HWD\u0003F\u0011\u0011\u00116\\VWHP'LVSHUVDQW\u00031DPH\u001d\u0003'DWH\u0003DQG\u00037LPH\u001d\u0003'LVSHUVDQW\u00035,\u001d\u00035HFRUG\u00031XPEHU\u001d\u0003\u0015\u0018\u000f\u0013&RXQW\u00035DWH\u0003\u000bNFSV\f\u001d\u00037HPSHUDWXUH\u0003\u000b\u0083&\f\u001d\u0003\u0015\u001b\u001a\u0003\n'LVSHUVDQW\u0003'LHOHFWULF\u0003&RQVWDQW\u001d\u0003\u0019\u0010\u0017\u001b\u000f\u001b\u001a\u000f\u0018\u0016\u0013\u000f\u0015\u0016\u00195HVXOW\u0003TXDOLW\\\u0003\u001d*RRG\n=HWD\u00033RWHQWLDO\u00035HSRUW0DOYHUQ\u0003,QVWUXPHQWV\u0003/WG\u0003\u0003\u0010\u0003\u008b\u0003&RS\\ULJKW\u0003\u0015\u0013\u0013\u001bY\u0015\u0011\u0016\n\u0003ZZZ\u0011PDOYHUQ\u0011FRP0DOYHUQ\u0003,QVWUXPHQWV\u0003/WG6HULDO\u00031XPEHU\u0003\u001d\u00030$/\u0014\u0013\u0015\u001b\u001a\u0016\u0013=HWDVL]HU\u00039HU\u0011\u0003\u001a\u0011\u0013\u0015\u0014\u0013\u0003GLF\u0003\u0015\u0013\u0015\u0014\u0003\u0014\u0015\u001d\u0018\u0015\u001d\u0018\u00135HFRUG\u00031XPEHU\u001d\u0003\u0015\u001b\u001a)LOH\u0003QDPH\u001d\u0003.\u00101/&\u2212250,000200,000150,000100,00050,000\nQuantitative determination of the essential oil during the formulation's technologicaland pharmacological investigationFormulation\u2019sChemicalCharacterizationHigh-performance Liquid Chromatography\ud835\udc79\ud835\udc86\ud835\udc84\ud835\udc90\ud835\udc97\ud835\udc86\ud835\udc93\ud835\udc9a=\ud835\udc47\ud835\udc5c\ud835\udc61\ud835\udc4e\ud835\udc59\ud835\udc45\ud835\udc52\ud835\udc50\ud835\udc5c\ud835\udc63\ud835\udc52\ud835\udc5f\ud835\udc52\ud835\udc51\ud835\udc38\ud835\udc60\ud835\udc60\ud835\udc52\ud835\udc5b\ud835\udc61\ud835\udc56\ud835\udc4e\ud835\udc59\ud835\udc42\ud835\udc56\ud835\udc59\ud835\udc3c\ud835\udc5b\ud835\udc56\ud835\udc61\ud835\udc56\ud835\udc4e\ud835\udc59\ud835\udc38\ud835\udc60\ud835\udc60\ud835\udc52\ud835\udc5b\ud835\udc61\ud835\udc56\ud835\udc4e\ud835\udc59\ud835\udc42\ud835\udc56\ud835\udc59\u00d7100\ud835\udc6c\ud835\udc8f\ud835\udc84\ud835\udc82\ud835\udc91\ud835\udc94\ud835\udc96\ud835\udc8d\ud835\udc82\ud835\udc95\ud835\udc8a\ud835\udc90\ud835\udc8f\ud835\udc6c\ud835\udc87\ud835\udc87\ud835\udc8a\ud835\udc84\ud835\udc8a\ud835\udc86\ud835\udc8f\ud835\udc84\ud835\udc9a=\ud835\udc38\ud835\udc5b\ud835\udc50\ud835\udc4e\ud835\udc5d\ud835\udc60\ud835\udc62\ud835\udc59\ud835\udc4e\ud835\udc61\ud835\udc52\ud835\udc51\ud835\udc38\ud835\udc60\ud835\udc60\ud835\udc52\ud835\udc5b\ud835\udc61\ud835\udc56\ud835\udc4e\ud835\udc59\ud835\udc42\ud835\udc56\ud835\udc59\ud835\udc3c\ud835\udc5b\ud835\udc56\ud835\udc61\ud835\udc56\ud835\udc4e\ud835\udc59\ud835\udc38\ud835\udc60\ud835\udc60\ud835\udc52\ud835\udc5b\ud835\udc61\ud835\udc56\ud835\udc4e\ud835\udc59\ud835\udc42\ud835\udc56\ud835\udc59\u00d7100\nSignal = 246 nm                              Spring School\nFlorence, 5th -9th April 2022\nMarco Michelozzi\nFelicia Menicucci\nEleonora PalaganoUniversity of Florence\nHEALTHY HERBS\nPhytotherapy as a Strategy against Antimicrobial Resistances\nPlant sampling for production of essential oil\nPlant sampling for production of essential oil\nEpigenetic variations in terpene constituents\nThe most common sources of qualitative and \nquantitative variation in monoterpenes are \nthose occurring between:\n-different tissues within a tree\n-juvenile and adult plants \n-juvenile and mature tissues.\nPlant sampling for production of essential oil\nVariations in terpene profiles between mature (1 -year tissue) and young (current -year tissue) needle (a) \nand cortex (b) samples of Pinus halepensis Mill., Pinus brutia Ten. and Pinus eldarica Medw .\nMenicucci et al . 2022. In: Luchi N. (ed.) Plant Pathology : Method and Protocols .Methods inMolecular Biology . Humana, New York, NY. (In Press).Plant sampling for production of essential oil\nDifferences interpene profiles between mature (1-year tissue) needle and mature (1-year tissue) cortex\nsamples ofPinus halepensis Mill.,Pinus brutia Ten.and Pinus eldarica Medw .\nMenicucci et al . 2022. In: Luchi N. (ed.) Plant Pathology : Method and Protocols .Methods inMolecular Biology . Humana, New York, NY. (In Press).Plant sampling for production of essential oil\n1 (-)-\u03b1-pinene\n2 (+) -\u03b1-pinene\n3 camphene\n4 sabinene\n5 myrcene\n6 (+) -\u03b2-pinene\n7 (-)-\u03b2-pinene\n8 (-)-limonene\n9 (+) -limonene\n10 p -cymene\n11 1,8 -cineole\n12 (-)-linalool\n13 camphor\n14 terpinen -4-ol\n15 borneol\n16 (-)-bornylacetate\n17 (-)-verbenone\n18 geraniol\n19 \u03b2-caryophyllene\n20 geranyl acetate\n21 \u03b1-humulene\n22 eugenol\n23 thymol\n24 carvacrol\n25 caryophyllene oxideFoliar tissue\nCortical tissue\nXylem tissueGC chromatographic terpene profiles of foliar (a), cortical (b) and xylem (c) tissues , \nBellumori et al . 2021 . Molecules , 26, 3425Plant sampling for production of essential oil\nRelative contents of volatile \nterpenoids in young and mature \ntissues and different tissue\nsources from Rosmarinus\nofficinalis L. \nData are means of 9 replicates + SE \n(standard error ). Different letters indicate \nsignificant differences (by the Mann \u2013\nWhitney U-test, p < 0.05) in the relative \ncontent of each single terpene between\nyoung and mature samples of different\ntissue sources . L, leaf; B, cortex ; X, xylem\ntissue ; Y , young ; M, mature. Samples\ncollected from the upper part of the branch\nare indicated with \u201cu\u201d.\nBellumori et al . 2021 . Molecules , 26, 3425Plant sampling for production of essential oil\nBellumori et al . 2021 . Molecules , 26, 3425\nTotal contents of volatile \nterpenoids (mg/g fresh weight\n(FW)) in young and mature \ntissues and different tissue\nsources from Rosmarinus\nofficinalis L. \nData are means of 9 replicates + SE \n(standard error ). Different letters\nindicate significant differences (by the \nMann \u2013Whitney U-test, p < 0.05). L, \nleaf; B, cortex ; X, xylem tissue ; Y , young\ntissue ; M, mature tissue . Samples\ncollected from the upper part (u) and at\nthe base (b) of the branch are indicated\nrespectively , as \u201cu\u201d and \u201cb\u201d.Antimicrobial activity of essential oil terpenes of rosemary against Alternaria alternata \na) Most terpenes induced asignificant fungal\ngrowth reduction\nb) Camphor and verbenone showed the best\nperformance\nThe fungus Alternaria alternata is known to \ninduce heavy damages on aerial part of the \nrosemary plants\nBellumori et al . 2021 . Molecules , 26, 3425Growth of A. alternata colony diameter (mm) in the presence of different compounds of \nrosemary leaves , after 14 days of incubation at25 \u25e6C. \nData are means of 6 replicates + SE (standard error ). Different letters indicate significant differences (by \nthe Mann \u2013Whitney U-test, p < 0.05) among the tested compounds .Antimicrobial activity of essential oil terpenes of rosemary against Alternaria alternata \na) Most terpenes induced asignificant fungal\ngrowth reduction\nb) Camphor and verbenone showed the best\nperformance\nThe fungus Alternaria alternata is known to \ninduce heavy damages on aerial part of the \nrosemary plants\nBellumori et al . 2021 . Molecules , 26, 3425Growth of A. alternata colony diameter (mm) in the presence of different compounds of \nrosemary leaves , after 14 days of incubation at25 \u25e6C. \nData are means of 6 replicates + SE (standard error ). Different letters indicate significant differences (by \nthe Mann \u2013Whitney U-test, p < 0.05) among the tested compounds .Thank you for your attentionFakult\u00e4t f\u00fcr Gesundheit und Medizin\nHerbal teaformulations\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 1and  \nmicroscopic drug\nidentification\nMag. pharm. C. Dungl -Hochleitner, MSc\nDr. Oliver Vendl\nwww.donau -uni.ac.at\nHealth effects\nharmful positive\nless high middle  \nDosageHormetic ingredients\nNon hormetic ingredientsHormetic Principle\nSpektrum der Wissenschaft, aberufen am Okt 2019 ,\nhttps:// www.spektrum.de/news/wie -giftige -pflanzenstoffe -\nuns-gesuender -machen/1405270\nChristiansen, J., Mattson M.P . ( 2015). Scientific America (S.3)\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 2Department f\u00fcr Gesundheitswissen\nDonau -Universit\u00e4t Krems. DieUniveschaften, Medizin und Forschung\nrsit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 3www.donau -uni.ac.at\nSymptoms of common cold and\nseasonal flu\nPRIMARY SYMPTOMS LESS FREQUENT  \nSYMPTOMS\nCOMMON COLD sneezing  \nstuffy nose  \nsore throat\nmild to moderate chest  \ndiscomfort and coughfatique  \nbody aches\nSEASONAL FLU fever or feeling feverish\n/chills  \ncough\nmuscle or body aches  \nheadache\nfatiquesneezing  \nsore throat  \nrunny or  \nstuffy nose  \nnausea  \ndiarrhea\nwww.donau -uni.ac.at\nInfection\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 4Sore  \nthroatCold\nHead ache,  \nChest discomfortIrritative cough\nUnp roductive  \ncough\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 5Herbal Formulations\nTraditional European Medicine\n\u27a2Remedium cardinale\n\u27a2Adjuvans\n\u27a2Constituens\n\u27a2CorrigensTCM -Perspective\n\u27a2chief herbs\n\u27a2minister herbs\n\u27a2adjutant herbs\n\u27a2messenger herbs\nwww.donau -uni.ac.atLinden flower\nTilia cordata, T.platyphyllos\n\u27a2Ingredients\n\u27a2Flavonoids (approx. 1 % quercetin and kaempferol  \nglycosides)\n\u27a2Mucilage (approx. 10 %)\n\u27a2Tannins (approx. 2 %)\n\u27a2Essential oil (ca. 0,02 -0,1%)\n\u27a2Dimeric procyanidins, phenolic carboxylic acids\n\u27a2Effect\n\u27a2Diaphoretic\n\u27a2Low sedative\n\u27a2Low antitussive\nVorf\u00fchrender\n2021 -09-0905:53:39\n--------------------------------------------\nKombination mitM\u00e4des\u00fc\u00df  \nWeidenrinde\nynonyme Drogenbezeichnungen:  \nF l o r e sTiliae, Flos Tiliae.\nHerkunft: \u00dcberwiegend aus  \nN o r d i t a l i e n ,  \u00d6sterreich, den  \nBalkanl\u00e4ndern, Polen und  \nRussland.\nInhaltsstoffe: Etwas \u00fcber 1 %  \nF l a v o n o i d e , fast ausschlie\u00dflich  \nGlykoside der Flavonole  \nQuercetin und K\u00e4mpferol,  \ndarunter mit dem Aglykon  \nQuercetin u. a. das Isoquercitrin,  \nQuercitrin, Hyperosid und Rutin  \nsowie mit dem Aglykon  \nK\u00e4mpferol u. a. das Astragalin  \nund Afzelin  (K\u00e4mpferol -3-O-\nrhamnosid)  sowie das Tilirosid, \nbei dem es  sich um einen  p -\nCumars\u00e4ureester des Afzelins  \nhandelt, ca. 10 %  \nSchleimstoffen, 2 % Gerbstoffe  \nvom Catechin -und  \nGallocatechin -Typ, verschiedene  \nPhenylpropans\u00e4uren und etwa  \n0,2 % \u00e4therisches \u00d6l, welches  \nsowohl aus verschiedenen  n -\nAlkanen, Phenylpropanen und  \nMonoterpenen besteht  \n(insgesamt ca. 70 Komponenten  \nnachgewiesen). Wirkungen: Eine  \nschwei\u00dftreibende  \n(diaphoretische), antitussive,  \nadstringierende, diuretische,  \nsedierende und analgetische  \nWirkung wird der Droge  \nzugeschrieben, jedoch fehlt fast  \nausnahmslos ein eindeutiger  \nNachweis der Wirkung. \nWirkungsmechanismus: Die  \ns c h w e i \u00df t r e i b e n d e Wirkung konnte bislang  \nkeinen Inhaltsstoffen  Department f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 6\nwww.donau -uni.ac.atElderberry  \nSambucus nigra\nElderflower -Fl.Sambuci\n\u27a2Ingredients\n\u27a2Flavonoids: approx. 3.5 %\n\u27a2 (mainly rutin)\n\u27a2Essential oil: up to 0,14 %\n\u27a2Triterpenes, phenolic carboxylic acids  \nmucilages, tannins\n\u27a2Effect\n\u27a2Diaphoretic\n\u27a2SecretolyticBlack elderberries  \nFr. Sambuci  \nIngredients\n\u27a2Flavonoids and\n\u27a2Anthocyanins Fruit acids\n\u27a2Vitamins C and Bcomplex\nEffect\n\u27a2Antioxidant\n\u27a2Antiviral\n\u27a2Highly dosed -shortens the  \nduration of the disease\nVorf\u00fchrender\n2021 -09-0905:53:39\n--------------------------------------------\nSignifikante Besserung \ninnerhalb  v o n2 Tagen, Verk\u00fcrzung \num 4 Tage reduzierte auch die  \nH\u00e4magglutination und inhibition\nAnti-influenza activity of elderberry  \n(Sambucus nigra)\nAuthor links open overlay \np a n e l G o l n o o s h T o r a b i a n a b P e t e r V a l t c h e v a b Q a y y u m A d i l c F a r i b a D e h g h a n i a b\nhttps://doi.org/10.1016/j.jff.2019.0\n1.031\nElderberry showed mild inhibitory  \ne f f e c tat the early stages of the  \ninfluenza virus cycle, with  \nconsiderably stronger effect  \n(therapeutic index of 12 \u202f\u00b1\u202f1.3) in  \nthe post -infection phase. Our  \ndata further support both direct  \neffects of elderberry extract by  \nblocking viral glycoproteins as  \nwell as indirect effects by  \nincreased expression of IL -6,  IL -\n8, and TNF. BMC  Complement \nAltern Med. 2011;  11: 16. \nPublished online 2011 Feb 25.  \nd o i :1 0 . 1 1 8 6 / 1 4 7 2-6 8 8 2-11-16PMCID: PMC3056848\nPMID: 21352539\nInhibitory activity of a standardized  \nelderberry liquid extract against  \nclinically -relevant human  \nrespiratory bacterial pathogens  \nand influenza A and B viruses  \nChristian Krawitz,#1 Mobarak  \nAbu Mraheil,#1 Michael Stein,2  \nCan Imirzalioglu,1 Eugen  \nDomann,1 Stephan Pleschka,2  \nand Torsten Hain1\nUnigiessenDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 7\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 8Tea during the cold season\nPreparation\n1 tablespoon of tea mixture pour 250 ml of boiling water on it,  \ninfuse for 10 minutes, then strain through a tea strainer.\nApplication\nThe tea should be drunken warm, sip by sip,\nif necessary it can be mixed with currant juice 1:1.\nwww.phytotherapie.atHeilpflanze g\nElderberry Flower\nLinden Flower\nRosehip\naa ad 60,0\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 9How two mix a preparation\nDrug g\nElderberry Flower\nLinden Flower\nRosehip\naa ad 60,0Drug g\nAnisi fr. 2\nAnisi stellati fr. 2\nFoeniculi fr. 4\nMalvae fl. 2\nRhoeados fl. 5\nVerbasci fl. 5\nTiliae fl. 5\nThymi hb. 5\nAlthaeae rx. 30\nLiquiritae rx. 40\nSpec. Pectoralis Pharm.\nHelveticae\nwww.donau -uni.ac.at\nMarshmallow  \nAlthea officinalis\nIngredients\n\u27a2Althaeae fol.\n\u27a2mucilage 6 -9 %\n\u27a2Althaeae radix\n\u27a2mucilage 20%\nmucilage content is strongly  \ndepending on season, highest  \ncontent in late autumnEffect\nAnti-irritant effect\nDue to the enveloping effect of the  \nmucus, especially in the area of the  \nhypopharynx and epiglottis\nAdhesion of marshmallow  \npolysaccharides to mucous  \nmembranes\nImmunostimulating effect -\nphagocytosis activity increases by\n2.2 times\nVorf\u00fchrender\n2021 -09-0905:53:39\n--------------------------------------------\nHemmung des mukozili\u00e4ren T r a n s p o r t s  \nim Tierversuch nachgewiesen\nPolysaccharide werden in die  \nS c h l e i m h a u t z e l l e n internalisiert, steigern die  \nZellvitalit\u00e4t und Zellteilungsrate \u00e0  \naktiv sch\u00fctzender und  \nregenerierender Effekt\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 10\nwww.donau -uni.ac.at\nMechanism ofaction\nMucinBioadh\u00e4 sive  \nSchichtAqueous extracts with polysaccharides\nStimulate cell regenerative processes in epithelial cells\nStimulate gene expression of factors with growth promoting properties\nGlycocalix\nCa2+\nZelle\nNach A.Hensel S\u00fcdtiroler Herbstgespr\u00e4che (2010)\nVorf\u00fchrender\n2021 -09-0905:53:39\n--------------------------------------------\nPolysaccharide werden in die  \nS c h l e i m h a u t z e l l e n internalisiert, steigern die  \nZellvitalit\u00e4t und Zellteilungsrate \u00e0  \naktiv sch\u00fctzender und  \nregenerierender Effekt\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 11\nwww.donau -uni.ac.at\nLicorice  \nGlycyrrhiza glabra\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 12\nwww.donau -uni.ac.at\nLicorice  \nGlycyrrhiza glabra\nIngredients\nFlavonoids\nSaponins (2 -15 %, main glycyrrhizin)  \nchalcones, coumarins, acid polysaccharides\nEffect\nantiphlogistic, antimicrobial  \nexpectorant\nsecretolytic, secretomotoric  \nspasmolytic\nApplication\ntea -there are no objections to its use as a  \nflavoring agent up to a maximum of 2.5 g of the  \ndrug.Tonote\nWith prolonged use, higher dosage  \nmineralcorticoid effects sodium and  \nwater retention, potassium loss with  \nhigh pressure, edema and  \nhypokalemia, in rare cases  \nmyoglobinuria.\nInteractions\nPharmaceuticals that affect ion  \nbalance (e.g. diuretics)\nPharmaceuticals whose effects are\nlinked tospecific ionconcentrations\n(e.g.cardiac glycosides)\nVorf\u00fchrender\n2021 -09-0905:53:40\n--------------------------------------------\n(Kalium -, Ammonium -und  \nC a l c i u m s a l z e  der Glycyrrhizins\u00e4ure,  \nAglykon = Glycyrrhetins\u00e4ure).  \nGlycyrrhizin schmeckt ca.  \n50fach s\u00fc\u00dfer als Rohrzucker,  \n24-Hydroxy -glycyrrhizin  \nca.100fach s\u00fc\u00dfer Lakritze soll  \nnicht mehr als 0,2 %  \nGlycyrrhizins\u00e4ure enthalten.\n. Der \"No -effect -level\" von G l y c y r r h i z i n   \nbetr\u00e4gt 2 mg/kg K\u00f6rpergewicht.\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 13\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 14Microscopy of medicinal plants\nDr. Oliver Vendl\nMicroscopy of medicinal plants\nCharacteristic structures for  \nmicroscopic drug identification  \nin leaves, flowers and roots\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nLeaves\nTrichomes (\u201ehairs\u201c)\n\u2022non-glandular\n\u2022glandular\nEpidermis with stomata\nCrystal cells\nIntercellular cavities\n(e.g. schizogenic/lysogenic  \noil glands\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nFlowers\nOften characteristic  \ntrichomes on calyx or  \ncorolla\nEndothecium (= inner  \nlayer ofstamina)\nPollen\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nRoots\nArrangement of vessels  \n(xylem) in cross section\nVessels (tracheae) with pits  \n(longitudinal section)\nCrystal cells\nStarch\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nNon -glandular trichomes \u2013\u201ejust hairs\u201c\nThymus vulgaris:\nShort, \u201edoor -handle\u201c hairs on leave  \nsurface, 2-3 cells\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nNon -glandular trichomes \u2013\u201ejust hairs\u201c\nAlthaea officinalis:\nStar-shaped hairs on leaves, stem and  \ncalyx\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nNon -glandular trichomes \u2013\u201ejust hairs\u201c\nMentha xpiperita:\nConiform, single -celled hairs on edges of leaves,  \nmembered hairs on backside ofleaves\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nGlandular trichomes \u2013oilglands\nLamiaceae -type\nAsteraceae -type\nPictures: user/uni -frankfurt.de\nGlandular trichomes \u2013oilglands\nLamiaceae -type\nMentha piperita\nPictures: \u00a9 B. Rahfeld/Springer VerlagMentha piperitaSalvia officinalis\nThymus vulgaris\nGlandular trichomes \u2013oilglands\nAsteraceae -type\nMatricaria chamomilla\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nLeaf epidermis and stomata\nMelissa officinalis\nPictures: \u00a9 B. Rahfeld/Springer VerlagEucalyptus globulus\nSalvia officinalis Plantago lanceolata\nIntercellular cavities in leaves \u2013\nOil glands in Eucalyptus globulus\nFlowers \u2013distinctive trichomes\nLavandula officinalis -Calyx Verbascum sp. -Corolla\nPrimula veris -Corolla Tilia sp. -Calyx\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nRoots (cross section) \u2013arrangement of  \nvessels\nGlycyrrhiza glabra\n Althaea officinalis\nRoots \u2013crystal cells\nAlthaea officinalis:\nCalciumoxalate druse cells as  \nwell as polysaccharide -\ncontaining cells (arrow) spread  \nwithin the parenchyma\nGlycyrrhiza glabra:\nCalciumoxalate druse cells  \nalongside xylem vessels (tracheae)\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nMicroscopy: From the book toreality\nAlthaea officinalis leaf, cross section\u00a9 B. Rahfeld/Springer Verlag\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 31The whole is more than the sum of itsparts\n(Aristotle)\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 32Species Althaeae \u00d6AB\nPreparation\n1 tablespoon of tea mixture with 150 ml (equivalent to 1 tea cup) of boiling  \nwater, infuse for 10 minutes, then strain through a tea strainer  \nApplication\nT ea should be drunk warm, sip by sip, as needed.\nwww.phytotherapie.atHeilpflanze g\nMarshmallow leaf\nMarshmallow root aa25,0\nLicorice root 15,0\nMallow flower 5,0\nat www.donau-uni.ac.\nEffect of herbal tea composition\nExcel -Tabelle mit Wirkung Heilpflanzen\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 33\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 34Wrap therapy  \nfor symptoms of common cold\nwww.donau -uni.ac.at\nWrap therapy\nInner cloth\nthin tea towel, linen clothes used for active  \nsubstance wrap as tightly as possible to the body in  \ncase of warm wrapping, check the temperature at  \nthe elbow beforehand\nIntermediate layer\nso that the overlay is not soaked by the inner cloth  \nshould be slightly larger than the inner cloth should  \nalso be air -permeable, only then can moisture  \nevaporate and cold or heat stimulus come about\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 39 39\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 40 40Wrap therapy\nOuter cloth\nshould keep wrapping temperature  \nterry towel or thick woolen scarf\nlarger than inner and intermediate towel, so that it covers well\nPutting on the wrap\nfirst put all 3 towels on top of each other\nplace the affected part of the body on top of the towel\nwrap the inner towel as tightly as possible around the body  \npart, then the intermediate and outer towel\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 41Neckwrap with lime\nApplication\nwarm -hot: beginning, acute sore throat, to loosen mucus, in case of chronic  \nsore throat\ncool: difficulty swallowing, sore throat, as an adjunctive measure in acute  \ntonsillitis\nActive ingredient:\nessential oils oflemon\nMaterial:\n1 unsprayed lemon peel with water (hot or cold, depending on the application,  \nsee above)\nfirm cotton cloth, linen cloth or bourette silk cloth -wool cloth or scarf\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 42Neckwrap with lime\nProcedure:\nHalve the lemon in a bowl under water and squeeze it, scoring the peel  \nseveral times (to obtain as much essential oil as possible).\nFold the wrap so that it fits around the neck.\nAttention:\nspine must remain free (do notcover)!\nDip the wrap in lemon water, wring it out vigorously, and place it on the neck  \nwith as few wrinkles as possible.\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 43Neck wraps with lime for a sore throat:\nDo not cover spine, wrap tightly with woolen cloth or scarf\nDuration\nwarm -hot wrap: a few minutes or as long as comfortable  \ncool wrap: approx. 1 hour or longer, depending on the  \nskincompatibility\nAfter thewrap:\ncover neck well for a while (scarf), possibly oil skin with good skin oil  \nin case of itching, remove immediately! Oil the skin\nwww.donau -uni.ac.at\nDepartment f\u00fcr Gesundheitswissenschaften, Medizin und Forschung\nDonau -Universit\u00e4t Krems. Die Universit\u00e4t f\u00fcr Weiterbildung. November | 2020 | Seite 44Wrap with cooked potatoes\nIndication\nInflammation of throat and pharynx  \nLaryngitis (hoarseness up to voicelessness)\nPreparation\nWrap cloths\nBoil 4 -6 potatoes, let them cool down a bit and mash them finely\nExecution\nPut the potato \"mash\" on the cloth, wrap it and check the temperature.  \nthe heat should be pleasant, not too hot!\nwrap the inner cloth with potatoes around the neck  \nin succession intermediate cloth and woolen scarf  \nmake sure that the wrap is not too wide\nThis article appeared in a journal published by Elsevier. The attached \ncopy is furnished to the author for internal non-commercial research  \nand education use, including for instruction at the authors institution \nand sharing with colleagues.\nOther uses, including reproduction and distribution, or selling or  \nlicensing copies, or posting to personal, institutional or third party \nwebsites are prohibited.\nIn most cases authors are permitted to post their version of the \narticle (e.g. in Word or Tex form) to their personal website or  \ninstitutional repository. Authors requiring further information  \nregarding Elsevier\u2019s archiving and manuscript policies are  \nencouraged to visit:\nhttp://www.elsevier.com/authorsrights\nAuthor's personal copy\nComplementary Therapies in Medicine (2013) 21, 388\u2014395\nAvailable online at www.sciencedirect.com\njourna lhomepage:www.elsevierhealt h.com/journals/ct im\nScienti\ufb01c case research in complementary and  \nalternative medicine \u2014\u2013Areview\nMichael Teut a,\u2217, Klaus Lindeb\na Institute for Social Medicine, Epidemiology and Health Economics, Charit\u00e9 University Medical Center, Luisenstr. 57, 10117  \nBerlin, Germany\nb Institute of General Practice, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany\nAvailable online 23 May 2013\nKEYWORDS\nReview;\nSingle case research;  \nComplementary and  \nalternative medicine;  \nCase reports;\nCase studiesSummary Thedescription ofindividual cases isprobably themost important didactic toolfor\nteaching inmedicine, especially incomplementary andalternative medicine (CAM) .However,\nonlyveryrarely istheinformation provided intraditional single casereports suf\ufb01cient toanswer\nscienti\ufb01c questions .These reports typically aredemonstrations ofthesolution toaclinical\nproblem .Tocontribute toscienti\ufb01c discussion single -case research must askcritical questions\nwhose answers areopen.Twofundamental questions are:(1)Ismyobservation reliable? (2)\nWhich factors, other than mytreatment, mayexplain theobserved outcome? Inthisreview\nwewillgiveanintroduction tosingle -caseresearch, aswellaspresent andexplain single -case\ndesigns asatoolforresearch anddiscuss their relevance andapplicability forclinical practice\ninCAM.Thisreview deals exclusively withsingle -caseresearch ontreatment effects andcovers\nobservational single -case studies, progressive andrepetitive experimental single case designs,\nn-of-1-RCT, multiple baseline design, bestcaseseries andmeta -analysis ofsingle -casestudies .\n\u00a92013 Elsevier Ltd.Allrights reserved .\nContents\nIntroduction..............................................................................................................  389\nQuantitative and qualitative approaches to single -case research .........................................................  389\nObservational single -case studies and case reports.......................................................................   390\nExperimental  single -case  designs......................................................................................... 390\nProgressive single -case designs ......................................................................................  390\nAB-/ABC -designs..............................................................................................   390\nRepetitive single case designs .......................................................................................  391\nABA-/ABAB -designs ...........................................................................................  391\nN-of-1-RCT.................................................................................................. .391\n\u2217 Corresponding author. Tel.: +49 30 450529234; fax: +49 30 450529902.\nE-mail address: Michael.teut@charite.de (M.Teut).\n0965-2299/$ \u2014see front matter \u00a9 2013 Elsevier Ltd. All rights reserved.  \nhttp://dx.doi.org/10.1016/j.ctim.2013.04.006\nAuthor's personal copy\nScienti\ufb01c case research in complementary and alternative medicine 389\nDesigns involving several or multiple single -case studies or case reports ................................................ . 392  \nBest case series .................................................................................................... .392\nSingle case -studies embedded in studies of groups of patients....................................................... 392  \nMultiple baseline design.............................................................................................  392\nMeta-analysis of single case studies ................................................................................ .393\nCognition -based medicine ...........................................................................................  393\nDiscussion................................................................................................................   393\nCon\ufb02ict of interests ......................................................................................................  394\nAcknowledgements....................................................................................................... 394\nReferences ...............................................................................................................  394\nIntroduction\nWhy aresingle -case studies needed? Themost important\ndidactic tool forteaching inmedicine isprobably the\ndescription ofindividual cases .Listening toapatient\u2019s nar-\nrative ofhis/her disease, including their personal pattern of\nsigns andsymptoms andwhat happened once they received\ntreatment isremarkable .Proponents ofCAMtreatments typ-\nically refer toreports ofindividual cases tohighlight the\nbene\ufb01ts oftheir method .Butwhyisitthat, ingeneral, case\nreports playaminor roleinproviding evidence toscienti\ufb01 -\ncally prove thatatreatment iseffective?\nMost case reports inCAM today areretrospective\naccounts ofanimpressive case asperceived anddocu-\nmented byatherapist .They serve more asanarrative to\ndemonstrate aproblem orthesolution toaproblem in\nclinical practice andcanbeconsidered veryimportant for\nteaching sessions, asadidactic tool, tohelp students\nremember keyinformation .They should beexemplary and\nencapsulate alltherelevant clinical issues .Awelltoldstory\nofacase willstick inone\u2019s memory andthecrucial points\ncanbecalled upon ifasimilar patient appears fortreat-\nment infuture clinical practice .Sometimes observations in\nsingle cases caneven generate newhypotheses oridentify\nnewtreatment options .\nHowever, most case reports cannot beconsidered sys-\ntematic research .Instead of\u2018\u2018demonstrating\u2019\u2019 something,\nempirical research tries toanswer open questions .The\nmethods used must betransparent andstand acritical\nevaluation .Forexample, imagine areport byatherapist\nwho isconvinced tohave afabulous cure forapatient\nwith advanced cancer .Even ifoneisonlyslightly sceptical,\nnumerous questions willimmediately arise:Didthepatient\ntruly suffer from thisspeci\ufb01c type ofadvanced cancer? Was\nthepatient truly cured? Ifso,didhe/she receive other treat-\nments which might have contributed tothecure? Could it\nhave been aspontaneous remission? Only very rarely isthe\ninformation provided intraditional single casereports suf\ufb01-\ncient toanswer such questions .Tobeconsidered research,\ncritical questions must beaddressed inacase report ora\nsingle -case study .Inourview, thetwomost fundamen -tal\nquestions are:(1)Ismyobservation reliable? (2)Which\nfactors other than mytreatment mayexplain theobserved\noutcome?\nSurprisingly, thenumber ofsystematic single -case stud-\niespublished inthe\ufb01eld ofCAM isvery small .This isa\npity,inouropinion, because such research could contributeconsiderably tothecritical evaluation ofCAMtherapies and\nCAMresearch maybene\ufb01t from improved understanding of\nbene\ufb01ts, limitations andutility ofsingle -cases .\nFurthermore, although theworkload associated with\nhigh-quality single -case studies must notbeunderesti -\nmated, they areprobably themost feasible research tool\nforthebusy practitioner .Inthisreview wewant togivean\nintroduction tosingle -caseresearch, topresent andexplain\nsingle -case designs asatoolforresearch anddiscuss their\nrelevance andapplicability fortheclinical practice .\nThisarticle exclusively addresses single -caseresearch on\ntreatment effects .Theaimofallsuchresearch istoprovide\nevidence forcausalities during thetherapeutic process .We\ndonotcover etiological, prognostic, diagnostic orproce -\ndural research .Throughout thisarticle wewillusetheterm\n\u2018\u2018case report\u2019\u2019 ifwerefer toretrospective analyses ofsin-\nglepatients andtheterm \u2018\u2018single -case study\u2019\u2019 ifthere isat\nleast some prospective element tothestudy .\nQuantitative and qualitative approaches to  \nsingle -case research\nWhile single -case research isapplied indiverse \ufb01elds, such\nasmedicine, education, rehabilitation, sport andathletic\nperformance, ithasparticularly strong roots inpsychology .\nSeveral textbooks summarizing methodological approaches\nareavailable (e.g.Refs.1\u20143).These textbooks focus mainly\nonexperimental single -casestudies (seebelow) withgraph -\nicalandstatistical analyses .Insuch studies thein\ufb02uence\nofan\u2018\u2018independent variable\u2019\u2019 (e.g.thetreatment vs.a\ncontrol condition) onaprede\ufb01ned outcome (e.g.blood pres-\nsure) isinvestigated .Theoutcome ismeasured repeatedly\n(e.g.daily over 12weeks) .The\ufb01ndings arethen displayed\nusing graphs .Speci\ufb01c statistical analyses areapplied totest\nwhether changes inoutcomes exceed those expected by\nchance .4This approach tosingle -case research isstrongly\nquantitatively orientated and theprinciples indrawing\ninferences regarding causality donotdiffer greatly from\nresearch performed withgroups ofindividuals .\nAsecond important \ufb01eldofresearch arequalitative case\nstudies .Thistype ofresearch isoften carried outbymed-\nicalanthropologists orsocial scientists .Especially when a\nresearcher isinvestigating a\ufb01eld ofresearch where little\nisknown, aqualitative case study orcase series might bea\ngood approach toenter the\ufb01eld, tocollect dataanddevelop\nscienti\ufb01c hypotheses andtheories .Aqualitative methodAuthor's personal copy\n390 M. Teut, K.Linde\nmayalsobeused toidentify questions anddevelop instru -\nments forquantitative research .5Applied tothesearch for\ntherapeutic effects qualitative research oramixed strategy\nofqualitative andquantitative research methods (\u2018\u2018mixed\nmethods approach\u2019\u2019) isespecially valuable toexplore the\nsubjective andcomplex experiences andthetheoretical\nconcepts ofpatients andtherapists .6\nObservational single -case studies and case  \nreports\nObservational single -case studies arescienti\ufb01cally lesscon-\nclusive than experimental single case studies .However, as\nthey donotinterfere oronlyslightly interfere with routine\nclinical practice, they areeasier toperform .Furthermore,\nwhile inmany countries oneshould always obtain writ-ten\ninformed consent from thepatient, onedoes notneed\napproval from anethical review board .\nIfyouhave verygood documentation, itwillbepossible,\natleast insome situations, toretrospectively doarigorous\ncaseanalysis .\nFrom amethodological point ofview, itismuch bet-\ntertoanalyze acase prospectively .Before actually starting\nthetreatment, youneed todecide with thepatient what\nyouwillanalyze during thecourse ofthedisease anddo\nthisaccurately andsystematically .Itishighly recommended\nthatyouclearly formulate objectives youaimtoreach with\nthetreatment, toverify theclinical diagnosis according to\nthehighest standard andtocarefully document how the\ncourse ofthedisease was\u2014depending onthecondition\n\u2014inthelasthours, days ormonths .Oneshould usevali-\ndated instruments tomeasure symptoms, signs, quality of\nlifeetc.before starting thetreatment andprede\ufb01ne when\nthese aretobemeasured .Inaddition, youshould carefully\nqualitatively document allimportant observations before,\nduring andafter treatment asneeded .Take care toensure\nthat several perspectives (patient, therapist, possibly also\nrelatives) arere\ufb02ected inyour documentation .Detail and\nconsistency increase theconclusiveness more than anything\nelse.Youarefreetotreat asyouwould treat outside ofthe\nstudy, butensure youdocument carefully .Anexample ofa\nprospective casestudy isprovided inBox1.Themain draw-\nback ofprospective case studies isthatyouhave todecide\ninadvance whether youwillstudy aparticular patient .It\nmight bethatthispatient turns outtobenon-compliant or\nthatthecourse ofdisease inthispatient isworse thaninthe\npatients youusually treat.Thelikelihood ofhaving selected\napatient which isnota\u2018\u2018best\u2019\u2019 caseishigh.\nSemi-prospective case studies could beacompromise,\nbalancing theadvantages ofretrospective case studies\n(focus onparticularly interesting cases) andprospective\ncase studies (systematic documentation) .Ifearly inthe\ntreatment process youbecome aware that aspeci\ufb01c case\nmight beofparticular interest, youshould carefully doc-\nument what hashappened sofarand then start the\nprospective documentation .\nThere aresome cases intheliterature where semi-\nprospective methods seem tohave been used asthe\ndocumentation isquite systematic .However, publications\nofsuch single -casestudies rarely describe their methods in\ndetail, soitisdif\ufb01cult toknow whether theapproachBox1Anexample ofaprospective observational sin-\ngle-casestudy\nTeut andWarning8prospectively observed an87-year-\noldwoman with severe joint painduetoosteoarthritis\noftheknee who presented with sideeffects from a\npotent pain medication (fentanyl) .Together with the\npatient, thefollowing outcome measures were chosen :\npain intensity (using anumerical rating scale), walk-\ningdistance andactivities ofdaily living (measured\nwith theBarthel Index) .Thepatient wastreated (in\nanin-patient setting) with leeches, herbal medicine,\nphysiotherapy andthree single doses ofmetamizol .\nUnder therapy thepatient experienced aclear reduc -\ntion inpain (from 8to3points onthenumerical\nrating scale) .Sheregained walking ability (increase in\nwalking distance from 0to70m)andshowed improve -\nments intheBarthel Index (from 45to65).Using the\ncriteria of\ufb01gural correspondence, several ofthese sug-\ngest acausal treatment effect :there wasafastand\nmarked improvement within afewdays post treat-\nment, although thecomplaints hadbeen stable for\nabout three months .Thetiming ofimprovement was\npredicted based ontheevidence available .\nComment :This isacarefully documented case-study\nwhich suggests acausal relationship between improve -\nment andthetreatment applied .However, italsoshows\nhow dif\ufb01cult itisinroutine care toprove causality\nbeyond reasonable doubt .\nwas retrospective (based on systematic high quality routine  \ndocumentation) or semi -prospective.7\nExperimental single -case designs\nExperimental single -casestudies typically share twocharac -\nteristics :\ufb01rst, they consist ofseveral prede\ufb01ned treatment\nand/or observation phases which areoften designated as\nphases A,B,C,etc.(see Fig.1).Wepropose todifferen -\ntiate progressive andrepetitive approaches (see below) .\nSecond, theanalysis focuses onaquantitative orgraphi -\ncalcomparison ofthedifferent phases often using speci\ufb01c\nstatistical methods (single case statistics) .Thesequence\nortiming ofthetreatment orobservation periods canbe\nnon-randomized orrandomized .\nProgressive single -case designs\nAB-/ABC-designs\nMost basic experimental single -case studies follow anAB\noranABCdesign (seeFig.1,upper part), where Aisapre-\nassessment phase (ortreatment 1),Bthetreatment phase\n(ortreatment 2),andCafollow -upphase (ortreatment\n3).Box2summarizes anexample .Wecalltheapproach\nprogressive because single phases follow each other without\nbeing repeated .There canbemore complex progressive\napproaches inwhich, forexample, there isasecond\nintervention phase (B\u2217)andasecond follow -upphase (C\u2217),\ntoinvestigate whether effects arelonglasting .Progressive\napproaches canbeapplied inalmost anychronic conditionAuthor's personal copy\nScienti\ufb01c case research in complementary and alternative medicine 391\nIntensity of complaints\nA B C\nA B A B\nWO A WO BWO BWO AWOa)\nb)\nc)\nTime/Phase\nFigure 1Basic designs ofexperimental single -case studies:\n(a) ABC design; (b) ABAB design; (c) variable phases with wash-\nout (WO) periods in between.\nTaken from Witt and Linde26 with permission from Elsevier.\nBox2Example ofasingle -case study using anABC\ndesign\nLeeetal.10observed a35-year-oldmanwith advanced\nlung cancer (stage IV,metastases inthestomach and\nbone) treated withradiotherapy andchemotherapy six\nmonths prior andcurrently receiving only morphine\nforpain.Atthestudy entry, hisgeneral condition was\npoor (Karnofsky Performance Scale 40,constantly high\npain levels) requiring special care andassistance over\ntheprevious month .After sixdays ofpre-treatment\nobservation, thepatient received eight sessions Korean\nexternal Qigong therapy onalternate daysover16days,\nfollowed byatwo-week post-treatment observation\nphase .Avariety ofsymptoms were assessed repeatedly\nusing avisual analog scale.Theresults were presented\ningraphs .\nComment :The study shows convincingly that the\npatient improved .After theinitiation oftheQigong\ntreatment, symptoms improved rapidly, consistently\nand distinctively .Improvements seem topersist in\ntheshort follow -upphase .Amain weakness isthe\nshort pre-treatment observation period with onlytwo\nmeasurements, which leaves some uncertainty asto\nwhether thesymptoms atthestudy entry were par-\nticularly bad.This would increase thelikelihood of\nregression tothemean orspontaneous improvement\n(although theauthors report thatthepatient feltbad\natleast fortheprevious month) .\nwithout interfering toomuch with routine practice .The\nobvious limitation ofsuch anapproach isthat itisnot\npossible toassess whether theeffects arereproducible due\ntothelackofalternation ofthedifferent phases .\nItispossible tointroduce arandom element into such a\nstudy byrandomizing, forexample, how long the pre-\ntreatment phase lasts andwhen thetreatment starts .9This tosome extent increases thevalidity ofsuch stud-\nies,particularly ifassessments aremade byanindependent\nobserver who does notknow when thetreatment began,\norifaplacebo intervention wasused during thebaseline\nphase .Ifseveral such studies arecombined toamultiple -\nbaseline study (see below) theconclusiveness increases\nconsiderably .\nRepetitive single case designs\nABA-/ABAB -designs\nAmore complex design istheABA-design, which iscalled\nreversal design .Anexperimental variable isrepeatedly\nintroduced andwithdrawn .Ifapatient, forexample, suf-\nfersfrom achronic condition andsymptoms re-appear atthe\nsame intensity shortly after disrupting atreatment, repet -\nitive approaches arepossible .If,forexample, apatient\nwith chronic painreceives theshort acting analgesic Xfor\nthree days, he/she might have lesspainduring that period\nbutafter stopping themedication thepainreturns .He/she\ncould then tryanalgesic Yinthesame way.Ifthisis\nrepeated once again inastudy thisisdescribed asanABAB\ndesign (see Fig.1b).Depending onthenum-berand\nsequence oftreatments, avariety ofdesigns arepossible\n(ABBA, ABBABAAB, etc.).Wash -out phases must be\nincluded iftreatments have longer -lasting effects (see Fig.\n1c).Several statistical methods areavailable toanalyze\nrepetitive single -case studies .1\u20143Theadvantage ofmore\ncomplex designs isthatconfounders arelesslikely tooccur\nrepeatedly .\nDesigns that\ufb01nish with atreatment phase, such asABAB\novercome theethical objection ofcomparing withthebase-\nlinephase .More complex multiple sequential withdrawal\ndesigns canbeused toanalyze theseparate effects ofdif-\nferent components ofcomplex settings .\nN-of-1-RCT\nTheconclusiveness ofarepetitive study canbegreatly\nenhanced ifthemultiple treatment phases arerandom -\nized.Such astudy canthen bedesigned asan-of-1trial.\nThenumber -of-1-randomized -controlled -trial-design (n-of-\n1-RCT) isbased onthesingle case experimental design but\napplies theprinciples ofconventional RCTinextension .11\nMultiple, randomized crossovers ofphase pairs areapplied\ntotheindividual patient incrossover order .This design\ncanbeused when arapid onset oftheintervention canbe\nshown, which ceases soon after thetreatment phase anda\ntherapeutic effect isnotmaintained without reap-plying\ntheintervention .Aminimum ofthree phase pairs is\nconsidered toprovide suf\ufb01cient data foraconclusion .This\ndesign isoften performed asdouble -blind andplacebo -\ncontrolled toassess thebestindividual therapeutic evidence\nincases with con\ufb02icting medical therapies, ortoindividu -\nallyprove thetherapeutic bene\ufb01t ofatherapeutic option .12\nAstatistical analysis isperformed toassess theindivid -ual\ntreatment effect .Itisalso possible toevaluate case\nseries,13byfocusing onthebest therapy foranindividual\npatient .Fortheevaluation ofthebestindividual treatment\noption then-of-1-RCTmethod wasconsidered byGuayatt\netal.tobeeven superior toevidence gained from sys-\ntematic reviews ormeta -analyses .14Then-of-1-RCTisalsoAuthor's personal copy\n392 M. Teut, K.Linde\nBox 3 An example of a randomized n -of-1 trial  \nEstrada and Young16 performed a double -blind multi -\nplecross-over, placebo -controlled trialina61-year-old  \nAfrican -American male who had experienced side  \neffects with several antihypertensive medications and  \nwas not willing to try any others. The patient received  \nthree treatment pairs (each single phase for three  \nweeks) ofagarlic -smelling placebo oragarlic prepara -\ntion in randomized order. To provide a washout period,  \ndatafrom the\ufb01rstweek after each cross-overwere not  \nincluded in the statistical analysis.\nWhile thepatient wastaking garlic, themean systolic\nblood pressure was146.9mmcompared to148.9under\nplacebo (p<0.05),themean diastolic blood pressure\nwas87.2vs.89.6(p<0.05).Thepatient identi\ufb01ed the\ncapsule hewastaking in75%oftheweeks .After review -\ningtheresults ofthestudy thepatient insisted on\nreceiving onlygarlic forthemanagement ofhishyper -\ntension inspite ofthesmall effect .\nComment :While unblinding might have introduced\nsome bias, thestudy suggests that there wasasmall\nblood pressure lowering effect with thegarlic treat-\nment .\navery interesting option formedical CAM research .15The\napproval ofanethical review board mayberequired ifanon-\nconventional orexperimental therapy istested forscienti\ufb01c\nreasons .\nInBox3oneofthefewexamples ofn-of-1trials inCAM\nissummarized .\nDesigns involving several or multiple  \nsingle -case studies or case reports\nBest case series\nAbestcase series isadocumentation ofanumber ofcases\nwhich have gone particularly well.Ifsuch abestcaseseries\nindicates surprisingly positive outcomes inanumber of\nindividuals, itcanstimulate further systematic research .\nForexample, theOf\ufb01ce ofCancer Complementary and\nAlternative Medicine (OCCAM) oftheUSNational Cancer\nInstitute launched abestcase series program inoncol -ogy\n(http://www .cancer .gov/cam/bestcase intro.html).\nProviders ofCAMtherapies areinvited tosubmit their best\ncases .Tobeconsidered conclusive, reports must meet\nstringent criteria .Inthecase oftheOCCAM program these\nare:(1)well-documented, de\ufb01nitive diagnosis ofcancer ;\n(2)anadequate documentation ofdisease response ;(3)\nabsence ofconfounders (noconcurrent treatments with\nknown therapeutic potential) ;(4)anadequately docu-\nmented treatment history .Anexample from such abest\ncase series issummarized inBox4.Obviously, best case\nseries canbeperformed forother conditions using adapted\ncriteria .Box4Anexample ofabestcaseseries\nBanerji etal.17published areport onabest case\nseries, evaluated intheprogram oftheOf\ufb01ce ofCancer\nComplementary andAlternative Medicine (OCCAM) of\ntheUSNational Cancer Institute .Lung andesophageal\ncarcinoma patients were treated with homeopathic\nremedies inanIndian centre according toaspeci\ufb01c\n(Banerji) protocol until there wascomplete regres -\nsionofthetumors .Case records including pathology\nandradiology reports from 14patients were submit -\ntedforreview bytheUSNCIBCSProgram .Four of\nthese cases hadindependent con\ufb01rmation ofthediag-\nnosis andradiographic responses andwere accepted\nassuf\ufb01cient information fortheNCItoinitiate further\ninvestigation .Theresults ofthereview were deemed\ntobesuf\ufb01cient towarrant anNCI-initiated prospec -\ntiveresearch follow -upintheform ofanobservational\nstudy .\nSingle case -studies embedded in studies of groups  \nofpatients\nItispossible tointegrate single -case studies intoobserva -\ntional orexperimental studies inlarger groups ofpatients .\nForexample, Hamre etal.18performed aprospective obser -\nvational study ofanthroposophic arttherapy in161patients .\nWithin thestudy theintensity ofcomplaints, quality oflife,\ndepressive symptoms, useofother treatments, satisfac -\ntion with thetreatment andavariety ofother outcome\nmeasures were documented repeatedly upto24months\nafter inclusion .Sixteen patients were selected foraddi-\ntional single case analysis forwhich additional interviews\nwere performed .Using \ufb01gural correspondence, theauthors\ntried toassess thelikelihood ofacausality ofobserved treat-\nment effects .Qualitative interviews areanexcellent toolto\nfurther understand subjective experiences ofpatients and\ntherapists andcomplement quantitative data.\nWalach etal.19conducted a1-year observational study\nof18patients with chronic headaches, whohadpreviously\nparticipated inaplacebo -controlled randomized trial of\nclassical homeopathy .Patients \ufb01lled indiaries which were\nanalyzed using single -casestatistical methods .\nSingle -case studies embedded instudies ofgroups of\npatients canserve tocollect additional qualitative informa -\ntiontoimprove theunderstanding ofprocesses, toprovide\nmore detailed andindividualized evaluation andpossibly to\nstrengthen theconclusiveness .\nMultiple baseline design\nIfthetherapeutic intervention isthought tohave asustained\ntherapeutic effect onthepatient, re-intervening with the\nbaseline phase willnotbeuseful tocontrol thetreatment\nphase .Inthese cases, theAB-design istheoption tostudy\ntherapeutic effects .Amultiple baseline design across par-\nticipants isanextension oftheclassical AB-design and\naims tosystematically compare thetherapeutic intervention\nbetween several patients inanAB-setting .Thebasic ideais\nthattheintroduction ofthetreatment phase isprogressivelyAuthor's personal copy\nScienti\ufb01c case research in complementary and alternative medicine 393\nIntensityof complaints\nTime\nFigure 2Multiple baseline design :several patients are\nobserved over alonger period oftime with repeated measure -\nments .Thetiming oftheswitch from baseline totreatment (fat\nlines) canberandomized .\nTaken from WittandLinde26withpermission from Elsevier .\ndelayed insuccessive participants .Inthe\ufb01rstphase (base -\nline) they donotreceive thetreatment investigated .The\nduration ofthebaseline phase andthetiming oftheswitch\ntothetreatment phase arevariable .Ifpossible, thetiming\noftheswitch israndomized andremains unknown toboth\nthepatient andthetreatment provider until thetreatment\niscommenced .Ifatreatment effect canbedemonstrated\nduring theintroductory treatment phase, theeffect will\nmost likely beduetotheintervention (Fig.2).Itisunlikely\nthat aconfounding effect could repeatedly coincide with\ntheintroduction ofthetherapeutic intervention .Confound -\ningvariables would therefore beseen asachange inall\nbaselines .Ifinsuch astudy, aplacebo canbeused orif\noutcome measurements canbeperformed byablinded\nindependent observer, thevalidity ofamultiple baseline\nstudy canbegreatly enhanced .Ifaconsistent response pat-\ntern with marked improvements after initiating treatment\nemerges, suchdesigns canprovide quite impressive prelimi -\nnaryevidence .Therefore, they aresometimes used aspilot\nstudies forlarger observational orexperimental studies .20,21\nInpsychological behavioral research, where multiple base-\nlinedesigns (MBD) aremainly applied, they have been used\nnotonly across participants, butalsoacross settings and\nbehaviors .\nMeta-analysis of single case studies\nIfmultiple single -case studies onthesame condition using\nasimilar methodology become available, these canbesum-\nmarized inasystematic review orameta -analysis .Tothe\nbest ofourknowledge, thishasnotyetbeen done inCAM\nduetothelackofasuf\ufb01cient number ofsimilar single case\nstudies .However, what hasbeen done already isaseries of\nrandomized n-of-1trials designed prospectively inamanner\ntoallow forcombined analysis .22Cognition -based medicine\nCognition -based medicine (CBM) takes quite adifferent\napproach toinvestigate causal inferences andisprimar -ily\napplied forobservational single -case studies and case\nreports .CBM wasdeveloped byHelmut Kiene etal.based\nonKarlDuncker\u2019s Gestalt theory .Formore details werefer\ntothepaper onCognition Based Medicine inthisspecial\nissue.\nDiscussion\nSingle -case study designs have notyetbeen integrated\nsystematically orwidely intoCAM research although they\ndeserve much more attention .Theneed todevelop modern\nmethods ofcase collection, documentation andevaluation\nhasalready been recognized butonlyrarely hasitbeen sys-\ntematically applied .23\nWebelieve thatthisisapitybecause suchresearch could\ncontribute considerably toacritical evaluation ofCAMther-\napies .Furthermore, although theworkload associated with\nhigh-quality single -casestudies must notbeunderestimated\nsingle case studies areprobably themost feasible research\ntoolforthebusy practitioner .\nCantheeffectiveness ofaCAMtherapy beproven bysin-\nglecases? Yesandno.Inprinciple, itispossible toshow a\ncausal treatment effect inasingle patient with arigorous\nsingle -casestudy .However, showing thatatreatment isgen-\nerally effective inagiven condition isnotpossible (unless\nthere areconsistent results from alarge number ofsimilar\ncasestudies) .\nSingle -case studies aregreat instruments toimprove\ntheability for(self-)critical observation .They canbeused\ntogenerate hypotheses, tocarefully observe and to\nanalyze clinical processes .They canbeused inquality\nassessments andserve asteaching material .Itisunlikely\nthatcasestudies willprovide evidence thatwillcon-vince\nskeptics, butopen clinicians maylisten carefully .Ifalarge\nnumber ofhigh quality single -case studies would become\navailable combined analysis mayprovide further insights .\nInsummary, itwould beunrealistic toexpect thatsingle -\ncase studies could revolutionize CAM research \u2014butthey  \nmaywellcontribute important pieces inanevidence puzzle.\nSingle case study designs have certain limitations which\nrestrict their useinpractice :\n-Themore complex atherapeutic intervention is,themore  \ndif\ufb01cult the analysis becomes.\n-Introducing a combination of therapeutic interventions at  \nthe same time complicates the analysis.\n-Acontinuous documentation ofinterventions andoutcome  \nparameters is essential but a time consuming task.\n-Assessment of potential bias factors can become detec -\ntive\u2019s work.\n-Prospective or semi -prospective scienti\ufb01c case research  \nrequires planning, which maydelay thestart oftreatment.\n-Experimental therapies may require the approval of an  \nethical board.Author's personal copy\n394 M. Teut, K.Linde\nThe ideal conditions for most single -case studies are:\n-Stable baseline, usually corresponding with chronic dis-\neases .\n-Ifthedisease isselfresolving orspontaneous remissions\noccur frequently, thesingle case designs might notbe\napplicable .\n-Introducing onlyoneneworrepeated therapeutic element\natatime.\n-Nocarry -overeffects between treatment phases .\n-Continuous assessment ofoutcome parameters (high num-\nber of measuring points).\n-Motivated patients with good compliance.\n-Clinical setting with enough time for research.\nGuidelines like CONSORT statement (http://www .\nconsort -statement .org/)have helped toimprove thequal-\nityofclinical trials.Theimplementation oradaptation of\nguidelines ondocumentation, evaluation andreviewing of\ncase reports might also bevery helpful forCAM case\nresearch .24\nAnimportant issue todiscuss istheethics .Theapproval\nofanethical review board isconsidered necessary ifa\nnon-conventional orexperimental therapy istested forsci-\nenti\ufb01c reasons, butnotincases where routine therapies are\napplied fortheindividual bene\ufb01t ofthepatient .25Ethical\nreview boards areoften notfamiliar with CAM andsingle -\ncase research andmight seethecase inadifferent light\nthan aCAM researcher orpractitioner :theCAM therapy\ninvolved might notbeatallunderstood asroutine therapy\nandnearly automatically beclassi\ufb01ed as\u2018\u2018experimental\u2019\u2019 .\nIncases where medical treatments areinvolved, authori -\ntiesmight even classify asingle -case study asavariation\nofaphase 2drug trialwith allthelegal andorganizational\nconsequences .\nToday many medical journals invite thesubmission of\ncasereports, butopportunities tostudy single caseresearch\nmethodology arestillrare.\nWebelieve thatsingle -case study designs canbeavery\nuseful toolforCAM researchers :forfundamental clinical\nresearch, asapilot study andtodevelop hypotheses for\nbigger andmore expensive clinical trials.They may well\nbridge thegapbetween CAMpractitioners andresearchers,\nasexpertise inboth\ufb01elds isneeded toconduct ahighquality\nsingle -casestudy .\nEspecially forgeneral practitioners, single -case studies\nmight turnouttobeaveryinteresting \ufb01eldofresearch .\nCon\ufb02ict of interests\nThere are no con\ufb02icts of interest. There was no funding for  \nthisresearch.\nAcknowledgements\nParts ofthisarticle aretaken from abook chapter by\nKlaus Linde inthebook Witt C.M.,Linde K.:Clinical\nResearch inComplementary andIntegrative Medicine \u2014A\nPractical Training book.M\u00fcnchen :Elsevier, 2011,ISBN:\n978-0-7020-3476,andfrom Teut M:Scienti\ufb01c case studies\ninhomeopathy .NewDirections inhomeopathy research,edited byClaudia Witt andHenning Albrecht, KVCPublish -\ners,Essen 2009.Wethank both publishers forgiving their\npermission touseourprevious work.\nReferences\n1.Petermann F,M\u00fcller JM.Clinical psychology andsingle -case\nevidence \u2014apractical approach totreatment, planning and\nevaluation .Chichester :Wiley ;2001.\n2.Julius H,Schlosser RW,Goetze H.Kontrollierte Einzelfallstu -\ndien.G\u00f6ttingen :Hogrefe ;2000.\n3.Franklin RD,Allison DB,Gorman BS,editors .Design andanalysis\nofsingle -caseresearch .Mahwah :Lawrence Erlbaum Associates ;\n1997.\n4.Parker RI,Brossart DF.Evaluating single case research data:a\ncomparison ofseven statistical methods .Behavior Therapy\n2003;34:189\u2014211.\n5.Thompson CB,Walker L.Basics ofresearch (part 12):qualitative\nresearch .AirMedical Journal 1998;17(2):65\u201470.\n6.Broom A.Using qualitative interviews inCAMresearch :aguide\ntostudy design, data collection anddata analysis .Complemen -\ntaryTherapies inMedicine 2005;13:65\u201473.\n7.Wode K,Schneider T,Lundberg I,Kienle GS.Mistletoe treat-\nment incancer -related fatigue :acase report .Cases Journal\n2009;2:77.\n8.TeutM,Warning A.Blutegel, Phytotherapie undPhysiotherapie\nbeiGonarthrose \u2014einegeriatrische Fallstudie .Forsch Komple -\nment\u00e4rmed 2008;15:269\u201472.\n9.Schulte D,Walach H.F.M.Alexander technique inthetreatment\nofstuttering \u2014arandomized single -case intervention study\nwith ambulatory monitoring .Psychotherapy andPsychosomat -\nics2006;75:190\u20141.\n10.LeeMS,Yang SH,LeeKK,Moon SR.Effects ofQitherapy (exter -\nnalQigong) onsymptoms ofadvanced cancer :asingle case\nstudy.European Journal ofCancer 2005;14:457\u201462.\n11.Guyatt G,Sackett DL,Adachi J,Roberts R,Chong J,Rosenbloom\nD,etal.Aclinician\u2019s guide forconducting randomised trials in\nindividual patients .Canadian Medical Association Journal\n1988;139(6):497\u2014503.\n12.Nicles CJ,Clavarino AM,DelMarCB.Using n-of-1trials asclin-\nicaltooltoimprove prescribing .British Journal ofGeneral\nPractice 2005;55:175\u201480.\n13.Nathan PC,Tomlison G,Dupuis LL,Greenberg ML,OtaS,Bartels\nU,etal.Apilot study ofondansetron plusmetopimazine vs.\nondansetron monotherapy inchildren receiving highly emeto -\ngenic chemotherapy :aBayesian randomized serial n-of-1-trials\ndesign .Support Care Cancer 2006;14:268\u201476.\n14.Guayatt G,Haynes B,Jaeschke R,Cook D,Greenalgh T,Mead M,\netal.Introduction :thephilosophy ofevidence based medicine .\nIn:Guayatt G,Rennie D,editors .User\u2019s guide tothemedical lit-\nerature :amanual forevidence based clinical practice .Chicago :\nAmerican Medical Association Press;2002.p.3\u201411.\n15.Johnston BC,Mills E.n-of-1randomized controlled trials :an\nopportunity forcomplementary andalternative medicine eval-\nuation .Journal ofAlternative andComplementary Medicine\n2004;10(6):979\u201484.\n16.Estrada CA,Young MJ.Patient preferences fornovel therapy :an\nn-of-1trialofgarlic inthetreatment ofhypertension .Journal\nofGeneral Internal Medicine 1993;6:619\u201421.\n17.Banerji P,Campbell DR,Banerji P.Cancer patients treated with\ntheBanerji protocols using homoeopathic medicine :abestcase\nseries program oftheNational Cancer Institute USA.Oncology\nReports 2008;20:69\u201474.\n18.Hamre HJ,Glockmann A,Kiene H.Wirksamkeitsbeurteilung\nderAnthroposophischen Kunsttherapie :EinzelfallstudieAuthor's personal copy\nScienti\ufb01c case research in complementary and alternative medicine 395\neingebettet in eine prospektive Kohortenstudie. Merkurstab\n2004; 57:194\u2014203.\n19.Walach H,Lowes T,Mussbach D,Schamell U,Springer W,Stritzl\nG,etal.Thelong-term effects ofhomeopathic treat-ment of\nchronic headaches :oneyear follow -upandsingle case time\nseries analysis .British Homoeopathic Journal 2001;90:63\u2014\n72.\n20.Kazdin A,Kopel S.Onresolving ambiguities ofthemultiple -\nbaseline design :problems and recommendations .Behavior\nTherapy 1975;6:601\u20148.\n21.Watson PJ, Workman EA.The non-concurrent multiple\nbaseline across -individuals design :anextension ofthe\ntraditional multiple baseline design .Journal ofBehav -ior\nTherapy andExperimental Psychiatry 1981;12(3):257\u20149.22.Coxeter PD,Schluter PJ,Eastwood HL,Nikles CJ,Glasziou P.\nValerian does notappear toreduce symptoms forpatients with\nchronic insomnia ingeneral practice using aseries ofran-\ndomised n-of-1trials.Complementary Therapies inMedicine\n2003;11:215\u201422.\n23.Baas C.Thepitfalls ofclinical case research :lessons from the\nDelphi Project .Homeopathy 2004;93(1):21\u20146.\n24.Hung SK,Hillier S,Ernst E.Case reports ofadverse effects of\nherbal medicinal products (HMPs) :aquality assessment .Phy-\ntomedicine 2011;18:335\u201443.\n25.Irweg L,Glasziou P,March L.Ethics ofn-of-1trials .Lancet\n1995; 345:469.\n26.WittCM,Linde K.Clinical research incomplementary andinte-\ngrative medicine .Apractical training book.M\u00fcnchen :Elesvier ;\n2011.Spring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nHow to prescribe herbal remedies\u2026\nand how to get health insurance coverage [in Austria]\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society forPhytotherapy (\u00d6GPHYT) | Medical University ofVienna (MUW)\nHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nWhat is the European definition of a herbal remedy?Spring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nHerbal preparations consist mainly of\u2026\n\u2022drugs (dried plant -[parts ])\n\u2022extracts\n\u2022plant secretions (essential oil, resin , balm , chyle )How to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nCrude DrugsSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\n\u2022Leaves \u2013Folium\n\u2022Whole herbs \u2013Herba\n\u2022Flowers \u2013Flos\n\u2022Bark \u2013Cortex\n\u2022Root \u2013Radix\n\u2022Rootstock -Rhizoma\u2026thereof derived preparations\n\u2022Herbal tea\n\u2022Infusions\n\u2022Macerations\n\u2022Decoctions\n\u2022Drug PowderHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nExtractsSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\n\u2022Water\n\u2022Ethanol/ Water -Mixtures\n\u2022Oil\n\u2022Non polar solvents\n\u2022CO2\u2026thereof derived preparations\n\u2022Herbal tea, Infusions , Macerations\n\u2022Tinctures , Elixirs\n\u2022Oil-Macerations\n\u2022Special Extracts\n\u2022CO2-Extracts\n\u2022dry extractsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nPlant secretionsSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\n\u2022Essential Oils\n\u2022Resins\n\u2022Balms\n\u2022Chyle\u2026thereof derived preparations\n\u2022Essential Oils, Aqua aromatica\n\u2022Tinctures\n\u2022Oil-Macerations , Ointments\n\u2022Latex, RubberHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nMain rules ofherbal preparations / phytotherapy :Spring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nThe Solvent defines theActive Agent. The Extract istheActive Agent.\nThe Active Agent isa Multicomponent Mixture .How to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nMain rules ofherbal preparations / phytotherapy :Spring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nThe Solvent defines theActive Agent. The Extract istheActive Agent.\nThe Active Agent isa Multicomponent Mixture .\npolar apolarwateroil,\norganic solvents , acetone \uf083ethanol -water -mixtures \uf084\nHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nWhat canbeprescribed ?\n\u2022crude drugs\n\u2022powdered drugs\n\u2022tinctures\n\u2022extracts\n\u2022fluidextracts\u2022macerations\n\u2022infusionsdry aqueous ethanolic\n\u2022essential oils\n\u2022resinsapolarHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nWhat canbeprescribed ? \u2013What canweformulate with these substances ?\n\u2022crude drugs\n\u2022powdered drugs\n\u2022tinctures\n\u2022extracts\n\u2022fluidextracts\u2022macerations\n\u2022infusionsdry aqueous ethanolic\n\u2022essential oils\n\u2022resinsapolar\u2026medical teas (also used asmouth wash , irrigation and rinsing fluids )\n\u2026powdered drugs canbefilled in capsules ! \nmouth wash , irrigation and rinsing fluids\n\u2026 canbeformulated aspart ofa syrup\n\u2026canbeused asthey are, orbediluted before final use\n\u2026canbemixed together\uf092mixtura\n\u2026canbeformulated aspart ofa syrup orsolutio /mixtura\n\u2026canbepart ofa topical formulation , canbeformulated into supp.\n\u2026canbeused asthey are, orbediluted before final use, mixed together\n\u2026canbefilled into capsules , canbeformulated into suppositories\n\u2026canbepart ofa topical formulationHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nparts ofa prescription formula\nINSCRIPTIO (name and adress oftheprescribing physician )\nINVOCATIO (\u201erecipe!\u201c, Rp./, Rc, \u211e, Rx, Rx, \u201etake !\u201c)\nORDINATIO (themedication / theformulation )\nSUBSCRIPTIO (size, quality , quantity )\nSIGNATURA (instructions forthepatient )\nNAME OF THE PATIENT\nSIGNATURE OF THE PRESCRIBING PHYSICIAN\nHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nparts ofa prescription formula\nINSCRIPTIO (name and adress oftheprescribing physician )\nINVOCATIO (\u201erecipe!\u201c, Rp./, Rc, \u211e, Rx, Rx, \u201etake !\u201c)\nORDINATIO (themedication / theformulation )\nSUBSCRIPTIO (size, quality , quantity )\nSIGNATURA (instructions forthepatient )\nNAME OF THE PATIENT\nSIGNATURE OF THE PRESCRIBING PHYSICIAN\nHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nbasic formulation rules forteas\nRp./\nI.Remedium cardinale (Main remedy)\nII.Adjuvans (adjuvant, complementing constituent)\nIII.Corrigens (taste improving constituent)\nIV.Constituens (filling material)\n+ SignaturaHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nbasic formulation rules forteas\nRp./\nI.Remedium cardinale (Main remedy, 1 -max. 3)\nII.Adjuvans (adjuvant, 1 -2)\nIII.Corrigens (only one, preferably drug with essent . oils)\nIV.Constituens (filling material, folium -drug, look)\n+ Signatura (do not forget dosing !)\nNot toolong!How to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nimportant vocabulary\naa ana partes aequales equal parts\naa ad ana partes aequales ad equal parts to\nM.f. misce fiat mix, so it becomes\u2026 e.g. species (tea)\nD.S. Da! Signa! Give (the patient)! Write the instruction \n(onto the formulation)!\nM.D.S. Misce , Da, Signa Mix! Give! Write the instruction!How to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\na formulation \u2013an example\nRp./\nTinct . Tormentillae ................. 5\nTinct . Ratanhiae\nTinct . Myrrhae ............... aaad30\nM.D.S: Mouthwash\n10-20 drops on 15ml water to rinse,\n20-40 drops on 2 tablespoons water to \ngargle,\nundiluted to brush on gums\nHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\na formulation \u2013an example\nRp./\nTinct . Tormentillae ................. 5\nTinct . Ratanhiae\nTinct . Myrrhae ............... aaad30\nM.D.S: Mouthwash\n10-20 drops on 15ml water to rinse,\n20-40 drops on 2 tablespoons water to \ngargle,\nundiluted to brush on gums\nHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\na formulation \u2013an example\nRp./\nHerba Visci albi\nFolium cum flore Crataegi\nFolium Melissae aaad 100\nM.D.S: Tea against mild hypertonia,\n2 teaspoons for one cup, 2x/d\nHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing herbal teas\nINDICATION FOR A TEA\nWhen do I prescribe a tea?\nstomach friendly elevate fluid intake inhibition threshold low non-alcoholic\nUTIs,\ncough ,\ncommon cold ,\nsore troatGIT disorders ,\nwater isa good solvent \nforbitternsgood forpatients that prefer\ngentle methods / areagainst\nsyntheticspossible tousein \nchildren , pregnant and \nbreast -feeding women ,\nrecovering alcoholicsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing herbal infusions\nINDICATION FOR INFUSIONS\nWhen do I prescribe infusions ?\nstomach friendly forpotent drugs hardly soluable compounds non-alcoholic\ninfusions areusually\nproduced from drugs\nyou wouldn\u2018t want to\ndrink a cup ofteaofwater -based :\nGIT disorders ,\nwater isa good\nsolvent forbitternspreferred fordrugs with hot\nwater soluable main active\ncompounds possible tousein \nchildren , pregnant and \nbreast -feeding women ,\nrecovering alcoholicsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing herbal mecerations\nINDICATION FOR MACERATIONS\nWhen do I prescribe macerations ?\nstomach friendly forheat sensible drugs heat sensible compounds non-alcoholic\ninfusions areusually\nproduced from drugs you\nwouldn\u2018t want todrink a \ncup ofteaofwater -based :\nGIT disorders ,\nwater isa good\nsolvent forbitternsfordrugs with mucilagepossible tousein \nchildren , pregnant and \nbreast -feeding women ,\nrecovering alcoholicsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing herbal decoctions\nINDICATION FOR DECOCTIONS\nWhen do I prescribe decoctions ?\nforhardly soluble compounds contaminated drugs non-alcoholic\nUsually used fordrug with only\nhardly hotwater suluable\ncompoundsan option fordrugs of\nprobably lower\nmicrobiological qualitypossible tousein children , \npregnant and breast -feeding\nwomen ,\nrecovering alcoholicsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing drug powders\nINDICATION FOR POWDERS\nWhen do I prescribe powders ?\ncanbefilled in capsules\nfordrugs with bad tasteHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| pros and cons ofwaterbased formulations\nnon-alcoholic\nstomach friendly formulation\neasy toprepare / user -friendly\nwatery solutions getquickly resorbeddifferent compounds than in an ethanolic extract\nnot so good ifpatient have hiatal hernia\nmicrobial contamination issues\nthey arelow-dose formulationsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing herbal tinctures\nINDICATION FOR A TINCTURE\nWhen do I prescribe a tincture ?\nhigh concentration often officinal liquid good stability\nprobably refundable\nand broadly\nestablished usedethanol -water -\nmixtures canextract\nsimply more from\ndrugsgood forpatients with\ndysphagia / difficulties\nswallowinghigher ethanol amount\ngives them a longer\nshelf -liveHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing herbal extracts\nINDICATION FOR A EXTRACT\nWhen do I prescribe an extract ?\nDrug Extract Ratio (DEV) is\nperfectly defined and \nreproduceabledefined concentration often officinal liquid higher stability\nprobably refundable\nand broadly\nestablished usedgood forpatients with\ndysphagia / difficulties\nswallowinghigher ethanol amount\ngives them a longer\nshelf -liveHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing herbal fluidextract\nINDICATION FOR A FLUIDEXTRACT\nWhen do I prescribe a fluidextract ?\nDrug Extract Ratio = 1:1\n1 part extract equals 1 part\nofthedrugdefined concentration sometimes officinal liquid higher stability\nprobably refundable and \nbroadly established usedgood forpatients with\ndysphagia / \ndifficulties swallowinghigher ethanol amount\ngives them a longer\nshelf -liveHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing herbal dry extract\nINDICATION FOR A DRY EXTRACT\nWhen do I prescribe a dry extract ?\nhigh concentration stability inhibition threshold low non-alcoholic\nnowater , less lifeGIT disorders ,\nwater isa good solvent \nforbitternsgood forpatients that prefer\ngentle methods / areagainst\nsyntheticspossible tousein \nchildren , pregnant and \nbreast -feeding women ,\nrecovering alcoholicsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| pros and cons ofextracts\nhigh -dose formulation\nbetter (microbial ) stability\na lotofofficinal preparations\nsometimes only in national pharmacopoeias\n[= canindicate national refundability ]Different compounds than just a tea\noften alcoholic\nsometimes only in national pharmacopoeias\nnational / social security sevice dependent\nrefundabilityHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing essential oils\nINDICATION FOR A ESSENTIAL OILS\nWhen do I prescribe a essential oils?\npure active compounds proprietary (?) variety ofapplication non-alcoholic\nthere are\nproprietary drugs\nwith some high \nquality study datamaybe need tobedilutedcanbediluted in oil, water , \nalcohol , in dermatological\napplications , suppositoriespossible tousein children , \npregnant and breast -\nfeeding women (?), \nrecovering alcoholicsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nformulations in use| prescribing herbal teas\nINDICATION FOR A RESINS\nWhen do I prescribe a resin ?\nanti-inflammatory anti-infective forencapsulation canbedissolved\ne.g. myrrh e.g. frankincensepharmaceutically used\n\u201eresins \u201c areusually \u201edry\u201cused per os, mouthwash\norother topical\napplicationsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nOff to practiceSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial ResistancesHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nPatient, male, 34y, productive cough, vesicular breath \nsound, oxygen saturation 95%, no fewerSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nWhat canweprescribe ?\ntea\ntincture syrupinfusion mixtura\nessential oilHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nPatient, female, 27y, UTI, no ascension, no fewerSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nWhat canweprescribe ?\ntea\nproprietary drugextractHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nPatient, male, 38y, sleeping problems, nervositySpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nWhat canweprescribe ?\ntea\ntincture syrupinfusionHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nPatient, female, 46y, flatulence, stomach troubleSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nWhat canweprescribe ?\nteatincture capsulesmixturaHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nTo consider when prescribing teas\u2026Spring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\n\u2022pharmacological effects\n\u2022side effects ?\n\u2022drug interactions (https://escop.com/interactions/ ) \n\u2022taste\n\u2022allergies\n\u2022(well) established formulasHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nTo consider when prescribing tinctures\u2026Spring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\n\u2022pharmacological effects\n\u2022side effects ?\n\u2022drug interactions (https://escop.com/interactions/ ) \n\u2022(taste)\n\u2022allergies\n\u2022established formulas , compound interaction (precipitation )How to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nHow to get health insurance coverage [in Austria] ?Spring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\n\u2022There isjust a small amount ofcovered proprietary drugs .\n(Legalon \u00ae, Tebofortan \u00ae, Cerebokan \u00ae, Tavipec \u00ae, BRUST -und HUSTENTEE St. Severin \u00ae, \nGALLEN -und LEBERTEE St. Severin \u00ae, PROSTA Urgenin \u2013Kapseln \u00ae, etc. )\n\u2022There isa great number ofdrugs and preparations covered\nbytheList of Reference Prices for Medicinal Products \n(Arzneitaxe )\n\uf092Physicians canprescribe covered formulationsHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nWeneed tocheck thenational List of Reference Prices \nfor Medicinal Products Spring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nhttps://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer= 10010306\nHow to prescribe herbal remedies\u2026\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nMag. pharm. Heinrich Justin Evanzin\nAustrian Society for Phytotherapy (\u00d6GPHYT)\nWhere can I find established formulations?Spring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nNational Materia Medica \u2013National Phamacopoeias\nFormulation Collections\nLiterature \u2013educational books on phytotherpy\nhttps://phytotherapie.at /\nhttp://www.juniormed.at/\nYoucanalso askyour Pharmacist ! ;-)How to prescribe herbal remedies\u2026\nand how to get health insurance coverage [in Austria]\nMag. pharm. Heinrich Justin Evanzin | heinrich.evanzin@gmail.com \nAustrian Society forPhytotherapy (\u00d6GPHYT) | Medical University ofVienna (MUW)\nSpring School -Healthy Herbs | Phytotherapy as a Strategy against Antimicrobial Resistances\nThank you for \nyour attention!Quality managementofmedicinalplants\nforrespiratorydiseases\nDr. Oliver Vendl, KOTTAS PHARMA Vienna\nMedicinalherbs: \nEuropean regulationsfor\n\u2022Therapeuticindication\n\u2022Dosage\n\u2022Application\n\u2022SafetyTherapy Quality ofherbs\nAssurance of\n\u2022Correctidentification\n\u2022Content ofactive\ncompounds\n\u2022PurityRegulatives formedicinalherbs\nEuropean Union\nHMPC-Monographies European PharmacopoeiaRegulation oftherapy Regulation ofherb qualityRegulatives formedicinalherbs\n\u00a9 Council ofEurope 2020Quality requirementsforpharmaceuticals\nSpecifiedin national andinternational pharmacopoeiae\n\u00a9 picturealliance/Jochen TackQuality requirementsforpharmaceutical drugs\nSpecifiedin national andinternational pharmacopoeiae\n\u201cA compendium of texts on the qualitative and \nquantitative composition of medicines and on the \ntests to be carried out on medicines, on the raw \nmaterials used in the production of medicines \nand on the intermediates of synthesis.\u201d\nSource: European Medicines Agency, www.ema.europa.eu\n\u2192 These textsarecalled\u201emonographs\u201cTest specificationsin monographsare\nassignedtothreequalityattributes:\n\u2022Identity \n\u2022Purity\n\u2022Assay (Content)\nMonographExample: Specificationsin Pharm. Eur\nmonograph\u201eThymi herba\u201c\nIdentification\nA \u2013Macroscopicexamination\nB \u2013Microscopicexamination\nC \u2013Thinlayerchromatography\nD \u2013Content ofthymoland carvacrolin essential oil\n(gaschromatography)\nPurity(\u201eTests\u201c)\nForeignmatter: Maximum 10 % stems, 2 % otherforeign\nmatter\nWater: Maximum 100 ml/kg\nTotal ash: Maximum 15 %\nAsh insoluble in HCl: Maximum 3,0 %\nAssay\nContent ofessential oil: Minimum 12 ml/kg\nSumofthymoland carvacrol: Minimum 40 % ofessential oil\u2022Macroscopicexamination\nIdentification\n\u00a9 Heilpflanzenatlas.de\u2022Macroscopicexamination\nIdentification\n\u00a9 B. Rahfeld, Mikroskopischer Farbatlas pflanzlicher Drogen\n21\n31\n2\n3\u2022ExampleThymi herba: Exclusionof Thymus \nserpyllum/T. pulegioidesIdentification\n\u201eLeaves with long trichomes at their base and with weakly\npubescent other parts are absent\u201c\n\u00a9 wilde-planten.nl\u2022Microscopicexamination\nIdentification\nCharacteristicstructuresaredisplayedin \nthemonographand havetobefoundin \nthesample (e.g. glandulartrichomes, \nstomata, epidermiscells, pollen\u2026)  Microscopy: Leaves\nTrichomes(\u201ehairs\u201c)\n\u2022non-glandular\n\u2022glandular\nEpidermis withstomata\nCrystal cells\n(e.g. Hederaefolium)\nIntercellularcavities\n(e.g. schizogenic/lysogenic\noilglandsin Eucalyptifolium)\nPictures: \u00a9 B. Rahfeld/Springer Verlag\nMicroscopy: Flowers\nOftencharacteristic\ntrichomeson calyxor\ncorolla\nEndothecium(= inner\nlayerofstamina)\nPollen\nPictures: \u00a9 B. Rahfeld/Springer VerlagMicroscopy: Roots\nArrangement ofvessels\n(xylem) in crosssection\nVessels(tracheae) withpits\n(longitudinal section)\nCrystal cells\nStarch\nPictures: \u00a9 B. Rahfeld/Springer Verlag\u2022Thinlayerchromatography\nIdentification\nChromatography: Separation ofmixturesintocomponentsbasedon their\nrelative distibutionbetweena mobile phaseand a stationaryphase.\nPicture: \u00a9MZ-Analysetechnik, http://mz-at.deMobile Phase \n(solvent)Mobile Phase \nsoakedupwardsDrug extractsStationary\nPhase (Silica)\nSeparation of\ndrugextractsThinlayerchromatographyofthyme\n2 redfluorescent\nzones\n1 bluefluorescent\nzone\n1 or2 blue\nfluorescentzones\n2 yellowor\norange \nfluorescentzonesLanes 1 + 3: Drug samples\nLane 2: Reference solution\nRosmarinicacid\nRutoside\nZone ismissing!\n\u2192 batchdoesn \u00b4tcomply!Purity\nCommon tests for purity in medicinal herbs:\n\u2022Loss of drying (drying cabinet)\ndetermination of residual moisture\n\u2022Thinlayerchromatography\ne.g.detection of L.x intermedia in Lavender\n\u2022Ash/Acid-insoluble ash\ngravimetric determination of anorganic\ncontamination (sand)\n\u2022other tests\n(macroscopic, microscopic, solubility\u2026)\nAdvanced purity examinations:\n\u2022Gaschromatography(GC)\ne.g.detection of \u201cother varieties\u201d of Lavender \nby examination of the essential oil\nSpecial puritytestin Ph.Eur. monographLavandulaeflos:\nExclusion of \u201cOther species and varieties of lavender\u201d \n\u2192 Gas chromatography\n\u00a9 ShimadzuScientific InstrumentsLavandulaangustifolia\nExclusion of \u201cOther species and varieties of lavender\u201d \n\u2192 6 Compounds havetobedetected in thesample;  Assignmentofpeaksto\ncompounds accordingtoretentiontimesdeterminedfromstandardssolution= an analysis done to determine the \npresence and/or amount of a \nsubstance of content associated with \nthe therapeutic effect of a drug\nAssayAssays in selectedmedicinalplants fortherespiratoraltract\nPlant Target ingredient* Assay (Method)\nEucalyptus globulus\nEssential oilSteam distillation(Pharm. \nEur. 2.8.12)Filipendulaulmaria\nLavandulaangustifolia\nMentha piperita\nPimpinellaanisum\nSalvia officinalis\nThymus vulgaris\nAlthaeaofficinalis\nPolysaccharidesSwellingindex\n(Pharm. Eur. 2.8.4) Cetrariaislandica\nEchinacea sp. Hydroxycinnamicacidderivates HPLC\nGlycyrrhizaglabra Glycyrrhyzicacid HPLC\nHedera helix Hederacosid HPLC\nPlantago lanceolata Hydroxycinnamicacidderivates UV/VIS -Spectroscopy\nPrimula sp. Saponines NoAssay\nRosa canina Ascorbicacid UV/VIS -Spectroscopy\nSambucus nigra Flavonoids UV/VIS -Spectroscopy\nTiliasp. Flavonoids, Polysaccharides NoAssay\n*mostlyamongothertherapeuticallyactiveingredientsQuantificationofessential oilin herbaldrugs\n(Ph. Eur.)\nwateressential oilSwelling index\nAssay\n\u2192CapacityofswellingindicatescontentofpolysaccharidesUV/VISspectroscopy\nAssay\nD\nUV/VIS -BeamDispersion unit\nMonochromatorSample \nDetector\n\u2192Quantificationofsubstancebygrade ofabsorptionUV/VISspectroscopy as assay in drugs for the respiratoral\ntract (examples)\nAssay\nDrug Target substance\nPlantaginis\nlanceolataefoliumHydroxycinnamic\nacidderivates\nRosae\npseudofructusAscorbicacid\nSambuciflos Flavonoids\nPictures: WikipediaHPLC (High pressure liquid chromatography) \nAssay\npressure\nDpumpsample \nsolution\ninjectorpackedcolumndetector\nsolvent\nchromatogramHPLC (High pressure liquid chromatography) \nAssay\n\u00a9 agilent.comHPLC as assay in drugs for the respiratoraltract \n(examples)\nAssay\nDrug Target substance\nEchinaceaepallidaeradix Echinacosid\nEchinaceaepurpureae\nherba/radixCaftaricacidand\ncichoricacid\nGlycyrrhizaeradix Glycyrrhizicacid\nHederaehelicisfolium Hederacosid\nPictures: Wikipedia\u2022Toxicresidues\n\uf02dPesticides\n\uf02dHeavy metals\nContaminantsin medicinalplants\n\u2022Microbiological contamination\n\uf02dBacteria, yeasts, molds\n\u2022Mycotoxins\n\uf02dAflatoxins, ochratoxin\n\u2022Pyrrolizidinealkaloids\n\uf02dHepatotoxiccompounds occurringin severalplant \nfamilies(Asteraceae, Boraginaceae,\u2026)  Pyrrolizidinealkaloids\n\u2022Hepatotoxiccompounds, potentially\ncarcinogenic\n\u2022Producedbyseveralgeneraof\nAsteraceae, Boraginaceae, Fabaceae\u2026\n\u2022Contaminationofherbalmedicinesby\nco-harvestingofPA-containingplantsPyrrolizidinealkaloids\n\u2022Recommendation of1 \u00b5g maximum dailyintakeofPA from\nherbalmedicinal products\n\u2022Austria: Measuresrestrictedto12 plants ofhigherriskStrategiesforqualityimprovement\n\u2022Procurement/Cultivation/Collection\n\uf02dEstablishment oflongterm-cooperationand communicationwith\nreliable retailers/growers\n\uf02dGoodAgriculturaland Collection Practice (GACP)\n\uf02dAvoidingincorporationofforeignplant matter\n\u2192 Special vigilanceforPA-containingplants!\n\u2022Drying\n\uf02dFast dryingminimisesenzymaticdegradation(\u201ebrowning\u201c) and \nmicrobialgrowth, but: Not toohot Mildtemperature!\n\u2022Quality control\n\uf02dInspectionand examinationnot onlyofdeliveredbatches, but also \nofpreliminarysamples( \u2192 pre-selection )\n\u2022Clean-up\n\uf02d(Sieving, airseparation)Air separationClean-upofmedicinalherbs\nAir streamTransport ofplant materiallight particles\nheavy particlesAir separationClean-upofmedicinalherbs\ncollecteddiscard cleanedchamomille\nflowers\nAir separationClean-upofmedicinalherbs\n\u2022Cultivation, collection, harvest\nGoodagriculturaland collectionpractice, \nvigilanceforPA-containingplants\n\u2022Drying\nMinimisingenzymaticdegradationand microbialgrowth\n\u2022Clean-up\nSieving, airseparation, selectionbyhand\n\u2022Macroscopic/microscopicexamination\nOptical identification, inspectionofpurity\n\u2022Laboratory tests\nExamination ofidentity, purityand contentaccordingto\nPharm. Eur. \nQuality assuranceat severallevels\nThankyouverymuchforyour\nattention!www.donau-uni.ac.at\nTincture/\n galenics\n : \nEchinacea, Ginseng and \nAstragalus Plants for the Respiratory Tract and Phytotherapy \nas a Strategy against Antimicrobial Resistances\nMag. pharm. Verena Silberbauer 4/6/2022 Page 1\nwww.donau -uni.ac.at\nIntroduction\nMag. pharm. Verena Silberbauer 4/6/2022 Page 2www.donau -uni.ac.at\nEchinacea\noEchinacea purpurea herba and \nradix\noEchinacear pallida radix\noEchinacea angustifolia radix \noAsteraceae \n(Polysacch ., Glycoprotein etc. )\n\u2022Traditinoal effects TCM:\n-Clears heat and wind- heat\n-Counteracts to toxic heat\n-Mildly sweaty\n-Tonifies Spree -Qi\n-It diverts heat over skinGinseng\noPanax Ginseng, Radix \noAraliaceae\noGinsenosids (Saponins)\noInteracts with corticosteroids \u2013\nincreases effectiveness;\ninfluences blood coagulation\n4/6/2022 Mag. pharm. Verena Silberbauer Page 3www.donau -uni.ac.at\nTincture\nMag. pharm. Verena Silberbauer 4/6/2022 Page 4\nwww.donau -uni.ac.at\nMag. pharm. Verena Silberbauer 4/6/2022 Page 5\u2022Videowww.donau -uni.ac.at\nHealth Claims\nMag. pharm. Verena Silberbauer 4/6/2022 Page 6\nwww.donau -uni.ac.at\n\u2022on the very first sight of a cold or an infection\n\u2022strengthen the bodies' defences through increasing the production of \nantibodies and pushing the activity of the immune cells\n\u2022Support the body in it\u2019s mission to defend from pathogens\n\u2022Eleva ting the resilience \n\u2022To tonic, strengthen at defence weakness, allergic reactions, Herpes \nsimplex etc.Indication\nMag. pharm. Verena Silberbauer 4/6/2022 Page 7www.donau -uni.ac.at\n\u2022Astragalus membranaceus , Faboidaea , \nFabaceae\n\u2022Radix Astragali Membranacei\n\u2022Mongolia and northern ChinaAstragalus, Tragant\nMag. pharm. Verena Silberbauer 4/6/2022 Page 8\nwww.donau -uni.ac.at\nComponents \n\u2022Astragaloside 1 to 7\n\u20224 \u2013Hydroxy \u20133 \u2013\nMethoxyisoflavon 7-sug\n\u2022Astraisoflavan\n\u2022Astramembranagenin\n\u2022Astraapterocarpan\n\u2022Betasitosterol\n\u2022Betain\n\u2022Formononetin\n\u2022GABA\u2022Isoastragaloside 1, 2 and 4\n\u2022Isoliquiritigenin\n\u2022Linol acid\n\u2022Linolen acid\n\u2022Soyasaponin, 1\n\u2022Kumatakenin\n\u2022Cholin\n\u2022Dihydroxy \u20137,4 \u2013Dimethyl \u2013\nIsoflavone, 3\u2019 \u2013\nHydroxyformononetin\n\u2022Selenium, Calcium, Folic acid, \nCupper, Iron, Magnesium, \nManganese, Potassium, Sodium \nand Zinc\n4/6/2022 Mag. pharm. Verena Silberbauer Page 9www.donau -uni.ac.at\nTraditional use\n\u2022Immune deficiency\n\u2022Allergic symptoms\n\u2022tonic for spleen, lung and blood in general\n\u2022Against shortness of breath\n\u2022to drainage in oedema\n\u2022to strengthen the mother after giving birth\n\u2022\u2026 \n4/6/2022 Mag. pharm. Verena Silberbauer Page 10\nwww.donau -uni.ac.at\n\u2022Adaptogen\n\u2022Antibacterial\n\u2022Antihepatotoxic\n\u2022Antiviral\n\u2022Supports the function of \nlung, spleen, stomach and intestineShortfacts Tragant\nMag. pharm. Verena Silberbauer 4/6/2022 Pag\ne 11\u2022Hypotensive\n\u2022Immune boosting\n\u2022Immunomodulating \n\u2022Immune Regenerating\n\u2022Cardioprotectivewww.donau -uni.ac.at\n\u2022Immunomodulating \u2013decreases the \ndistribution of stress hormones and \nincreases the stress resistance\n\u2022Improves symptoms at allergic rhinitis \n(Lectranal gains popularity in \nsuccessfully treating allergic patients at \nleast in Austria)\n\u2022Immune boosting \u2013pushes the \nunspecific and humoral immunity\n\u2022Immune boosting as it contains a high \nlevel of selenium\n\u2022It increases the production of \nAntibodies, die Natural Killer Cells, T -\nCells and the Scavenger CellsEffects Tragant \nMag. pharm. Verena Silberbauer 4/6/2022 Pag\ne 12\u2022Anti -inflammatory\n\u2022Supports the maturation of \nErythrocytes in medulla and therefore \nsustains the red blood cell count\n\u2022Increases the level of adiponectin -\nthe sensitivity of insulin is improved\n\u2022Astragalosides (Saponins) enhance the \ncontractile force of the heart\n\u2022Antioxidant -preventive attributes \nwith cancer or cardiovascular diseases www.donau -uni.ac.at\n\u2022All kind of states of exhaustion\n\u2022Immune deficiency \n\u2022Allergic rhinitis\n\u2022Convalescence after giving birth\n\u2022In addition to chemo therapy -\nstimulates T \u2013Cells\n\u2022In oedemas and haemorrhoids \n\u2022Psoriasis \u2013 it reduces inflammatory \nfactors in skin cells and also make \nlesions fade faster\n\u2022Diabetes mellitusApplication Tragant\nMag. pharm. Verena Silberbauer 4/6/2022 Pag\ne 13\u2022Anaemia -for at least four months\n\u2022Benefits in liver and kidney issues\n\u2022High Blood Pressure \n\u2022Atherosclerosis\n\u2022Angina Pectoris\n\u2022Athletes benefit from the Yang and \nQi \u2013empowerment of strength and \npersistencewww.donau -uni.ac.at\n\u2022Pubmed lists nearly 11000 studies (03/2022)\n\u2022Safe and beneficial impact of Echinacea, Ginseng and Astragalus in \ncontribution while cancer therapy\n\u2022Effective in immune stimulation: with heart and cancer patients \ncould be found that Tragant increased CD4+, decreased CD8+, and \nsignificant raised the ratio of CD4:CD8\n\u2022Heart disease: benefits symptoms of angina pectoris , shortness \nof breath and the function of the left ventricle . 92 Patients with \nischemic heart disease benefited more from Astragalus treatment \nthan of NifedipinLiterature\n4/6/2022 Mag. pharm. Verena SilberbauerPag\ne 14www.donau -uni.ac.at\n\u2022Anti -inflammatory effect : by blocking NFK \u2013B Signal way and\nblocking effects of IL -1. Astragalosid IV inhibits histamine induced \nincrease of microvascular permeability. Lowered capillary \nhyperpermeability\n\u2022beneficial contribution on Fatique Syndrome: a controlled double \nblinded study could significantly improve Fatique \u2013Scores\n\u2022Neurologic effectsLiterature\n4/6/2022 Mag. pharm. Verena Silberbauer Pag\ne 15www.donau -uni.ac.at\nTragant\nSide effects and \ncontraindication\n\u2022Noside effects reported\n\u2022Must no be used in late progress \nof lyme -disease or transplant \npatients\n\u2022Must not be used with feverDrug interaction\n\u2022Synergistic impacts :\n\u2022Increase effects of Interferon \nand Aciclovir\n\u2022Inhibitory effects: \n\u2022the efficiency of \nCyclophosphamid (a zytostatic\nagent) could be reduced\n\u2022Interactions :\n\u2022synergistically enhances the immune stimulating effects when combined with Echinacea and Licorice root\n4/6/2022 Mag. pharm. Verena Silberbauer Page 16", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}